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Abstract 
Transcriptional regulator protein family members Activator Protein-1 (AP1) bind to their target 
site TGAC/GTCA during the normal cell cycle. Their over-expression is linked to the initiation of 
cancer. Regulating cFos and cJun interactions with AP1 binding sites is a potential cancer 
therapy strategy. How the proteins find their target sites and whether non-specific DNA binding 
occurs will be investigated. The Protein Fragment Complementation Assay (PCA) derived 
inhibitor FosW is also capable of interfering with its target cJun. To study these proteins, DNA 
tightropes were created where single strands of λ, pUC19, pUCap1 and target-free λ (TFλ) DNA 
were suspended above the surface of a glass coverslip on 5 μm high pedestals. Oblique Angle 
Fluorescence (OAF) microscopy was used to image Quantum dot (Qdot) conjugated proteins in 
vitro.  
The protein combinations cFos:cFos, cJun:cJun, cFos:cJun, FosW and FosW+cJun (Mason et 
al. 2006, Worrall and Mason 2011) were studied interacting with the different DNA substrates 
and within the AP1 family. 71 ± 3.1% cJun:cJun, 53 ± 6.1% cFos:cJun heterodimers diffused 3-
Dimensionally and 1-Dimensionally along λ DNA, indicating this is a crucial part of their search 
mechanism. Surprisingly, cFos is capable of dimerising, a previously unseen observation. 45 ± 
3.7% of these cFos:cFos homodimers also diffused 3-Dimensionally  and 1-Dimensionally. 
Diffusion decreased when the proteins interacted with pUC19 and pUCap1 and cJun only 
showed 3 ± 1.5% movement on TFλ, an unexpected observation.  
The interaction between FosW and cJun:cJun indicated clear interference with cJun 
dimerization. 55 ± 11.0% FosW and 39 ± 11.0% FosW+cJun diffused 3-Dimensionally and 1-
Dimensionally. This was observed to occur directly on DNA and clarifies the mechanism of 
competitive inhibition and partner exchange in the AP1 family. This insight may significantly 
impact our understanding on how these proteins regulate transcription and help define new 
mechanisms of inhibition.   
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Chapter 1: Introduction 
Cancer researchers are constantly trying to understand the intricate mechanisms used by 
cancerous cells to ensure their survival, and to find specific treatments to combat cancer and 
save the lifes of those who suffer. This chapter looks at how single molecule techniques enable 
the direct visualisation of the AP1 transcription factors cFos and cJun as they interact with DNA 
tightropes.  
1.1: What is cancer? 
Cancer, also referred to as malignant tumours and malignant neoplasms, is a generic term used 
to describe a collection of diseases that are caused by abnormal cellular growth that can occur 
within any part of the body. To date, over 100 different types of cancer have been found and it is 
crucial to understand the links between these cancer types (Kandoth et al. 2013). All types of 
cancerous cells are heterogeneous, meaning they are diverse in character and content. In most 
instances there are various mechanisms in place to promote their survival, such as increased 
cellular proliferation and the suppression of apoptosis due to mutations within the signalling 
cascade. This leads to the expansion and invasion of cancer within the body (Evan and 
Vousden 2001).  
Throughout the last seventy years, researchers have been trying to provide a precise rationale 
for the pathogenic mechanisms causing cancer (Klausner 2002). This poses a significant 
challenge for cancer research as it is important to understand each molecular step within the 
different processes that influence cancer initiation and its survival. Understanding the molecular 
fingerprint of different types of tumours can help with the development of target specific 
therapies (Evan and Vousden 2001, Cairns et al. 2011).  
1.2: The role of cFos and cJun in cancer 
Within the mammalian genome, the activation of a vast array of genes requires a combination of 
interactions between multiple transcription factors within specific promoter and enhancer 
regions  that are located along the DNA (Hager et al. 2009, Champe et al. 2005, Lemon and 
Tjian 2000).  
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The transcription factors Fos and Jun are present within mammalian eukaryotic cells (Eferl and 
Wagner 2003). As proto-oncogenes, Fos and Jun encode functional proteins that prevent 
apoptosis, promote cell division and inhibit cellular differentiation, all of which are necessary for 
growth and development. However, if mutations occur within the proto-oncogenes, oncogenes 
develop; stimulating normal cells to become cancerious due to an increase in cell division, 
reduction in cellular differentiation and the prevention of apoptosis (Chial 2008). 
Interest in these particular transcription factors primarily arose due to the discovery of the viral 
oncoproteins v-Fos and v-Jun that were identified within the chicken retroviruses avian sarcoma 
virus ASV17 and Finkel-Biskis-Jinkins osteosarcoma, respectively (Latchman 1995, van Dam 
and Castellazzi 2001). Fos and Jun were identified as their cellular counterparts (Shaulian and 
Karin 2001). As members of an AP1 family that are a class of DNA binding proteins (Vinson et 
al. 1993), Fos and Jun were originally identified in the 1980’s (Bohmann et al. 1987). This family 
contains an array of proto-oncogenenic transcription factors consisting of 9 homologues. These 
are Fos (cFos, FosB, Fra-1, Fra-2) and Jun (cJun, JunB, JunD) (Rajaram and Kerppola 1997, 
Hai and Curran 1991, Angel and Karin 1991). Even though there is a high level of sequence 
homology, each AP1 functional protein has different transcriptional properties and biological 
effects that can modulate normal, healthy physiological functions (Nakabeppu and Nathans 
1989, Leaner et al. 2003). These include cellular differentiation, proliferation and apoptosis 
(Jochum et al. 2001, Shaulian and Karin 2001, Santarpia et al. 2012). Under “normal 
circumstances,” cFos has an important role in coordinating the function and differentiation of 
osteoclasts and osteoblasts, the two main bone tissue cell types. This occurs when the 
osteoclastogenic ligand RANKL, a Tumor Necrosis Factor (TNF) family member necessary for 
osteoclast differentiation becomes tightly regulated. This occurs when cFos specifically targets 
and induces RANKL genes within precursor osteoclast cells that are expressed via interferon 
α/β signalling (Wagner 2002). cJun can also promote the proliferation of cells via the cell cycle 
and differentiation in cell lineages such as myloid, epithelial, hepatic and epidermal cells (Leppä 
and Bohmann 1999, Das et al. 2011, Zhang et al. 2006). 
3 
 
However, when cells within these cell lineages become cancerous, they present six distinct 
hallmarks (Hanahan and Weinberg 2011, Frémin and Meloche 2010). Firstly, maintaining 
proliferative signalling; this occurs when cancerous cells disable their senescence or apoptotic 
circuitry due to adapting to high levels of oncogenic signalling, resulting in increased cell 
proliferation and tumour growth. To sustain proliferation and growth, the oncogenic signalling 
between cancerous cells evoke maximum mitogenic stimulation while at the same time avoiding 
antiproliferative defences incurred by the cell cycle. Such hyperproliferation incurs DNA damage 
(Collado and Serrano 2010, Hanahan and Weinberg 2011). Secondly, growth suppressors 
avoidance; the TP53 protein that is responsible for triggering apoptosis downstream in the cell 
cycle in response to extracellular signalling such as stress becomes inactivated in cancerous 
cells (Hanahan and Weinberg 2011). Thirdly, invasion and metastasis activation; this occurs 
due to the suppression of TP53’s tumour suppressing function, enabling cancerous cells to 
avoid the apoptotic circuitry within the cell cycle using anti-apoptopic mechanisms. Signalling 
within the cancerous cell population may promote the production of malignancies followed by 
metastasis where part of the tumour disseminates and travels to other organs around the body 
via blood vessels (Muller et al. 2011, Hanahan and Weinberg 2011, Muller et al. 2009). 
Fourthly, enabling immortal replication; typically there are two barriers imposed by the cell cycle 
which limit the number of cells that are able to grow and divide via the cell cycle. The first barrier 
is senescence, resulting in cells remaining viable but unable to proliferate. The second barrier is 
termed crisis, resulting in cell death. However there are occasions when cells overcome these 
two barriers, emerging from the crisis stage while displaying unlimited replication, resulting in 
cells becoming immortal and forming tumours (Hanahan and Weinberg 2011, Shay and Wright 
2010). 
Fifthly, causing angiogenesis; for tumours to grow like regular tissue, they also require oxygen, 
nutrition and be able to remove metabolic waste and carbon dioxide. To achieve this and assist 
with growth, the tumour induces new blood vessels by angiogenesis to develop from existing 
vessels via angiogenic regulator signalling proteins that bind to surface receptors located on 
vascular endothelial cells. Without angiogenesis, tumours could not grow or metastasise to 
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other organs around the body (Carmeliet and Jain 2000, Tonini et al. 2003, Duffy et al. 2008). 
Sixthly, cell death resistance; apoptosis is a natural barrier imposed by the cell cycle in order to 
avoid cancer progression. This occurs when apoptosis is regulated by effector components both 
upstream and downstream of the cell cycle. Balancing pro-apoptotic triggering proteins such as 
Bax and Bak and anti-apoptotic Bcl-2 family members helps control apoptosis. When this 
balance becomes disrupted, Bax and Bak promote the release of cytochrome c, a pro-apoptotic 
protein, from a cells mitochondrial outer membrane that activates proteolytic cascade that is part 
of the apoptotic program. In addition, oncoproteins such as Myc can also trigger apoptosis via 
hypoactive, oncogenic signalling (Zhang et al. 2013, Hanahan and Weinberg 2011). 
The AP1 family members cFos and cJun are known to implement tumorigenesis due to their 
over-expression and how this occurs is still under investigation (Eckhoff et al. 2013, Leaner et 
al. 2003, Hamacher et al. 2013). During tumorigenesis, cFos mediates the manifestation of 
malignant osteosarcomas and connective tissue neoplasms due to the transformation of 
chondroblasts and osteoclasts, causing tumorigenesis within these two different cell lines (Eferl 
and Wagner 2003, Karin et al. 1997, Wang et al. 1995). cJun mediates hepatocellular 
carcinoma which is the proliferation of hepatocytes within the liver (Das et al. 2011, Fausto 
1998). Non-melanoma type skin cancer such as sqaumous cell carcinoma, a malignancy of the 
epidermal keratinocytes is also mediated by cJun (Zhang et al. 2006). Examples of these 
different cancer types are shown in Figure 1. 
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Figure 1: Images showing the effects of tumorigenesis initiated by over-expressed cFos and cJun. (a) X-
ray of a knee showing osteosarcoma (McFadden 2002) that is caused by the over-expression of cFos. (b) 
Computerised tomography scan showing hepatocellular carcinoma. This is indicated by the arrow 
(Hinshaw. J. L. et al. 2012). Hepatocellular carcinoma can be caused by over-expressed cJun. (c) 
Squamous cell carcinoma (Healthwise 2008) can also caused by the over-expression of cJun. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a b c 
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The proliferation and differentiation of healthy and tumorigenic cells occurs using different 
signalling pathways. In the case of cFos and cJun, the cell cycle becomes initiated through the 
mitogen-activated protein (MAP) kinase cellular signalling pathway (Figure 2) (Shaulian and 
Karin 2001, Brown 2007). The Ras protein, a member of the GTPase family, is a regulator of 
cellular growth within this signalling cascade (Downward 2003). Ras functions as a molecular 
switch, transmitting signals downstream to effector molecules, resulting in gene transcription. 
However, mutated Ras has also been reported in some types of cancer, whereby the signalling 
cascade is permanently on due to mutated Ras (Santarpia et al. 2012).  
The transcription factors cFos and cJun become activated downstream from Ras at the closing 
stages of the MAP kinase pathway and regulate gene expression by controlling the rate of 
transcription (Whitmarsh 2007). This occurs by cFos and cJun binding to specific AP1 target 
sites (Angel et al. 1988, Brown 2007, Hager et al. 2009, Simonson et al. 1992, Nakabeppu and 
Nathans 1989), also known as a TPA (12-O-Tetradecanoylphorbol-13-acetate) response 
element (TRE), and this is characterised by the seven base pair, palindromic recognition 
sequence TGA 
 
 
TCA (Nakabeppu and Nathans 1989, Simonson et al. 1992, Angel and Karin 
1991). This is a potent tumour promoter and regulator of biological responses that include 
cellular proliferation and apoptosis (Shyy et al. 1995, Eferl and Wagner 2003, Angel and Karin 
1991). Homologous to Fos and Jun is the yeast transcription factor GCN4 (Nakabeppu et al. 
1988, Ellenberger et al. 1992). Unlike cFos and cJun, GCN4 can activate transcription in 
Saccharomyces cerevisiae yeast cells upon binding to its target sequence: TGACTC (Oliviero et 
al. 1992, Arndt and Fink 1986).  
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Figure 2: A cartoon diagram outlining the Map Kinase Pathway (adapted from (Frémin and Meloche 
2010)). When the Epidermal Growth Factor (EGF) binds to the extracellular portion of the ligand receptor 
tyrosine kinase, causes the receptors two subunits to dimerise. The intracellular portions of the receptors 
catalyse self phosphorylation, enabling the binding of GRB2 (Growth Factor Receptor-bound protein-2). 
SOS (Son of Sevenless) can then bind onto GRB2 and the membrane bound protein Ras which is 
inactivated due to its GDP state.  Ras activates upon catalysing GDP to GTP and can bind to proto-
oncogenic effector protein, B-Raf, which in turn phosphorylates the kinases Mek1/2 which phosphorylate 
the kinases ERK 1/2. These kinases activate Fos and Jun that bind to their AP1 target site, enabling them 
to exert their biological function, such as cell proliferation. To inactivate GTP bound Ras, GAP (GTPase-
Activating protein) assists with GTP hydrolysis to GDP, therefore turning off the MAP Kinase signalling 
pathway (Frémin and Meloche 2010, Weinberg 2007 ). 
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cFos and cJun’s AP1 target sites are located within promoter regions along DNA that are 
adjacent to the genes they regulate (Chinenov and Kerppola 2001). Chromatin is the form in 
which eukaryotic DNA is packed into cells. The nucleosome is the basic unit of chromatin and is 
composed of two copies of four globular core histones: H3, H4, H2A and H2B that are wrapped 
with 147 bp of DNA (Kouzarides 2007, Shogren-Knaak et al. 2006). For transcription to occur, 
the DNA and its sequence-specific sites must become accessible to transcription factors, 
however, when chromatin is in a non-modified form, it represses transcription. To activate 
transcription, the chromatin must become available to the transcription factors  (Narlikar et al. 
2002). Histone modifying processes such as; acetylation which decreases interactions between 
internucleosomes and alters electrostatic charge and methylation which recruits proteins that 
require access to DNA without influencing electrostatic charge. This will cause the N-terminal 
histone tails to extend outwards from the nucleosomes core, enabling the DNA to become more 
accessible to transcription factors. In addition, modifications to histones can also alter  the 
structure of the nucleosome and this contributes towards increasing DNA accessibility (Sims et 
al. 2003, Berger 2007). 
The start of the transcription cascade occurs at the focus core promoter and commences when 
RNA is synthesised from a DNA template using RNA polymerase II machinery. However, for 
RNA polymerase II to recognise this promoter, it requires basal transcription factors such as; 
TFIID (Transcription Factor for RNA polymerase II D) which recognises focus core promoters, 
binding to the TATA promoter element deforming promoter DNA and recruiting TFIIA and TFIIB. 
TFIIA helps to stabilise TFIID DNA-binding, blocks transcription inhibitors and promotes positive 
and negative gene regulation. TFIIB assists with recruiting RNA polymerase II to the focused 
core promoter while helping to fix transcriptions starting site (Juven-Gershon and Kadonaga 
2010). When TFIID, TFIIA and TFIIB form a stable complex, this phosphorylates RNA 
polymerase II and TFIIF which is part of the RNA polymerase II initiation complex. In parallel, an 
activated complex forms between TFIIE which binds the promoter near to the site of 
transcription and TFIIH which assists with keeping the DNA unwound and open. These basal 
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transcription factors enable the promoter to be clear, enabling RNA synthesis to take place 
(Juven-Gershon and Kadonaga 2010, Hahn 2004). This process has been shown in Figure 3. 
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Figure 3: A cartoon diagram showing an overview of the transcription initiation and re-initiation pathway 
for RNA polymerase II (adapted from (Hahn 2004)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
These two transcription factors have a significant role in controlling cellular responses to a 
variety of extracellular stimuli, such as bacterial/viral infections, extracellular stress signals and 
various cytokines and growth factors (Zenz et al. 2008). However, when cFos and cJun become 
over-expressed, pleiotropic changes to the cells occur, known as malignancies,  when the 
closely regulated stages of the cell cycle are no longer able to produce normal, healthy cells 
(Chow 2010). Cancerous cells are produced instead via the cell cycle. This occurs when the 
p53 gene responsible for tumour suppression becomes antagonised downstream, resulting in 
tumour cells being protected against apoptosis (Zhang et al. 2007, Weinberg 2007 , Evan and 
Vousden 2001). It has also been reported that when cJun initiates the proliferation and 
differentiation of cells within the MAP kinase pathway, the MAP kinase p38α, an important 
regulator of both cancer progression and cellular development, becomes activated due to auto-
phosphorylation events in response to cellular stress (Bradham and McClay 2006). 
1.3: The structure of cFos and cJun 
cFos and cJun are composed of amphipathic α-helical coiled coils  (Krylov et al. 1994). Located 
at one end of each coiled coil is the N-terminus. This contains a transactivation domain which 
enables chromatin to decondense downstream causing a transcription initiation complex to be 
established (Landschulz et al. 1988, Moras and Gronemeyer 1998). The basic region contains a 
DNA binding recognition sequence and a leucine zipper region that brings the two α-helical 
coiled coils together. These are located at the C-terminus at the other end of the coiled coil 
(Vinson et al. 1993, Mason et al. 2006). This structure is shown in Figure 4. 
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Figure 4: A diagram showing a cFos:cJun heterodimer that has bound to DNA (Glover & 
Harrison, 1995 (PDB access number 1FOS)).  
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As cFos and cJun dimerise via the leucine zipper interface of each α-helical coiled coil (Kohn et 
al. 1997, Viadiu and Aggarwal 2000, Ellenberger et al. 1992), they form a left-handed, super-
helical conformation (Burkhard et al. 2000). This unique characteristic occurs due to the 
continuous contact of the hydrophobic amino acid residues present within each α-helical leucine 
zipper region (Abate et al. 1991), forming tightly bound homodimeric or heterodimeric 
complexes due to their juxtaposed basic regions (Chen et al. 1998). The most common coiled 
coil structure is a left-handed supercoil that contains two right-handed α-helix that have wrapped 
around each other (Lupas and Gruber 2005, Mason and Arndt 2004, Nakabeppu et al. 1988, 
Landschulz et al. 1988, Vinson et al. 1993). This occurs when side chains within the cores 
adopt their designated positions turn by turn, resulting in 3.6 residues per turn being reduced to 
3.5 residues, the equivalent of 7 residues. This is known as a heptad repeat in a supercoiled 
structure (Lupas and Gruber 2005). This heptad repeats at least twice along each α-helix 
(Landschulz et al. 1988) and has been described using the nomenclature ‘abcdefg’, as shown 
in Figure 5.  
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Figure 5: (a) Schematic diagram of a helical wheel. This shows the dimerisation of two α helices through 
hydrophobic interactions between residues in position a (typically asparagine) and position d (leucine). 
Residues such as glutamate, glutamine, lysine and arginine are located within positions e and f. These 
maintain structural stability via ionic interactions. Positions b, c and f contain hydrophilic residues, 
however their function remains unknown. Cited from (Mason and Arndt 2004). (b) A sequence alignment 
diagram showing the amino residue sequences of cFos, cJun and the antagonistic peptide inhibitor FosW 
(adapted from ProteinSynthetics). The DNA binding region of cFos has been highlighted in orange. cJun 
and FosW DNA binding regions are identical and are shown in blue. These regions are highly enriched 
with arginine (K) and lysine (R) residues. It is these residues that form an electrostatic interaction with the 
DNA upon binding. Shown in purple are the peptides LZIP region containing a leucine (L) residue every 
7th residue. A tyrosine (Y) residue is present within all LZIP regions. This has been highlighted in pink. 
 
 
 
 
 
 
 
 
a 
b 
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During dimerisation, the two α-helix oligomerise through the hydrophobic residues that are in 
positions a and d within the hydrophobic core (as seen in Figure 5). Predominantly, evolutionary 
conserved leucine is favoured within position d and these are aligned along the dimerisation 
interface within cFos and cJun (van Dam and Castellazzi 2001, Mechta-Grigoriou et al. 2001, 
Wagner 2001). As the core is slightly solvent exposed, having hydrophilic asparagine, a 
conserved residue in position a helps maintain the structures stability (Woolfson and Alber 
1995, Arndt et al. 2000). This is in keeping with Crick’s (1953) conventional ‘knobs in holes’ 
pattern along the dimerisation interface, ensuring that these hydrophobic residues remain 
unexposed to the external solvent (Crick 1953). Therefore, hydrophobic interactions occur when 
the residue in position a on one α helix directly interacts with position a on the opposite α helix. 
This interaction also occurs between residues in position d which have a major role in 
oligomerisation (Woolfson and Alber 1995).  
Originally, Landschulz et al (1988) proposed that cFos and cJun can both homodimerise and 
heterodimerise. It is now thought that cFos can only form a stable heterodimer with cJun, 
whereas cJun can also homodimerise (Hai and Curran 1991, Ito et al. 2001). Upon dimerisation, 
cFos and cJun form a transcriptionally active, classic AP1 complex (Leaner et al. 2003) that can 
bind onto their AP1 target sites located on the major grooves of the DNA backbone (O’Neil et al. 
1990). For DNA binding to occur, the proteins DNA binding domain, enriched with arginine and 
lysine amino residues (Olive et al. 1997, Talanian et al. 1990), enables specific base pair 
sequences along the double stranded DNA phosphate backbone to be recognised, such as the 
proteins specific target site sequence. These specific interactions are supported and stabilised 
by electrostatic interactions that occur between the negatively charged DNA phosphate 
backbone and the amino residues that surround the proteins target binding site (Von Hippel 
2004). 
However, DNA binding specificity can become complicated due to the occurrence of non-
specific binding events taking place between the protein and non-specific areas of the DNA. 
Works performed using the lac repressor have helped with understanding how DNA binding 
proteins use different mechanisms when binding non-specifically to DNA (Von Hippel 2004, 
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Riggs et al. 1970). These non-specific DNA interactions assist with the protein locating 
sequence specific target sites (Kalodimos et al. 2004). The more non-specific binding that 
occurs on DNA, the less free lac repressor, or other DNA binding proteins, remain in solution. 
The binding of proteins to non-specific regions of DNA is weaker than target site binding when 
under physiological salt concentrations. To stabilise the structural integrity of the proteins when 
non-specifically bound to the DNA, a net positive charge is created around the binding site only 
which orientates the protein while facilitating its recognition of the target site (Von Hippel 2004). 
Therefore, 1-Dimensional diffusion such as sliding and hopping will enable the protein to locate 
its specific target site (Von Hippel 2004).  
Glover and Harrison (1995) used X-ray crystallography to identify the actual structure of a 
bound cFos:cJun heterodimer to its AP1 target site, forming a protein-DNA complex. They 
showed that the DNA binding domain of cFos:cJun heterodimers can bind to the AP1 target site 
in any orientation and this has been supported by the work of others (Chen et al. 1995, Leonard 
et al. 1997, Glover and Harrison 1995).  
Due to cFos’ inability to form stable homodimers, it is believed that core residues within 
hydrophobic position a, such as hydrophobic isoleucine, hydrophilic threonine and basic lysine 
prevent cFos homodimerisation (Oliviero et al. 1992, Schuermann et al. 1989, Woolfson and 
Alber 1995). It is also thought that cFos:cJun heterodimers have a more stable core region than 
cJun homodimers (Halazonetis et al. 1988, Mason et al. 2006), however, the strength of this 
interaction within the cFos and cJun leucine zipper region still remains unknown (Newman and 
Keating 2003). 
1.4: The antagonistic peptide inhibitor FosW 
To overcome the tumorigenic effects of cJun over-expression, Fos Winner (FosW), an in vitro 
designed antagonistic peptide inhibitor, disrupts cJun homodimers with high specificity and 
affinity (Mason 2009). FosW is a member of a peptide library that contains many variations of 
cFos where residues within the dimerisation region were substituted to improve its stability. 
cFos was chosen due to its instability and has more scope for improvement when compared 
with cJun (Mason et al. 2006). This was selected using protein-fragment complementation 
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(PCA) assay (Remy et al. 2007), as shown in Figure 6, allowing in vitro protein-protein 
interactions to be determined . This assay is a biochemical process that enables the assembly 
and disassembly of protein complexes via protein-protein interaction. To achieve this, two 
proteins of interest, known as protein X and Y, are fused to a reporter protein, such as the 
enzyme dihydrofolate reductase (DHFR) that is composed of two complimentary fragments. If 
an interaction between proteins X and Y occur, this brings the two parts of the reporter protein 
together which then proceed to fold into its native structure, restoring its activity (Remy et al. 
2007). Therefore, in the case of cJun+FosW, the interaction between the coiled coils of FosW 
and cJun to form a heterodimeric complex mediates the full activation of DHFR enzyme when 
FosW+cJun form a stable heterodimeric complex with high specificity, prior to production inside 
Escherichia coli (E. coli) (Hagemann et al. 2008, Hager et al. 2009). 
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Figure 6: A cartoon showing the basic principle used during Protein Fragment Complementation Assay 
(PCA) (Remy et al. 2007). The enzyme dihydrofolate reductase is separated into two complementary 
parts which are each fused to a protein of interest, that is protein X (blue) and Y (red). When an 
interaction occurs between the two proteins, this brings the DHFR complementary parts together, 
activating the enzyme. 
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1.5: Biochemical and biophysical methods for probing protein-DNA interactions 
Before the study of individual proteins interacting with DNA using single molecule techniques, 
more traditional biochemical and biophysical methods were used to determine protein-nucleic 
acid interactions. Electromobility Shift Assay (EMSA) is one classic method used to detect 
protein-nucleic interactions (Hellman and Fried 2007, Orchard and May 1993). The nucleic acid 
used varies in size from short oligonucleotides to thousands of base pairs long and is 
radioisotope-labelled with 32P. This results in a highly sensitive assay being performed with 
either protein-DNA concentrations at <0.1 nM or sample volumes of <20 µL. If protein-nucleic 
acid complexes form, these will migrate more slowly through the gel matrix showing a mobility 
shift unlike free nucleic acid (Hellman and Fried 2007).  
Although EMSA provides quantitative results, this method also has further limitations, for 
example; the size of the protein interacting with the DNA determines how much mobility shift will 
be ascertained; proteins that rapidly dissociate from the DNA are not detected and proteins that 
slowly dissociate from the DNA results in their overall binding density being underestimated 
(Hellman and Fried 2007). Primarily, EMSA is a technique that formed the backbone of 
numerous protein-DNA interaction studies (Orchard and May 1993), but this methodology is 
potentially flawed by its inherent averaging and the forces experienced by the complexes as 
they travel through the gel matrix. When performed using cFos and cJun, EMSAs were only 
able to provide a bound protein-DNA ratio. Therefore it was concluded that cFos could not 
associate with DNA containing AP1 but cJun could form DNA-bound homodimers and 
heterodimers (Turner 1989).  
Filter binding assays are also used to determine protein-DNA interactions (Rio 2012). The basic 
principle uses a nitrocellulose filter to quantify the affinities between protein and radioactive 
labelled 32P-DNA. As the nitrocellulose paper is negatively charged, any unbound DNA will not 
adhere to the paper, however the paper will immobilise protein-DNA complexes due to the 
proteins having a positive net charge. The quantification of protein-DNA complexes immobilised 
on the paper can be determined, once the paper has been dried, using a scintillation counter 
(Shindo et al. 1993).  
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Another method used to determine protein-DNA interactions is isothermal titration calorimetry 
(Freyer and Lewis 2008, Keller et al. 2012). This physical technique is used to determine the 
thermodynamic parameters of molecular interactions taking place in solution between large 
macromolecules like protein and DNA. The heat generated from each reaction can be 
determined by an aliquot containing the protein that is injected into a sample cell containing the 
DNA. The more protein that is injected into the sample chamber, the more saturated the DNA 
becomes and the heat generated starts decreasing (Keller et al. 2012). Like the fore mentioned 
methods, ITC is able to quantify the amount of protein-DNA interactions that occurred within 
solution. Positive attribute to this method when compared with the filter binding assay and the 
EMSA is that there are no molecular weight restrictions as the reactions all take place in 
solution and Kd values are obtained without any radioactive labels (Milev 2013). 
From the data obtained from the fore mentioned techniques, dissociation constants (Kd) can be 
determined from the point at which half of the DNA appears bound with protein and the other 
half appears unbound (Heffler and Walters 2012). Alternatively, a more precise Kd can be 
determined by using ImageJ to quantify the fluorescent signal in each DNA band and plotting a 
graph showing the fraction of bound DNA protein against the concentration of 32P labelled DNA. 
The use of additional software can obtain the Kd from non-linear regression (Heffler and Walters 
2012, Shindo et al. 1993). All of these methods are able to provide a bound protein-DNA ratio, 
however they are unable to provide information about each individual protein that binds to DNA.  
1.6: Single molecule techniques 
The first single molecule study was performed using patch clamp experiments on ion channels 
in frog muscle fibres (Neher and Sakmann 1976). This work initiated a new wave of 
experimentalism that offered a new view of biological mechanism not shrouded by the cloak of 
averaging as single studies allow individual molecules to be studied. Now single molecule 
techniques enable the direct visualisation of individual proteins and the search mechanisms 
they use to locate their target sites as they move along DNA in real time (Hilario and 
Kowalczykowski 2010, Kad et al. 2010). This is important as it allows each protein’s movement 
and interaction with each other and with the DNA to be observed over long periods of time.  
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For proteins to be visualised, Quantum dots (Qdots) have become increasingly popular due to 
their high resistance to photobleaching and brightness (Wang et al. 2008). Their properties 
make them favourable over more traditional fluorescent labels, such as GFP (green fluorescent 
protein) that provide a much shorter photostable time (Bruchez et al. 1998, Leutwyler et al. 
1996). Another advantage of using Qdots is they have a broad excitation spectrum and multiple 
coloured Qdots can be imaged simultaneously to enable many systems to be studied within a 
single assay. However, like all experimental techniques, Qdots also have their limitations. When 
under continuous excitation by the laser beam the Qdots ‘blink’. The rationale behind this 
property is still not fully understood (Medintz et al. 2005).  
To visualise protein-DNA interactions, the DNA must be elongated since in solution it normally 
exists as a polymer globule. One technique uses magnetic tweezers where a DNA molecule can 
be manipulated and elongated by tethering one end to a superparamagnetic Dynabead and the 
other to a surface or another bead. This bead is made from crosslinked polystyrene that 
contains Fe2O3 and Fe2O4 and displays magnetic properties only when in the presence of a 
magnetic field (Zlatanova and Leuba 2003, Haber and Wirtz 2000). Using molecular tweezers is 
a particularly useful single molecule technique as it enables a single protein to bind and interact 
with a single piece of DNA. One disadvantage however is this method would be very time 
consuming while producing minimal data. 
The elongation and linearisation of DNA can also be achieved using DNA curtains. This 
technique involves one end of the DNA being anchored to a lipid bilayer that covers the surface 
of a flowcell (Granéli et al. 2006). The DNA remains linearised using a hydrodynamic force that 
orientates the curtains in the same direction as the buffer flow. Microscale diffusion barriers are 
etched into the flowcell to assist with keeping the DNA molecules aligned with respect to each 
other. This single molecule technique is useful as it allows the simultaneous imaging of 
approximately 100 bound proteins per DNA molecule, resulting in several hundred (or even 
thousands) of aligned DNA molecules being imaged within a single field-of-view (Song et al. 
2016, Fazio et al. 2008). Another positive attribute is that data can be acquired from thousands 
of individual molecules rapidly. However, the DNA curtains technique also has limitations. The 
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accumulation of DNA molecules along the edge of the microscale diffusion barriers occurs, 
compromising the quality of the visual surface and leads to the scattering of light during 
imaging. Some of the DNA molecules may be unevenly aligned and the field-of-view may also 
be inefficiently covered with DNA molecules and bound proteins (Fazio et al. 2008). 
Another technique used to elongate and linearise DNA is using a DNA tightrope approach. DNA 
is suspended 5 µm above the surface of a slide on silica bead pedestals coated in Poly-L-lysine. 
This technique allows the direct visualisation of individual fluorescently labelled Quantum dot 
(Qdot) conjugated proteins in real time and is useful for observing protein-protein and protein-
DNA interactions as there is no interference from artefacts adhered to the slides surface that 
can hinder protein movement (Hughes et al. 2013, Kad et al. 2010). The single molecule 
technique used in this study, the DNA tightrope approach, has provided an invaluable insight 
into how cFos, cJun and the biological peptide inhibitor FosW interact with each other and 
search the DNA for their targets. DNA tightropes have been used extensively with proteins from 
the Nuclear Excision Repair Pathway (Kad et al. 2010). cFos and cJun have never been studied 
using single molecule techniques before. 
Total Internal Reflection Fluorescence microscopy (TIRFM), as shown in Figure 7, offers a 
means to detect single molecules with improved signal to noise (Joo et al. 2008, Mattheyses et 
al. 2010). This imaging technique is useful when visualising material, such as cells, that are 
localised to the surface of a slide (Fish 2009).  
TIRFM uses an optical phenomenon where the light beam is refracted at a glass surface of a 
high refractive index meeting a solution of a lower refractive index. The refractive index is 
determined by how much an excitation light beam is deflected. In this case, the refractive index 
of the glass and water interface is determined by measuring the deflection of a light beam as it 
enters and leaves the glass and water interface at an angle, known as the angle of incidence 
(Fish 2009). This has been stated in Snell’s law whereby a line is drawn perpendicular to the 
mediums interface and the angle of incidence, θ1 is determined by the angle of which the light 
beam exits the medium, θ2. This is represented by the formula (Smith et al. 2004): 
Sin (θ1) = nsin(θ2) 
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It is the difference between the glass and water interface that determines the angle of incidence. 
In TIRFM, as the angle of incidence is raised so is that of the emergent refracted beam until it 
no longer propagates into the solution. This is known as the critical angle (Fish 2009) and at this 
point the laser beam is reflected back towards the source (Ishijima and Yanagida 2001, Pierce 
et al. 1997). A consequence of this geometry is that an evanescent field is produced 
approximately 50-200 nm above the reflecting interface in the solution, however  the intensity of 
this evanescent wave decreases exponentially the further the wave is from the glass 
(Mattheyses et al. 2010, Walter et al. 2008). This evanescent wave is determined by the 
incident illumination angle (Fish 2009). Primarily, TIRFM works by selectively illuminating the 
fluorescently labelled proteins that remain close to the interface surface within the evanescent 
field (Ishijima and Yanagida 2001). Fluorescently labelled proteins outside of this evanescent 
field are not excited by the light beam. According to Granéli et al (2006), this results in a 
significant reduction in background fluorescence signals (Granéli et al. 2006). TIRFM is 
therefore a suitable visualisation tool for analysing biological matter such as cellular membranes 
that are on the surface of the slide. This is due to high resolution images being generated at the 
flow cells surface with minimal background fluorescence (Mattheyses et al. 2010). 
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Figure 7: TIRFM imaging. TIRFM uses an evanescent wave that is generated when a beam of light, at a 
critical angle of 63°, is totally internally reflected at the glass-water interface. It is when this light beam 
encounters the interface between the glass and the slide that it becomes refracted by 90° in a direction 
parallel to the interface. This results in the illumination of fluorophores that are adjacent to the glass-water 
interface and within a 200 nm area above the surface. OAF microscopy, however, has its collimated light 
beam angled away from the critical angle. This results in the illumination of a thin section and the 
reduction in background noise. 
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When using TIRFM to visualise cellular material for example, fluorescently labelled molecules at 
a nanomolar range between 10-100 nM can be resolved at a sufficiently high signal/background 
ratio, ideally, one fluorescently labelled molecule per diffraction limit, the maximum angle at 
which the laser beam can be at before being totally internally reflected at the critical angle (van 
Oijen 2011, Geertsema et al. 2015). This nanomolar limit consequently decreases the amount 
of biomolecular interactions, resulting in dissociation constants (Kd) being within the nanomolar 
range or lower (Geertsema et al. 2015).   
TIRFM is a good technique to use when visualising cellular structures such as; cytoskeletons 
which are located near to the plasma membrane; the formation of endocytotic vesicles which 
assist with the recruitment of cytosolic proteins to the plasma membrane; secretory carriers can 
be visualised near the cell membrane and the visualisation of different types of intracellular 
signalling (Mattheyses et al. 2010). 
Oblique Angle Fluorescence (OAF) microscopy however is an alternative illumination strategy 
whereby a lens is used to defocus and steer the beam off the edge of the back aperture unlike 
in TIRFM as shown in Figure 8. This results in an inclined collimated beam of light that is less 
than the critical angle. OAF can image deeper in the experimental chamber unlike TIRFM (Kad 
et al. 2010). Unlike TIRFM, using OAF to image at a surface to visualise individual proteins may 
be problematic since a protein’s movement along DNA can be significantly hindered by 
interactions that occur on the surface, affecting their kinetic and dynamic behaviour. Raising the 
DNA platform, in the form of tightropes, away from the surface will reduce background 
fluorescence and the proteins can move without surface-induced artefacts. Any fluorescence 
within the focal plane does not occur due to fluorescently labelled proteins that may be attached 
to the surface, but from proteins bound to the DNA tightropes (Kad et al. 2010).  
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Figure 8: Our custom built OAF microscope uses a 20 mW 480 nm, 1.66 mm DPSS laser (JSDU) for 
excitation that expanded 17.5x and focussed onto the back focal plane (bfp) of a high NA objective lens 
(Olympus 1.45 NA 100x) using a 250 mm lens. By translating the laser across the bfp, its angle of 
incidence could be manually adjusted to achieve OAF. This optimisation was achieved by adjusting the 
angle of incidence until fluorescence could still be seen at the height of the beads. Any further adjustment 
would then begin to send the laser beam below the height of the tightropes, resulting in this imaging 
technique failing to work.  All emitted light was passed through an Optosplit III to separate the image into 
three different wavelengths. The dichroic mirrors used for this were D565/20m, D605/20m and D655/20m 
(Chroma technology). Finally, images were collected using a DU897 EMCCD camera (Andor, Belfast UK) 
(Figure 5). 
Variable time recordings were taken of proteins bound to DNA tightropes. Usually recordings ranged from 
2-10 minutes with an exposure time of 0.1 seconds and a kinetic cycle time of 1.00011 seconds. This 
meant that an image was taken every 1.00011 seconds throughout the duration of the recording. 
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Another type of single molecule technique used to visualise fluorescently labelled material that 
is located deeper in the experimental chamber is epiflourescence microscopy. This was the first 
conventional, fluorescence imaging technique used to visualise individual fluorophores (Funatsu 
et al. 1995). During imaging using epiflourescence microscopy, the laser beam is passed 
directly through the sample and the slide, resulting in background noise from fluorophores 
deeper in solution. Therefore, this type of microscopy is more suited for imaging protein 
dynamics that are beyond the localised area of a slide surface (Funatsu et al. 1995).  
Although not classed as a single molecule technique, chromatin immunoprecipitation coupled 
with high throughput sequencing (ChIP-Seq) is a powerful technique that can identify DNA 
binding sites for transcription factors and other proteins on a genome-wide scale  (Håndstad et 
al. 2011).  The transcription factors or proteins of interest are covalently cross-linked to the 
DNA. Small fragments of DNA containing cross-linked proteins suitable for sequencing are 
sheared by either sonication or enzymic digestion (Kharchenko et al. 2008). Prior to DNA 
purification, an antibody that is specific to the cross-linked proteins reverses the cross-linking. 
ChIP-Seq is useful as it can find differences between where transcription factors and other 
proteins mostly occupy within different cells (Håndstad et al. 2011, Raha et al. 2010, 
Kharchenko et al. 2008).  
Raha et al (2009) studied the close association of the transcription factors cFos and cJun with 
RNA polymerase III (Pol III) using ChIP-Seq in human K562 erythroleukemia cells. Using ChIP-
Seq, a map was generated to show the distribution of cFos and cJun within the K562 cells. The 
results showed that there were 23,369 and 35,746 binding sites detected for cFos and cJun 
respectively. They also found that 86% and 76% of cFos and cJun AP1 target sites were 
located 100 bp upstream from the Pol II and Pol III genes. Binding in close proximity to Pol II 
and Pol III suggests that cFos and cJun play a greater role in eukaryotic gene expression and 
both polymerases work together to assist with the coordination of gene expression (Raha et al. 
2010).  
In contrast to the study performed by Raha et al (2009), Seldeen et al (2009) used isothermal 
titration calorimetry to determine the thermodynamics behind cFos:cJun heterodimers binding to 
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synthetic dsDNA oligonucleotides that contained the AP1 target site; TGA 
 
 
TCA and all single 
nucleotide variations of this sequence. In addition, it was shown that cFos:cJun heterdimers 
also bound to specific variations of the AP1 target site based on their lowest Kd values. The 
variant sites containing the single nucleotide substitutions (highlighted and underlined) were; 
TGAGTCA, TGATTCA, TGACACA and TGACGCA. However, the study also found that 
cFos:cJun heterodimers could also bind to DNA containing the variant target sequences; 
CGACTCA, TGACTCG, TGTCTCA, TGACACA, TGCCTCA and TGACGCA, despite having a 
higher Kd. Mutating the AP1 target sequence does not hinder cFos:cJun heterodimers from 
binding to these variant target sites (Seldeen et al. 2009). 
1.7: Diffusion mechanisms and AP1 binding theories 
cFos and cJun can exert their biological function upon binding to their AP1 target sequence 
TGAC/GTCA as previously discussed in this chapter. However, how these transcription factors 
locate this site is yet to be understood. Winter et al (1981) tried to answer the question: ‘How at 
a transcriptional level does gene expression become regulated by proteins once their target 
binding site has been located?’ (Winter et al. 1981). Although the AP1 proteins were discovered 
in the 1980s, the way cFos and cJun locate their target sites still remains unclear (Lu et al. 
2005). In recent years, researchers have come up with theories to try to answer this question 
(Gorski et al. 2006) by performing single molecule studies on protein-DNA interactions (Hughes 
et al. 2013, Kad et al. 2010). This enabled a greater insight into how DNA binding proteins 
locate their final destination.  
How a protein can locate its specific target amongst a huge excess of non-specific DNA regions 
remains unclear (Viadiu and Aggarwal 2000). In 1970, Riggs et al studied how the LacI 
repressor located its target ‘operator’ site. They found that the LacI repressor travelled one 
thousand times faster than was originally predicted and used 3-Dimensional facilitated diffusion 
and random molecular collisions in order to locate its target site (von Hippel and Berg 1989, 
Riggs et al. 1970). To understand how this is possible, numerous models have been proposed 
(Gorman and Greene 2008). 
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Researchers such as Kampmann (2004) suggest that a mode of 3-Dimensional diffusion occurs 
when a DNA-binding protein diffuses through a 3-Dimensional space before binding to a non-
specific part of the DNA sequence (Kampmann 2004, Von Hippel 1994, Berg et al. 1981). This 
implies that there are mechanisms in situ to prevent the protein from unnecessary target 
searching along a stretch of DNA that is target free (Halford and Marko 2004). This mode of 
diffusion was also confirmed by Wang et al (2006) on LacI-DNA binding and showed that once 
bound, the protein will diffuse for a period of time before dissociating from the DNA (Wang et al. 
2006, Riggs et al. 1970).  
Following on from the Riggs et al (1970) study, Gorski et al (2006) also suggested that proteins, 
such as transcription factors, can rapidly traverse throughout a nucleus within a few seconds 
whilst utilising a random 3-Dimensional scanning mechanism before rebinding to a specific or 
non-specific site (Berg et al. 1981, Hager et al. 2009, Riggs et al. 1970, Gorski et al. 2006). It 
was also suggested that once bound to DNA, the protein will also search for its specific site via 
sliding and hopping mechanisms within a localised region (Gorman et al. 2010). 
In 2010, Gorman et al proposed that once a DNA binding protein bound onto the DNA non-
specifically, there must be a mechanism used to facilitate its mode of diffusion while locating its 
target site (Elf et al. 2007, Gorman et al. 2010, Hughes et al. 2013). Upon binding, the proteins 
use 1-Dimensional diffusion mechanisms to scan the DNA for their target sites (Wang et al. 
2006, Li et al. 2009). It has been proposed that there are different classifications of 1-
Dimensional diffusion. These include hopping and sliding (Gorman and Greene 2008, 
Kampmann 2005, Li et al. 2009). A hopping mechanism has been defined as a series of 
microscopic association and dissociation events. The protein will re-associate itself with the 
DNA at the same site where it dissociated, or it will re-associate at a site near by (Kampmann 
2004). Proteins employing a 1-Dimensional sliding mechanism follow the helical path defined by 
the DNA phosphate backbone or grooves (Kampmann 2005, Gorman and Greene 2008). This 
type of diffusion results in the protein taking a random walk, meaning it will continuously move in 
any direction along the DNA without dissociating (Gorman and Greene 2008, Berg 1993). Other 
modes of diffusion include jumping where a protein also uses a series of association and 
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dissociation events and this occurs over a greater distance. When a protein jumps, it will rebind 
at a site distal to its current location (Gorman and Greene 2008). Direct intersegment transfer is 
another mode of diffusion. This refers to DNA bound proteins transferring from one non-specific 
DNA site to another without dissociating and occurs when the protein is simultaneously bound 
to both sites (Halford and Marko 2004). It is thought for this type of diffusion to occur that a high 
concentration of proteins must be present within the vicinity or they can access two sites by 
folding the DNA (Kampmann 2005, von Hippel and Berg 1989). Gorski et al (2006) suggests 
when a protein locates and makes contact with its specific binding site, it becomes immobilised 
for a short time period due to having a high affinity, exerting its biological function (Gorski et al. 
2006). The time duration necessary for the exertion of this biological action was unknown (Chiu 
et al. 1988). However, Elf et al (2007) found that the lac repressor bound to its taget site with a 
residence time of <5 milliseconds (Elf et al. 2007).  
Berg et al (1981) originally proposed that proteins using 1-Dimensional sliding mechanism while 
diffusing must form an electrostatic encounter with a neighbouring site before breaking contact 
with its current position. This enables the net DNA counter ions to be equal (Berg et al. 1981). It 
is believed that proteins target their desired location using both 1-Dimensional and 3-
Dimensional diffusing mechanisms (Li et al. 2009, Mirny et al. 2009a). The final theorised mode 
of diffusion is direct intersegment transfer. This involves the bound protein moving from one site 
to another using an intermediate, looped piece of DNA (Gorman and Greene 2008). 
A limitation that occurs when studying DNA binding proteins at a single molecule level is that the 
DNA used does not resemble chromosomal DNA that is present within all eukaryotic cells 
(Gorman et al. 2010, Brown 2007, Gorman and Greene 2008). Therefore, when proteins 
commence a 1-Dimensional random walk along the DNA backbone, they are not exposed to the 
same environment that in vivo proteins experience, such as overcoming obstacles that are in 
their path. This poses the question whether the proposed 1-Dimensional diffusion mechanism is 
relevant under such physiological diversity? (Hager et al. 2009, Kampmann 2005, Li et al. 
2009). In vivo, DNA is tightly packed into the nucleus of eukaryotic cells in the form of 
chromatin. This structure is far more complex than the elongated, linear DNA used in vitro as 
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the DNA organisation in chromatin remains out of reach for the proteins (Bénichou et al. 2011). 
It is during transcription, as described in section 1.2, that enables the DNA to be more 
accessible (Berger 2007).   
Elf et al (2007) studied how the lac repressor located its target sites within living Escherichia coli 
in real time using wide-field fluorescence microscopy to understand how transcription factors 
locate its lac operator sites and mediate transcription. They found that the lac repressor could 
use 3-Dimensional diffusion to translocate through areas of cytoplasm and search sections of 
DNA using 1-Dimensional diffusion. However ~90% of the time, the lac repressor was non-
specifically binding and diffusing along the DNA (Elf et al. 2007). This study is useful as it gives 
an insight as to how transcription factors may be diffusing along chromosomal DNA in vivo 
based on the findings generated by the lac repressor and how gene expression may be 
regulated. The way in which the lac repressor associates and dissociates from DNA while using 
1-Dimensional and 3-Dimensional diffusion assists with the understanding as to how DNA 
binding proteins, such as transcription factors, translocate along DNA in search of their target 
sites.  
1.8: The “waiting room model” 
This work proposes a “waiting room model” as shown in Figure 9. This model can be defined as 
target areas of DNA that the transcription factors have a high affinity for in addition to their AP1 
target sites, termed variant AP1 target sites. This has described in section 1.6. The transcription 
factors cFos, cJun and cFos:cJun heterodimers may intermittently bind and pause within these 
variant target sites until an AP1 target site becomes available, enabling them the ability to exert 
their biological function at this classic site.  
Alternatively, it has been suggested that cFos:cJun heterodimers may be regulating specific 
genes upon binding to these variant sites (Seldeen et al. 2009). Currently, this remains 
unknown, however, the research presented within this thesis could lead to the knowledge that 
these variant AP1 target sites may be important in cellular pathways that controls the 
transcription of other genes in addition to the ones already controlled by AP1. 
32 
 
One way to prove that this model is feasible would be to perform an EMSA (as described in 
section 1.5). Oligonucleotides containing each variant AP1 target site could determine the ratio 
of proteins that bound to site. An alternative method to prove the model would be to use a ChIP-
Seq assay (as described in section 1.6). This would enable all of cFos, cJun and cFos:cJun 
heterodimer AP1 and variant AP1 target sites to be determined on a genomic scale.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
 
 
 
 
 
Figure 9: A cartoon diagram illustrating the “waiting room model.” (a) A transcription factor, in this 
example a cFos:cJun heterodimer, remains in the variant AP1 target site while the neighbouring AP1 
target site is occupied by another transcription factor. (b) Once the AP1 target becomes available, the 
transcription factor that was waiting in the neighbouring variant AP1 target site is now able to occupy the 
AP1 target site and exert its biological function. Another transcription comes and binds to the now vacant 
variant AP1 target site. 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
b 
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1.9: Aims of this thesis 
This study will investigate how the AP1 family members cFos, cJun and cFos:cJun, and the 
antagonistic peptide inhibitor FosW, interact with DNA tightropes while searching for their AP1 
target sites. These protein-DNA interactions will be imaged using OAF microscopy throughout 
this investigation. The existence of homodimeric and heterodimeric species will also be 
investigated. These observations are important as they may provide insight into how these 
transcription factors can initiate cancer when in excess by binding to their AP1 target sites. In 
addition, studying FosW will provide a firsthand insight into how this inhibitor interacts with cJun 
on DNA. This insight will become the beginning of a long road towards the development of a 
cancer treatment when cJun becomes over-expressed.  
The aim of Chapter 2 is to use λ DNA tightropes to observe for homodimerisation and 
heterodimerisation occurring between the transcription factors cFos, cJun, cFos:cJun 
heterodimers and FosW with cJun. Each transcription factors mode of diffusion, diffusion 
constant and α-value will be determined through mean square displacement (MSD) analysis 
performed on each protein trace presented as a kymograph. To identify where these 
transcription factors were binding and pausing along λ DNA, the position of all AP1 and variant 
AP1 targets will be identified Gaussian distribution plots and a Binding Site Position Finder. This 
chapter shows that cFos is capable of homodimerising, binding to DNA and moving in search of 
its AP1 target sites like cJun and cFos:cJun heterodimers, and all of the complexes pause 
within variant AP1 target sites in addition to AP1. Partner swapping within the AP1 family does 
occur and FosW colocalises with cJun.  
In chapter 3, the aim was to study how cFos, cJun and cFos:cJun heterodimers interact with 
different DNA substrates such as AP1 target free pUC19, a modified form of pUC19, pUCap1, 
where a single AP1 target site has been introduced, and Target Free λ (TFλ) DNA where no 
AP1 or variant AP1 target sites are present. Each proteins mode of diffusion, diffusion constant, 
α-value and pause location were also determined as described above. This chapter shows that 
cFos, cJun and cFos:cJun are capable of binding and moving along these DNA substrates in 
addition to λ DNA. Binding to variant AP1 target sites in addition to AP1 does occur. Minimal 
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movement of cJun was also observed when bound to TFλ. Chapter 4 summarises the major 
conclusions from this study and goes on to outline a number of possible future experiments.  
To summarise, in this thesis, cFos can homodimerise, bind and diffuse along λ, pUC19 and 
pUCap1 DNA substrates. cFos, cJun and cFos:cJun heterodimers can pause at sites other than 
AP1 and the antagonistic peptide inhibitor FosW is capable of interfering with cJun homodimers.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
Chapter 2: Imaging cFos, cJun, cFos:cJun and FosW interactions using single molecule 
techniques 
This chapter aims to study how cFos, cJun, cFos:cJun heterodimers and FosW+/- cJun interact 
with λ DNA using OAF microscopy. From the proteins kymographic trace, the mode of diffusion, 
diffusion constant and α-value will be determined using MSD analysis. Any partner swapping 
within the AP1 family to form homodimers or heterodimers will also be identified based on the 
combination of protein dimers.  
Another aim in this chapter is to determine where the proteins are binding and pausing along 
the DNA and whether they are pausing directly within their AP1 target sites only or whether 
pausing occurs within the variant AP1 target sites as well. This will be determined using 
Gaussian distribution plots and the Binding Site Position Finder.   
2.1: Introduction 
The transcription factors cFos and cJun have been identified as modulating physiological 
functions which include the initiation of cellular differentiation, proliferation and apoptosis. This 
happens through the regulation of gene expression at the final stages of the MAP kinase 
cellular signalling cascade (Jochum et al. 2001, Brown 2007, Shaulian and Karin 2001). When 
these transcription factors bind their AP1 target sequence TGACTCA (Eferl and Wagner 2003, 
Nakabeppu and Nathans 1989, Angel and Karin 1991), they are able to initiate certain biological 
functions that include cellular differentiation, proliferation and apoptosis (Campbell 2005, 
Shaulian and Karin 2001, Jochum et al. 2001). However, when the p53 gene becomes 
antagonised downstream, any tumour cells become protected against apoptosis due to the 
disruption of the cell cycle (Weinberg 2007 , Latchman 1995) and cancer develops as a result of 
over-expressed cFos and cJun (Zhang et al. 2007): as described in Chapter 1. cFos causes 
osteosarcomas and cJun initiates hepatocellular carcinoma and squamous cell carcinoma 
(Wang et al. 1995, Zhang et al. 2006, Leaner et al. 2003). The mechanism behind tumour 
suppression is currently unknown (Wagner 2001). However, while this is essential information, it 
is important to quantify the amount of homodimeric and heterodimeric complexes and 
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understand how these transcription factors locate these AP1 target sites that are situated along 
the DNA backbone (Jochum et al. 2001, Woolfson and Alber 1995).  
As mentioned in Chapter 1, cJun can homodimerise and heterodimerise with cFos while cFos 
can only heterodimerise with cJun (Hai and Curran 1991, Ito et al. 2001). As a brief structural 
overview, both native cFos and cJun are α-helical coiled coils that are characterised by a 
repeating pattern of 7 amino acids that are hydrophobic and hydrophilic forming a heptad repeat 
(Woolfson and Alber 1995, Landschulz et al. 1988). These α-helical coiled coils have a 
transactivation domain at the N terminus that is situated at one end of the protein. A basic 
region located above the transactivation domain contains a DNA binding region that is enriched 
with arginine and lysine enabling electrostatic interactions with the DNA. Near to the C-terminus 
at the other end of the protein is a leucine zipper region. Dimerisation occurs within the leucine 
zipper via the conserved leucine heptad repeat on the dimerisation interface (Woolfson and 
Alber 1995). It was therefore believed that a cFos:cJun heterodimer forms a more stable 
complex than a cJun homodimer, although the strength of this interaction currently remains 
unknown (Mason et al. 2006, Nakabeppu et al. 1988). Due to the continuous interaction 
between hydrophobic residues inside of the leucine zipper region, it is thought that tightly bound 
homodimers and heterodimers form in a left-handed, supercoiled conformation (Burkhard et al. 
2000) as described in Chapter 1. In this chapter, when cFos was pre-mixed with cJun, red 
labelled cFos, green labelled cJun and dual labelled cFos:cJun complexes were observed 
bound to λ DNA tightropes. This is direct evidence that partner swapping within the AP1 family 
does occur. When cFos was labelled with 2 colours, as described in section 2.2.9, this 
confirmed that cFos is capable of homodimerising and binding to DNA. However, how this 
homodimerisation occurs is currently unknown.   
When cJun causes tumorigenesis due to over-expression, the antagonistic peptide inhibitor Fos 
Winner (FosW) was designed to disrupt cJun homodimerisation with high specificity, rendering 
cJun inactive (Mason 2009, Worrall and Mason 2011). As a member of a peptide library 
containing variations of native cFos, FosW contains residues within its dimerisation region that 
enable the formation of a stable heterodimeric complex with its target cJun. This interaction is 
38 
 
more stable than a cJun homodimer (Mason et al. 2006). The FosW peptide was selected using 
protein-fragment complementation assays (PCA) as described in section 1.4. One advantage 
to this potential in vitro derived inhibitor is that it is highly specific for its target cJun, 
especially when cJun becomes implicated in cancer (Mason et al. 2007b). 
Once bound to the DNA as either a homodimeric or heterodimeric complex, single molecule 
techniques have enabled cFos, cJun, cFos:cJun and the peptide inhibitor FosW to be tracked 
as they bind to the DNA using 3-Dimensional facilitated diffusion to locate part of the DNA for 
which they have a high affinity for. Once bound, 1-Dimensional diffusion was seen to be used to 
locate their target sites as described in Chapter 1. This suggests that the proteins have evolved 
to prevent excessive DNA searching. However, while travelling along the DNA, the transcription 
factors were observed non-specifically pausing. This suggests that there are other areas along 
that the DNA that they had a high affinity for in addition to AP1. In this study, where the proteins 
are non-specifically binding in addition to their AP1 target sites was investigated to determine 
whether there were any sites in addition to AP1. 
To understand where cFos:cJun heterodimers were binding on the DNA in addition to their 
known AP1 target sites, Seldeen et al (2009) performed a study where they substituted single 
nucleotides throughout the entire AP1 target site sequence. For example, TGACTCA became 
AGACTCA, CGACTCA and GGACTCA (Seldeen et al. 2009). All of these variant sites, known 
here as variant AP1 target sites, were integrated into this study. Therefore, in addition to the 8 
known AP1 target sites along λ DNA, a total of 95 variant AP1 target sites were also located 
along λ. 
The methods in this chapter were used to try and understand how cFos and cJun transcription 
factors and the inhibitor FosW interacted with λ DNA tightropes, forming protein-DNA 
complexes. DNA tightropes enable the proteins to freely associate, dissociate and diffuse along 
the DNA without any obstructions from artefacts adhered to the surface of the slide. By 
performing an MSD analysis on the data obtained from each diffusing proteins kymograph, the 
mode of diffusion, diffusion constant and α-value for each protein could be determined. As the 
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proteins diffused along the DNA, they also paused. The Binding Site Position Finder is an 
analytical method used to identify whether the proteins paused in their AP1 target sites only, or 
whether they were also pausing in variant AP1 target sites. This rationale is to try and 
understand whether non-specific binding within these variant AP1 target sites is a mechanism 
used by the proteins to control transcription or whether the AP1 transcription factors may be 
exerting their biological function within these variant sites in addition to AP1. 
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Chapter 2.2: Materials and methods 
2.2.1: Flow cell construction 
To set up a DNA tightrope assay, a custom built flow cell was designed (Kad, 2010) as shown in 
Figure 10. This design enables microsphere beads, DNA, buffers and proteins to be introduced 
into the chamber. Applying methods 2.2.7, 2.2.8 and 2.2.9, DNA tightropes were constructed 
and DNA-protein interactions can be visualised. Firstly, two 1 mm holes were drilled 12 mm 
apart on a 75 mm x 25 mm glass slide (Thermo Scientific) using a Dremel electric hand drill with 
a diamond coated drill tip. The slide was cleaned and silanised as described in method 2.2.3. 
Next, polyethylene tubes (0.75 mm inner diameter and 1.22 mm outer diameter, (Smiths 
Medical) 20 mm long were placed in each hole and expanded using a heat gun. This expanded 
the tubing’s end enabling a tight seal. These were fixed to each hole with UV glue (Norland 
optical adhesive 320-400 nm curing, Thorlabs) that cured under a 365 nm UV lamp (Model 
UVGL-58 365 nm. UVP) for approximately 30 minutes. Excess tubing and glue on the underside 
of the slide were removed using a scalpel, ensuring a smooth surface. A double sided adhesive 
gasket made from transparent polyester coated with a pressure sensitive modified acrylic 
adhesive, 180 μm deep, was applied to the underside of the glass side, ensuring that each hole 
was within the gasket. A watertight seal was created by affixing a PEGylated silica coverslip to 
the underside of the slide. As described in methods 2.2.2 and 2.2.3, these coverslips were pre-
treated with ABT (1xABC buffer (50 mM KCl, 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2), MilliQ 
ultrapure H2O (resistivity at 18.2 MΩ.cm), 1mg/mL bovine serum albumin (BSA), 0.001% (v/v) 
Tween20) buffer to reduce interactions occurring with the beads and proteins (Lei and 
MacDonald 2008). After construction, the flow cell was left blocking overnight in ABT buffer. It is 
the BSA component that reduces non-specific hydrophobic binding to the flow cell surfaces 
(Kad et al. 2010). 
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Figure 10: (a) A cartoon diagram showing the different components of a flow cell. Affixing a gasket and 
coverslip to the slide creates a watertight chamber. The tubing enabled buffers, DNA and proteins to be 
introduced into the chamber. The flow cell was then attached to an adapted microcentrifuge tube 
(contains 2 vertical holes enabling the addition of solutions) and a pump to create DNA tightropes. (b) A 
cartoon of a flow cell chamber. As DNA is pump in, the DNA unravels upon sticking to the silica beads 
(red), forming multiple DNA tightropes (black) of varying lengths. 
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2.2.2: PEGylation of silica coverslips 
Coverslips were PEGylated to prevent proteins from interacting with the surface. During 
imaging, this minimised any background interference. 
Firstly, to remove any contaminants from the glass coverslips (Agar Scientific 25 mm x 40 mm), 
were sonicated for 30 minutes in 100% ethanol using a sonication bath. The Ethanol was then 
replaced with 1 M KOH and sonicated for a further 30 minutes. These 2 wash steps were 
repeated to ensure the coverslips were clean. Before being sonicated in acetone, the coverslips 
were dried using Nitrogen gas. The clean coverslips were gently agitated in a 3-
aminopropyltriethoxysilane (Sigma Aldrich) solution for 2 minutes. The reaction was quenched 
with water prior to drying in an oven for 30 minutes at 100 °C. 100 mg/ml methoxypolyethylene 
glycol 5,000 propionic acid N-succinimidyl ester (mPEG) (Sigma Aldrich) was mixed with 100 
mM NaHCO3 at pH 8.2. 10 µL of mPEG mixture was pipetted onto the newly silanised 
coverslips. 2 coverslips were gently sandwiched together. This ensured that the mPEG mixture 
was evenly distributed over the 2 surfaces. The coverslips were left for 3 hours at room 
temperature (23 °C) before being carefully separated, washed with water and dried. 
The coverslips were then ready to be attached to a flow cell. If they weren’t used immediately, 
they were stored in a humidor at room temperature for up to a maximum of 1 week. After a 
week, it was generally found that the high fluorescence was of poor quality and images showed 
degradation due to a high noise to signal ratio caused by the surface of the slide becoming 
excessively covered with artefacts. 
2.2.3: PEGylation of silica coverslips in situ 
Several adaptations of the above PEGylation protocol were tested throughout the duration of 
this study. One modified method was found that significantly reduced the background signal. 
The coverslips (Agar 25 mm x 40 mm) were sonicated in an ultrasonic bath for 30 minutes in 
100% ethanol. The ethanol was replaced with 1 M KOH prior to sonication again for 30 minutes. 
These 2 wash steps were repeated to ensure that the coverslips were clean. The coverslips 
were thoroughly rinsed the slides with 100% acetone to remove residual KOH. The coverslips 
were sonicated in an ultrasonic bath for 10 minutes in 100% acetone. After sonication, the 
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slides were submerged and gently agitated in 2% (v/v) aminopropyltriethoxysilane in acetone for 
2 minutes. The coverslips were thoroughly washed with water and dried using Nitrogen gas. To 
ensure the coverslips were completely dry, they were incubated at 110°C for >2 hours.  
The coverslips were then ready to be attached to the flow cells, forming a watertight seal using 
a gasket that was die-cut to size using computer software and a die-cutting machine. The newly 
constructed flow cell and attached tubing were incubated at 4°C overnight with 25 mg/ml mPEG 
in situ. The flow cell was flushed through with water and blocked overnight with ABT buffer from 
inlet to outlet tube. These were incubated at 4°C until use. This method was more economical 
than the previous PEGylation method as it enabled more flow cells to be generated within a 
week and improved the signal to noise ratio. 
2.2.4: Silica microspheres coated with poly-L-lysine 
Silica microsphere (beads) (PolySciencesLtd. 2011) are commercially available, are stable and 
have non-specific interactions with proteins and DNA (Lauer and Nolan 2002). 5 μm beads were 
used. The beads were incubated at 4 °C in water and would settle to the bottom of the container 
when not in use. To resuspend the beads, they were vortexed for 1 minute. 100 μL of beads 
were immediately added to 500 μL of water. The beads were pelleted using centrifugation for 2 
minutes at 13,300 xg. The supernatant was removed and the beads were resuspended in 400 
μL of 350 μg/mL poly-L-lysine hydrobromide (stock: 5 mg/mL added to 372 µL MilliQ H2O. 
Stored at -20 °C) (Sigma Aldrich). Poly-L-lysine enables the beads to adhere to the flow cell 
surface as well as the DNA to the beads. The beads were stored at 4°C for >1 hour prior to use.  
Before introducing the poly-L-lysine coated beads into the flow cells chamber, they were 
resuspended by vortexing. 10 μL of resuspension was added to 500 μL of water and centrifuged 
for 2 minutes at 13,300 xg. The supernatant was removed, replaced with another 500 μL of 
water and recentrifuged for 2 minutes at 13,300 xg. This ensured that the beads were clean and 
free from contaminants. The pelleted beads were resuspended using a sonicator (cycle 8, 
amplitude 80%, up50H ultrasonic processor) 4 times using 1 second bursts and immediately 
added to the flow cell to randomly adhere on the chamber surface.  
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Before DNA was introduced, the flow cell was flushed with 100 μL of water. This was to ensure 
that there were no bead clumps within the inlet and outlet tubes that could cause blockages. 
The density of the beads within the chamber was verified using brightfield microscopy (Nikon 
Diaphot). 
There is one disadvantage to using Poly-L-lysine coated silica microspheres. The beads 
fluoresce due to YOYO-1 intercalated DNA also adhering to their sticky surface, they appear as 
fluorescent white objects either side of a tightrope. This meant that any Qdot conjugated 
proteins that bound at the ends of a tightrope could not be analysed accurately. However, one 
an advantage is that these beads do offer a quick, yet reliable, DNA binding tool. 
2.2.5: Buffers 
2.2.5.1: ABC buffer 
When introducing DNA tightropes into the chamber, a buffer containing 50 mM KCl, 50 mM Tris-
HCl (pH 7.5), 5 mM MgCl2 was used. This shall be referred to as 1x ABC buffer. When YOYO-1 
was introduced into the chamber to label the DNA, this was present in 50 mM KCl, 20 mM 
MgCl2,100 mM Tris-HCl (pH 7.5), H2O and 100 mM DTT. This will be referred to as low salt 
buffer. This buffer was modified by increasing the KCl molarity to 150 mM, referred to as high 
salt buffer, mimicking intracellular conditions in vivo (Khatter et al. 2014). 100 mM DTT was an 
essential component to this buffer as it reduced the Qdots blinking by encapsulating the Qdots, 
resulting in increased photostability during long exposure to fluorescence illumination (Antelman 
et al. 2009). DTT also limited the amount of YOYO-1 photo-bleaching. 
2.2.6: Bacteriophage Lambda methylated and non-methylated DNA tightropes 
2.2.6.1: Bacteriophage Lambda DNA  
Bacteriophage Lambda DNA (λ DNA. New England BioLabs), as shown in Figure 11, is linear, 
double stranded, 48,502 bp in length and methylated. λ DNA contains the methylation sites 
Dam, Dcm and EcoKI (all methylated nucleotides have been underlined). The Dam gene 
encodes methylase to transfer bulky methyl groups to the adenine residues N6 position at the 
recognition sequence GATC. The Dcm gene encodes methylase to methylate cytosine residues 
C5 position at the recognition sequences CCAGG and CCTGG (Ringquist and Smith 1992). The 
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EcoKI gene methylates adenine at position N6 in the recognition sequences AACGTGC and 
GCACGTT (Powell et al. 1998).  
Bacteriophage Lambda DNA (λ DNA. New England BioLabs) is linear, double stranded, 48,502 
bp in length and contains an overhang of 12 bases either end enabling self annealing to take 
place between neighbouring strands. λ DNA is methylated from the E. coli host strains 
methylase enzymes, however which Dam and Dcm sites were methylated is unknown. Non-
methylated λ DNA contains Dam sites that are only 50% methylated (Palmer and Marinus 
1994). It was found that a DNA concentration of 500 ng/μL provided a sufficient amount of 
reliable tightropes (Kad et al. 2010, Hughes et al. 2013). If necessary, these pre-formed 
tightropes could be stored overnight at room temperature. 
To reduce the number of freeze-thaw cycles during the storage of λ DNA, 50 μL aliquots were 
prepared and stored at -20 °C in microcentrifuge tubes. If an aliquot was used for experiments, 
this was stored at 4°C. Over time it was found that the length of λ DNA increased due to self 
annealing and this was observed during imaging. This resulted in longer tightropes being 
formed. More care was taken as long DNA is more prone to shearing. To help prevent this from 
occurring, the DNA was never re-frozen and wider pipette tips were used. These were made by 
cutting the narrow end off of a 1000 µL pipette tip. 
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Figure 11: A linear map representing a single piece of double stranded λ DNA (made using SnapGene) that is 48,502 bp in length. AP1 ‘Wild type’ (WT) 
target sites and their locations are indicated in red. There are 4 AP1 target sites that are within close proximity to each other. These are located between 
positions 19,119 bp – 22,688 bp. 
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2.2.6.2: Lambda DNA with additional variant AP1 target sites 
As a protein travels along the DNA, it occasionally paused. Therefore, to try and understand 
where, the λ DNA sequence was reviewed to see whether there were any other alternative 
binding sites. 
One study by Seldeen et al (2009) made single nucleotide substitutions (underlined) to each 
nucleotide base within the AP1 target site sequence. The following sequences were located 
along a single piece of λ DNA (as shown in Figure 12): AGACTCA, CGACTCA, GGACTCA, 
TAACTCA, TCACTCA, TTACTCA, TGCCTCA, TGGCTCA, TGTCTCA, TGAATCA, TGAGTCA 
(palindrome sequence to AP1 target site), TGATTCA, TGACACA, TGACCCA, TGACGCA, 
TGACTAA, TGACTGA, TGACTTA, TGACTCC, TGACTCG and TGACTCT. In this study, these 
nucleotide substitutions shall be referred to as variant AP1 target sites. There were 95 variant 
AP1 target sites in total. 
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Figure 12: A diagram representing a single piece of λ DNA (created using SnapGene). In addition to the 8 known wild type (WT) AP1 target sites, there are 
also 95 variant AP1 target sites. Each target sites sequence has been labelled with the same colour. This diagram shows that λ DNA is overcrowded with WT 
and variant AP1 target sites. 
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2.2.7: Creating tightropes 
Beads were introduced into a flow cell chamber via the inlet tube. Prior to the addition of DNA, 
the flow cell outlet tube was connected to a pump (AL-1000 programmable syringe pump. World 
precision instruments) and a 10 mL plastic syringe (BP Plastipak) containing 500 μL of 1x ABC 
buffer. Attached to the flow cell inlet tube was an adapted microcentrifuge tube. 1x ABC buffer 
was flowed through the flow cell and into the microcentrifuge tube. 500 μL of 1x ABC buffer was 
withdrawn back through the flow cell towards the pump. This ensured that any contaminants 
within the flow cell were removed.  
500 ng of DNA (1 μL DNA in 99 μL 1x ABC buffer) was introduced into the chamber. Using the 
pumps bi-directional flow setting at 300 μL per minute and switching every 100 μL, tightropes 
were formed by one end of the DNA attaching to a ‘sticky’ poly-L-lysine coated bead, 
unravelling and attaching to a neighbouring bead. As each bead is 5 μm in diameter, this meant 
that tightropes were suspended 5 μm above the slides surface.  
Before imaging, the tightropes were labelled with YOYO-1 (1-20 µL YOYO-1 in water making a 
100 µL final volume. YOYO-1 stock at 1 µM) as shown in Figure 13 image a. 
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Figure 13: Here are some examples of DNA tightropes and Qdot conjugated proteins that have bound 
onto the DNA. (a) An image of several DNA tightropes that have been labelled with YOYO-1 dye. It is 
important to identify tightropes before proceeding to the addition of Qdot labelled proteins. (b) A cartoon 
representing proteins that are conjugated with red and green Qdots and bound to a DNA tightrope. (c) An 
image of green Qdot labelled cJun proteins that have bound onto a single λ DNA tightrope. Labelled 
proteins (in high salt buffer containing 150 mM KCl to mimicking intracellular conditions in vivo) are added 
to the chamber after the YOYO-1 dye has been washed out with low salt buffer. Equilibrating the chamber 
using low salt ensures that the final KCl concentration within the chamber remains at 150 mM when 
imaging the proteins. 
 
 
 
 
 
a 
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2.2.8: Biotinylated proteins 
cFos and cJun transcription factors are basic zipper (bZIP) proteins and members of the AP1 
family (as mentioned in Chapter 1). They do not have a transactivation domain but do have an 
additional Biotin tag that is situated at their C-terminus (Figure 4). This enables Qdots to attach 
through conjugation. The biotinylation tags were away from the proteins dimerisation and DNA 
binding domains and did not affect the proteins from colocalising, binding to DNA and diffusing 
as these were observed during imaging. 
These are the only differences between the substitute peptides and their native forms. cFos 
contains 59 residues and is 7252 Da and cJun contains 60 residues and is 7247 Da. Their 
configurations and sequences can be seen in Figure 5. 
Basic-FosW-Biotin (FosW) however is an antagonistic peptide inhibitor that contains 61 
residues and is 7643 Da. This was designed to interfere with cJun homodimeric complexes 
(Mason et al. 2006). FosW was based on the structure of cFos, although its coiled coil region 
contains different residues surrounding the leucine zipper (LZIP) region and traditionally FosW 
does not contain a DNA binding region or a Biotin tag (Mason et al. 2006). However, for the 
purpose of this study, this peptide inhibitor has a DNA binding region that is an exact replica of 
cJun. This enabled the inhibitor to bind to the DNA and diffuse using 1-Dimensional sliding. 
Without this DNA binding domain, it would not be possible to visualise FosW colocalising with 
cJun due to a loss of signal. A Biotin tag at the C terminus also meant a Qdot could be 
conjugated. 
The proteins cFos, cJun and the inhibitor FosW were ordered from the company 
PeptideSynthetics and were kindly supplied for this study by Dr. Jody Mason. 
PeptideSynthetics performed Reverse-Phase High Performance Liquid Chromatography (RP-
HPLC) to purify the proteins. cFos has >88% purity and cJun is >94% pure. Figure 14 shows 
the representative RP-HPLC data for cFos and cJun. 
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Figure 14: Chromatograms representing the purity of cFos and cJun using RP-HPLC. Performed by 
PeptideSynthetics. cFos is >88% pure and cJun has >94% purity. 
 
 
 
 
 
 
 
cFos 
cJun 
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A tyrosine residue is present within the LZIP region of cFos, cJun FosW. This has an extinction 
coefficient of 1209 m-1cm-1 and is absorbent at A280 nm wavelength (shown by the example in 
Figure 15) and is the only residue in the sequence that absorbs at A280 nm.  By using the Beer-
lambert Law: 
A = εcl 
A is the sample absorbance using spectrophotometry, ε represents the molar extinction 
coefficient. This is the tyrosine (Y) extinction coefficient (1209 Lmol-1cm-1). l is the path length of 
the sample and c represents the concentration of the compound in solution (mol/L-1).This 
formula enabled the peptides molarity to be calculated. 
To avoid freeze-thaw cycles that could potentially degrade the peptides, 1 µL aliquots 0.5 µM 
were stored in sterile microcentrifuge tubes at -80 °C. 
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Figure 15: An absorbance graph of cJun that was taken using a UV-Visible spectrophotometer (Cary 50). 
Like cFos and cJun, FosW has a single tyrosine (Y) residue that is present within the peptides LZIP 
region. The graph clearly shows that light is being absorbed by the Y residue at a wavelength of A280 
nm. Similar graphs were observed for cFos and cJun. 
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2.2.9: Labelling the biotinylated peptide 
Prior to labelling the biotinylated peptide with Streptavidin conjugated Qdots (Invitrogen), a 
single 1 µL aliquot of peptide at a concentration of 0.5 µM was thawed on ice for 30 minutes. 
The peptide was diluted to a concentration of 100 nM upon the addition of high salt buffer and 
Qdots. This resulted in a final Qdot concentration of 400 nM. This 1:4 peptide to Qdot ratio 
increased the probability of each protein being conjugated to a single Qdot. The mixture was left 
to incubate for 15 minutes on ice. Prior to imaging, an aliquot of labelled peptide was diluted to 
0.4- 2.5 nM in high salt buffer, making a final volume of 100 µL. The concentration of labelled 
peptide imaged was dependent on the amount of protein-DNA binding observed in the previous 
experiment. 
2.2.10: Quantum dots  
Proteins bound to DNA were visualised using Quantum dots (Qdots. Invitrogen) during this 
study.  
Qdots are inorganic nanocrystals that are roughly protein-sized atomic clusters. These are 
composed of a mixture of cadmium and selenium which are semiconductor materials. An 
additional semiconductor shell made from zinc sulphide improves the optical properties of the 
material (Chan and Nie 1998). Qdots, unlike organic fluorophore labels, can enable multicolour 
assays to be visualised simultaneously due to the narrow emission spectrum. This is due to the 
direct relationship between the size of each Qdot and their emission wavelength (Alivisatos 
1996).  
Unlike more traditional organic labels such as the Green Fluorescent Protein (GFP), Qdots are 
less susceptible to chemical and metabolic degradation, have a greater photostability threshold, 
enhanced brightness and a narrower emission spectrum (Jaiswal et al. 2002). It is these 
enhancements that enable individual protein-Qdot conjugates to be tracked over longer periods 
of time and their fast dynamics to be monitored during single molecule studies (Wang et al. 
2008). 
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2.2.11: Imaging using Oblique Angle Fluorescence (OAF) microscopy  
Oblique Angle Fluorescence (OAF) microscopy, a variation of TIRFM was used to image all 
protein assays during this study. A diagram is shown in Figure 16 illustrating OAF setup.  
TIRFM uses an evanescent wave to selectively illuminate and excite fluorophores within a 200 
nm area that is directly adjacent to the glass-water interface. An evanescent wave occurs when 
the incident light beam becomes totally internally reflected at the glass-water interface. This 
occurs when the light beam encounters the interface at a critical angle of 63°. This refraction 
occurs due to the high refractive index of the glass medium and the low refractive index of the 
water/aqueous solution medium. This results in either a portion of the light becoming confined to 
the solution side of the interface or all of the light being dispensed in the higher index medium 
(Reichert and Truskey 1990).  
OAF microscopy, like TIRFM, uses a collimated beam of light. It is the difference between the 2 
mediums refractive indexes and the incident angle that determines whether the light beam 
becomes refracted as it enters the lower refractive index medium or reflected at the interface 
(Figure 10). Unlike TIRFM, the OAF light beam is angled away from the critical angle. This 
means a thin section becomes illuminated and background noise becomes reduced. This 
strategy also enables tightropes to be visualised at least 5 μm above the surface. Imaging away 
from the slides surface will reduce the amount of noise caused by excess fluorescence being 
emitted from surface artefacts upon excitation by the laser, such as adhered Qdots. This 
illumination strategy also increases the signal by only illuminating Qdot-bound proteins that are 
within the lasers path. This will also help to reduce background noise being emitted from nearby 
fluorophores as they will not be excited by the beam. 
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Figure 16: A diagram showing the optical 
setup of OAF microscopy. Firstly, a 1.66 
mm DPSS laser passes through a 10 mm 
focusing lens before expanding 17.5 times 
as it passes through a second 250 mm 
focusing lens. This determines the size of 
OAFs illumination spot. On the back of the 
objective, the laser beam is focused down 
onto a diffraction limiting spot. The laser 
beam then passes through the flow cell 
before travelling back through the system 
and separated into three 565, 605, 655 
nm beams. This happens when the beam 
hits the first dichroic and passing through 
3 separate dichroic filters, located within 
the Optosplit III system. The images were 
collected using the DU897 EMCCD 
camera.  
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2.2.12: Data analysis 
This section will describe how the time lapse recordings taken of Qdot conjugated proteins 
interacting with DNA using OAF microscopy were analysed. Firstly, kymographs show the direct 
interaction of the Qdot bound proteins as they interact with the DNA, frame by frame throughout 
the entire recording. This data meant that the number of motile proteins could be quantified and 
what proportion of proteins visited their AP1 or variant AP1 target sites. Based on the location of 
the Qdot within the kymograph, the proteins motion could be ascertained and calculated by 
using an automated Gaussian fitter program. The error for all observed diffusing proteins, 
including their α values and diffusion constants (µm2s-1), have been recorded using the standard 
error of the mean (SEM). 
2.2.13: Statistical tests 
A t-test was used to prove the statistical significance of results when comparing two proteins 
that bound to DNA and were observed to be diffusing. 
2.2.14: Kymograph analysis 
A kymograph, produced using ImageJ (NIH, USA), is a frame by frame report of the interaction 
between a Qdot conjugated protein with its DNA substrate. Kymographs can provide 
information about how each protein interacts with the DNA and how it changes its position 
during translocation. 
Before creating a kymograph, a tightrope was chosen that was not overcrowded to avoid any 
interference from adjacent proteins during analysis. Prior to kymograph construction, the 
tightrope of interest was rotated (using ImageJ tools) so that it was horizontal. A region of 
interest (ROI) was then drawn around the tightrope. It is within this ROI of the movie that each 
horizontal line, a single pixel in height, was scanned in single pixel increments down the y-axis, 
forming a series of time slices. These were vertically stacked according to their original position 
and the stacked data was rotated by 90° to the right. This simply aided data analysis, meaning 
that the protein displacement was along the y-axis and time was along the x-axis. Using such a 
kymograph permitted every pixel per time frame to be visualised throughout the recording. If any 
Qdot conjugated proteins appeared extremely bright, these were not accounted for as this 
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indicated that multiple Qdots may have bound. If a protein was observed to move 2 pixels or 
more from its previous position per time frame, this protein was considered to have moved 
(Figure 17). 
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Figure 17:  (a) Shows 2 cFos molecules that have bound to a DNA tightrope during a 120 second movie. 
The arrow above one of the more motile protein-DNA complexes shows the position of the protein at 
various time points in seconds. The orientation of the tightrope has been rotated to a vertical position 
using imageJ software to assist with the analysis of the kymograph. (b) Shows the same tightrope 
containing the 2 cFos molecules but displayed in the form of a kymograph using ImageJ. The most motile 
protein (as indicated by the arrows in (a) at various time intervals) shows its position along the DNA. The 
X axis represents time (s), that is 1 second per frame, and the Y axis shows the proteins position along 
the DNA. 10 pixels is 0.819 μm (in height), equivalent to 2410 bp (represented by the scale bar).  
 
a 
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2.2.15: Random walker simulations with specific and non-specific pausing 
A model was designed to simulate a dimer taking a random walk. This has been described in 
Figure 18. The model assumes a 50 % probability of a dimer taking a step forwards or 
backwards during its translocation along λ DNA, mimicking in vivo DNA-bound protein 
movement. Pauses can be manually introduced by the user at any time. Random numbers 
between 0 and 1 were generated. Within this simulation, if a random number is above 0.5, a 
forward step will be taken. A backward step occurs with numbers less than 0.5. Depending on 
the random number, the dimer can either move forwards (new position = previous position + 
increment) or backwards (new position = previous position - increment). The increment (μm) is 
user defined. Figure 18 shows the simulated dimer taking a random walk and specifically 
pausing along the DNA. Unlike in Figure 19, Figure 20 shows a simulated dimer taking a 
random walk along a DNA tightrope while pausing for varying lengths of time, mimicking real 
data traces.  
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 Figure 18: A flow diagram of a dimer taking a random walk. X2 is equal to the dimers next position and X1 represents the proteins previous position. The 
increment is defined as the step size (μm) taken by the dimer per time frame and is user defined. 
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Figure 19: A print screened image showing a model of a simulated dimer taking a random walk as described in method 2.2.15. In this example, the simulated 
dimer was formed using over 480 data points. It can be seen translocating along a single λ DNA tightrope, taking a step (µM) forwards or backwards every 
second. The dimer also specifically pause at each of the 8 AP1 target sites, remaining static for 5 seconds for the purpose of this demonstrative model, before 
translocating again in search of the next target site. This simulation serves as a positive control as it depicts a dimers movement along the DNA ‘in an ideal 
world’, meaning, the dimer visits each target site without returning to the proceeding site. The model is an exact representation of λ DNA and has been scaled 
down 100 times. 
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Figure 20:  A print screen image showing a model of a simulated dimer taking a random walk as described in method 2.2.15. Unlike the model shown in 
Figure 19, the user decides when and where the simulated dimer can move and pause along the λ DNA tightrope and for how long. Pausing of varying time 
durations was implemented to mimic actual data traces. 
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2.2.16: Diffusion constant and α value 
Kymographs showing moving proteins were further analysed to identify their diffusion constant 
(µm2s-1) and mechanism of motion, as determined by their α value. An α value of less than 1 
suggests subdiffusion, 1 suggests unbiased diffusion and 2 indicates directed motion (Saxton 
1997). This was defined by the slope of a log-log axis after plotting the MSD (as described in 
section 2.2.16). Firstly, using ImageJ application tools, a box was drawn around a single protein 
kymograph close to its trace. This helped prevent background fluorescence from being 
analysed.  
An un-biased, customised and automated Gaussian distribution macro was installed into 
ImageJ. This generated a Gaussian distribution graph per time frame based on the point spread 
function of each Qdot fluorophore, providing positional accuracy that exceeded the diffraction 
limit. The peak of the Gaussian distribution determined the spatial accuracy of the system. This 
was determined to be 8.7 nm using Equation 1 (Hughes et al. 2013, Thompson et al. 2002):  
Equation 1:                   
The standard deviation of the Gaussian distribution is represented by s, a represents a pixels 
length at 82 nm and b represents the standard deviation of the background noise. N represents 
the number of photons that were collected. Brownian motion, background noise and camera 
noise have been incorporated into the value of uncertainty (Thompson et al. 2002). Throughout 
this study, the Andor camera used (as described in 2.2.11) has 160000 electrons per pixel 
count. This is an average conversion ratio. In the Andor camera, the gain is expressed in 
electrons per count. In this case, this means that the camera produces 1 count for every 160000 
electrons. 
2.2.17: MSD analysis  
To understand how each protein moves along DNA, its mean-squared displacement (MSD) was 
determined as shown in Figure 23. To determine the proteins α value, the MSD was logged per 
time frame. This can be seen in Figure 24. This methodology utilised the raw data that was 
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generated from the Gaussian distribution as described in Table 1 and Figures 22 and 23. Non-
linearities occurred when the MSD was fitted to a straight line. This typically occurred after the 
first 10% of the frames, which translates into the first 12 seconds and 12 time steps, assuming 
the imaging occurred over 120 seconds. The standard deviation, showing the distribution of 
data, and R2 values, representing the Gaussian distribution fit, were used together to filter out 
any Gaussian distributions that did not fit within these parameters. This filtering method 
excluded data points were marked by an X. An example of this can be seen in Table 1.  
To establish the standard deviation and R2 parameters to be used in this dual filter, 50 Gaussian 
distribution data were analysed and their means taken. It was concluded that any R2 values 
<0.84 and any standard deviation values >2.32 should be excluded as these data corresponded 
to a bad Gaussian distribution fit,, as shown by the Gaussian distribution plots in Figure 21. If 
any values were on these dual filters threshold, they were analysed and introduced into the data 
set. The corresponding mean values to the Gaussian distributions standard deviations and R2 
values that fitted within the parameters of the dual filter were converted from pixels into 
micrometers. Equation 2 was used to determine the proteins MSD: 
Equation 2:  
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Figure 21: Printscreen images of Gaussian distribution plots for a cJun protein. (a) A Gaussian 
distribution plot with a good fit. This can be seen by the R
2
 value 0.9. (b) This Gaussian distribution plot 
has an R
2
 value 0.3, illustrating a bad fit. 
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Cycle 
Time (s) 
Mean 
Position 
(pixels) 
Mean 
Position 
(µm) 
 
Cycle 
Time (s) 
Mean 
Position 
(pixels) 
Mean 
Position 
(µm) 
1.00011 7.61 0.62 
 
93.01023 6.73 0.55 
2.00022 7.93 0.65 
 
94.01034 7.58 0.62 
3.00033 8.02 0.66 
 
95.01045 7.89 0.65 
4.00044 8.14 0.67 
 
96.01056 8.01 0.66 
5.00055 8.62 0.71 
 
97.01067 7.92 0.65 
6.00066 9.31 0.76 
 
98.01078 8.8 0.72 
7.00077 9.31 0.76 
 
99.01089 9.17 0.75 
8.00088 8.91 0.73 
 
100.011 9.13 0.75 
9.00099 8.51 0.70 
 
101.01111 9.24 0.76 
10.0011 8.08 0.66 
 
102.01122 9.64 0.79 
11.00121 7.76 0.64 
 
103.01133 9.64 0.79 
12.00132 8.08 0.66 
 
104.01144 9.34 0.76 
13.00143 8.65 0.71 
 
105.01155 9.72 0.80 
14.00154 8.86 0.73 
 
106.01166 12.23 1.00 
15.00165 8.71 0.71 
 
107.01177 12.97 1.06 
16.00176 8.31 0.68 
 
108.01188 14.13 1.16 
17.00187 8.33 0.68 
 
109.01199 12.64 1.04 
18.00198 8.62 0.71 
 
110.0121 13.48 1.10 
19.00209 8.77 0.72 
 
111.01221 13.08 
 
20.0022 8.57 0.70 
 
112.01232 12.71 1.04 
21.00231 8.12 0.67 
 
113.01243 12.35 1.01 
22.00242 7.82 0.64 
 
114.01254 11.58 0.95 
23.00253 8.06 0.66 
 
115.01265 11.86 0.97 
24.00264 8.42 0.69 
 
116.01276 12.87 1.05 
25.00275 8.64 0.71 
 
117.01287 12.76 1.05 
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Table 1: An example of raw data obtained from a kymograph trace of cFos moving along λ DNA at 2 
different time intervals over 120 seconds. The first column shows a cycle time of 1.00011 seconds. This is 
the time duration between each image captured by Andor Solis (as described in method 2.2.11). The 
second column shows the raw data that was produced by the automated Gaussian fit program. This 
shows the proteins displacement (pixels) per time frame. The third column shows the proteins 
displacement in μm. This unit conversion occurred by multiplying the data in pixels by 0.0819 μm, the 
length of a single pixel as determined by a graticule. Any absent data from the second and third columns 
meant that these values did not fall within the data isolation parameters as described in method 2.2.16.  
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Figure 22: A section of cFos on λ DNA raw data generated from the automated Gaussian fit program that utilised the MSD equation as calculated in Equation 
2. The first column shows the proteins displacement by subtracting each number with the number directly below, i.e., 1 to 2, 2 to 3 etc. The second column 
subtracts every third number, i.e., 1 to 3, 2 to 4 etc. The increments between the displacement numbers increases by 1 as you move towards the right of the 
table. This methodology covers all displacement configurations. The MSD was calculated by taking the average of each column.  
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Figure 23: A mean-squared displacement plot of a single cFos molecule (as shown in Table 1) that 
travelled along λ DNA. The protein was imaged every 1 second for 120 seconds. After the first 20% or 25 
frames of the data trace, non-linearity can be seen. This is reflected by the R
2
 value that determines the 
quality of the fit to the data. Imaging typically has a time duration of 120 seconds to 600 seconds with a 
cycle time of between 0.2 to 1 frame per second. 
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Figure 24: An example MSD of cFos that travelled along λ DNA. This was calculated using Equation 2. 
(a) Shows the average displacement (µm) per time frame. (b) Shows log displacement (µm) per log time 
frame. Both panels a and b in this example show a total of 25 time steps, equating to the first 21% of the 
data set (the full data set is shown in Figure 21). The data was quantified based on how well the data 
fitted to the straight line. This was achieved by removing data from the bottom of the MSD upwards until 
an R
2
 value of 0.7 and above was achieved as this provided the best quality fit. Although the data set is 
smaller than the original data, linear data is required to perform an MSD. (c) A plot showing the proteins 
displacement (µm) against time (s) using the data from panel a. The slope of the linear line determines 
the diffusion constant. (d) A plot showing log displacement (µm) against log time (s) using the data from 
panel b. 
 
 
 
 
 
74 
 
2.2.18: The Binding Site Position Finder 
2.2.18.1: Binding Site Position Finder for λ DNA  
The Binding Site Position Finder is an analytical method designed to calculate whether the 
measured distance between two pause sites corresponded with their AP1 target sites. Three 
pieces of virtual λ DNA were placed in tandem. This approach ensured that all binding distances 
were quantified.  
First, the starting and end positions for each of the eight 7 bp AP1 target sites were identified 
and input into the program. An error margin was added to either end of the target site. To 
calculate this error, cJun was used as this protein is the most mobile out of all of the complexes. 
The error margin was calculated based on cJun pause locations as the protein travelled along λ, 
PCE pUC19 (Chapter 3) and PCE pUCap1 (Chapter 3) DNA substrates. These pause locations 
were identified by their Gaussian distribution graphs mean values (in bp) that were obtained 
from each peak. The difference between the mean values corresponded to 2 pause sites (as 
described in Figure 27). For each protein analysed, the standard deviations for these mean 
values was calculated. The average standard deviation was then determined for cJun on each 
DNA substrate. The mean average that determined the error margin was 80 bp. 
Next, all possible target site configurations could be calculated, for example, the distance 
between sites 1 to 2, sites 1 to 3, sites 1 to 4 and so forth. If the distance corresponds to 2 AP1 
target sites, a “Yes” will flag up within the grid situated to the right of the program. By clicking on 
the “Yes”, the precise binding sites can be determined. 
To activate the program, the user simply types the distance into the box and presses enter. Part 
of this Binding Site Position Finder can be seen in Figure 25.  
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Figure 25: Showing part of the Binding Site Position Finder analysis output. Part of strand λ DNA 2 (highlighted green) and the whole of  strand 1 (highlighted 
purple) can be seen in this screenshot image. This method used 3 strands (the third DNA strand cannot be seen in this image) of λ DNA which have been 
placed in tandem, covering 24 AP1 target sites in total. This analytical method was designed to calculate whether the measured distance between two pause 
sites corresponded to the protein landing within its AP1 target sites. 
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2.2.18.2: The adapted Binding Site Position Finder incorporating variant AP1 target sites 
Initially, the Binding Site Position Finder, as described in method 2.2.18.1, was used to identify 
whether the measured distance between two pause sites corresponded with their AP1 target 
sites. An unexpected percentage of translocating proteins paused directly within the 8 AP1 
target sites. This contradicted studies showing that these AP1 transcription factors can only bind 
to theit AP1 target site (Angel et al. 1988, Nakabeppu and Nathans 1989). The Binding Site 
Position Finder was therefore adapted to accommodate the single nucleotide substitutions 
within the AP1 target site sequence based on work performed by Seldeen et al (2009) 
described in sections 2.3.3 and 2.2.6.2. This adapted can only bind to theit AP1 target site 
(Angel et al. 1988, Nakabeppu and Nathans 1989). The Binding Site Position Finder now shows 
103 sites being present in total along a single piece of λ DNA. The order of these binding sites 
can be seen in Table 2. This analytical model functions in the same way as the previous Binding 
Site Position Finder.  
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Figure 26: The adapted Binding Site Position Finder. This program functions in the same way as the Binding Site Position Finder that is mentioned in Figure 
25. It incorporates 8 AP1 target sites and 95 variant AP1 target sites. This results in 103 sites in total that span the length of a single piece of λ DNA. Only 1 
piece of λ DNA has been used in this adapted program and all distances entered were quantified.  This meant that a single piece of DNA was sufficient for 
this analytical technique. Each AP1 target site has been highlighted in yellow. Like the previous Binding Site Position Finder, the user simply types the known 
distance in the red outlined box and presses enter. 
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Binding site Site number Binding site Site number 
TGACTCT 1 TGAATCA 53 
TCACTCA 2 TGACTAA 54 
TGACGCA 3 TTACTCA 55 
TGGCTCA 4 TCACTCA 56 
TGCCTCA 5 TTACTCA 57 
TGACACA 6 TGAATCA 58 
TGACTGA 7 TGTCTCA 59 
TAACTCA 8 GGACTCA 60 
TGACTCA 9 TGACCCA 61 
TGGCTCA 10 TGACTCG 62 
AGACTCA 11 TGACTGA 63 
TGAATCA 12 TGAATCA 64 
TGACTGA 13 TGACTGA 65 
TGTCTCA 14 TGGCTCA 66 
TGACTTA 15 TAACTCA 67 
GGACTCA 16 TGACTTA 68 
TGACCCA 17 TGACTCG 69 
TGACTCT 18 TGACTGA 70 
TGACTCC 19 TAACTCA 71 
AGACTCA 20 TGACGCA 72 
TGACTCT 21 TGAATCA 73 
TGACTCG 22 CGACTCA 74 
TCACTCA 23 TAACTCA 75 
AGACTCA 24 TGACGCA 76 
TGACTCT 25 TGACACA 77 
TGACTGA 26 TGAATCA 78 
TGGCTCA 27 TGAATCA 79 
TGACACA 28 TGAATCA 80 
TCACTCA 29 CGACTCA 81 
TGACCCA 30 TGCCTCA 82 
TGGCTCA 31 TGACTCA 83 
TGACTCA 32 TGGCTCA 84 
TGGCTCA 33 TGACTCC 85 
TGACTGA 34 TGACTCA 86 
TGACTCA 35 TGAATCA 87 
TGACGCA 36 CGACTCA 88 
TGACGCA 37 TGACTCT 89 
TGACTAA 38 TGACTCT 90 
TGACTGA 39 TGACTTA 91 
TGACTCA 40 TGACTCA 92 
TGTCTCA 41 CGACTCA 93 
TGACTCC 42 TGACTCG 94 
TCACTCA 43 TGACTCT 95 
TCACTCA 44 TGACGCA 96 
TGACGCA 45 TGACTGA 97 
TGCCTCA 46 TGGCTCA 98 
TGACTCA 47 TAACTCA 99 
AGACTCA 48 TGCCTCA 100 
TGAATCA 49 TGACTGA 101 
TGGCTCA 50 TGACCCA 102 
TGAATCA 51 TGACGCA 103 
TGACTAA 52   
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Table 2: A table showing the order of each binding site as they appear along a single piece of λ DNA. 
There are a total of 103 target sites. The wild type AP1 target sites have been highlighted in yellow.   
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2.2.19: Data for the Binding Site Position Finder 
cFos, cJun and cFos:cJun heterodimers travel along λ DNA in search of their AP1 target sites. 
As each single protein translocates, it can pause. Each pause time can vary in duration and 
some can be more obvious than others. Figure 15 shows examples of pauses that can be easily 
seen and those that cannot. 
To identify pauses as a protein diffuses along the DNA, the mean (pixels) value from each 
Gaussian distribution was first converted into base pairs. The mean values (base pairs) were 
then binned. The bin ranges were 5 times greater than the 8.7 nm (equivalent of 26 bp) spatial 
resolution of the Andor camera used during imaging. This meant that large, clear peaks could 
be seen in the histogram. A Gaussian distribution of each peak was calculated based on the 
peaks amplitude, the mean and standard deviation. The sum of the Gaussian distributions were 
calculated and Microsoft Solver program was used to fit the graph.  
The solved mean values for each Gaussian fit determined the position of each pause relative to 
each other. The difference between each pause site was quantified. This represented the 
distance in base pairs between pauses. These numbers were then entered into the adapted 
Binding Site Position Finder (as described in method 2.2.18.2) to identify whether the proteins 
paused specifically in their AP1 target sites or within the variant AP1 target sites. Examples of 
this have been shown in Figure 27.  
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826.08 249.31 293.62 315.90 317.33 
 
1075.39 542.93 609.52 633.22   
 
1369.01 858.82 926.84 
  
 
1684.91 1176.15 
   
 
2002.23   
     
Figure 27: As a protein travels along λ DNA, it pauses. This figure describes how each pause site was 
identified and whether the distances corresponded to the protein pausing inside AP1 or variant AP1 target 
sites. (a) An example kymograph of cFos travelling along λ DNA over a time frame of 120 seconds. 10 
pixels is 0.819 μm, the equivalent of 2410 bp (represented by the scale bar). Some pauses can be clearly 
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seen, whereas others are harder to identify. (b) The overlaid Gaussian distribution plots obtained from the 
above kymograph. The mean position of each solved Gaussian distribution plot are 1181 bp, 2007 bp, 
2256 bp, 2550 bp, 2866 bp and 3183 bp. These distances determined the proteins pause positions 
relative to each other. (c)  This table shows the number of times a site was visited as shown by the 
frequency. The mean position of each Gaussian distribution corresponds to a pause site and the standard 
deviation (SD) for the first plot has been identified. This number has been fixed across all Gaussian 
distributions in order to fit the data using Microsoft Solver. (d) Using the method outlined in Figure 22, the 
distinces between each Gaussian distributions mean (as shown in Figure 27c) have been calculated. For 
example, the distance between peak 1 and 2, peak 1 and 3 etc. This method meant that all of the 
distances between each pause site could be quantified. 
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2.3: Results 
To understand how cFos, cJun, cFos:cJun, FosW and FosW+cJun interact with λ DNA, the 
number of proteins bound to DNA were quantified and studied. The number of DNA tightropes 
bound complexes were quantified for the following: cFos (n = 330), cJun (n = 174) and 
cFos:cJun (n = 241). Similarly, when determining the number of bound complexes for FosW and 
FosW+cJun, 109 and 67 tightropes were observed respectively. Following this, further studies 
were performed to gain an insight into how the proteins interacted with the DNA and the 
formation of homodimeric and heterodimeric complexes were identified using dual colour Qdot 
labelling.  
2.3.1: Protein interaction with λ DNA. 
A Biotin tag was conjugated to the C-terminus of cFos, cJun and FosW. However, for the 
purpose of this study, a Biotin tag and a cJun DNA binding domain was a necessity as FosW 
could not be visualised without conjugated Streptavidin Qdots (as described in method 2.2.9). 
Qdot conjugated proteins could be visualised during imaging using OAF microscopy. 
Typically, cFos and FosW were labelled with red 655 nm emitting Qdots and cJun was labelled 
with green 525 nm emitting Qdots (Invitrogen) using a 1:4 peptide to Qdot ratio (as described in 
method 2.2.9). cFos, cJun and FosW were labelled with the afore-mentioned Qdots colours. 
cFos:cJun and FosW+cJun complexes were labelled using 2 colours. Dual colour experiments 
provided a host of red, green and dual coloured complexes. Dual colour labelling identified true 
heterodimeric complex formation. This colour labelling strategy was adopted throughout the 
entire duration of this study, ensuring that all proteins were fluorescently tagged prior to being 
loaded onto the DNA by using a 4 Qdots: 1 protein ratio as described in method 2.2.9. All 
studies were performed in a high salt buffer, mimicking intracellular conditions in vivo.  
Many Qdot-protein complexes were observed bound to the DNA. The longer the DNA tightrope, 
the more complexes bound. It was also found that very long tightropes tended to “sway”, 
resulting in the bound proteins not being analysed as they would present identical moving 
patterns that could be seen in the kymographs. Tightropes that appeared highly decorated with 
proteins were also avoided because of overcrowding. Therefore, tightropes with a minimum of 2 
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proteins bound were analysed. Proteins that were seen next to a bead were also not analysed. 
This was due to high fluorescence being emitted from the beads, obscuring protein movement 
from analysis.  
The first study performed aimed to determine the number of Qdot labelled cFos, cJun, 
cFos:cJun, FosW and FosW+cJun complexes that were observed bound to λ DNA, forming 
protein-DNA complexes, and to calculate the percentage of molecules that moved. Surprisingly, 
cFos was observed binding to the DNA. This is an unexpected phenomenon as many studies 
reported that cFos is unable to homodimerise or bind to DNA (Mason et al. 2006, Nakabeppu 
and Nathans 1989). 518 cFos, 266 cJun and 206 FosW molecules were observed using their 
respective single colours. To quantify cFos:cJun heterodimers, equal amounts of red labelled 
cFos and green labelled cJun were mixed (as described in 2.2.9). From this mixture 326 
molecules were analysed. 139 were red cFos complexes, 82 were green cJun complexes and 
105 were dual colour cFos:cJun heterodimers. Similarly, FosW+cJun dual coloured complexes 
were also identified. From this dual coloured mixture, 112 molecules were analysed. 60 
molecules were red FosW complexes, 24 molecules were green cJun and 28 molecules were 
dual labelled FosW+cJun heterodimeric complexes. 
In order to identify the number of bound molecules that moved along the DNA, kymographs 
were produced. These provided a fast and effective way of enabling each individual protein 
displacement to be tracked per time frame. Kymographs also enabled the diffusion constant 
(µm2s-1) and alpha value to be determined for each sliding protein. The data from this part of the 
study showed that 45% cFos, 71% cJun (t-test p-value = 0.03) and 55% of FosW diffused along 
λ DNA. 39% of cFos:cJun heterodimers (t-test p-value = 0.06) and 39% of FosW:cJun (t-test p-
value = 0.7) dual labelled complexes were also observed to diffuse along λ DNA (shown in 
Table 3). This data shows that cJun is the most mobile and the antagonistic peptide inhibitor 
FosW is the second most mobile complex. Surprisingly, cFos is the third most mobile complex 
and is capable of moving along DNA in addition to simply binding to it. cFos:cJun heterodimers 
and FosW+cJun are the least mobile. 
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As λ DNA contains methylated bases, non-methylated λ DNA was also used to understand 
whether these CH3 groups hindered protein movement. cJun was loaded onto the DNA as this 
molecule was the most mobile protein. 244 cJun molecules were observed bound to the DNA. 
When cJun was loaded onto non-methylated λ DNA, 60 ± 3.0 % moved in comparison to cJun 
on methylated λ DNA (t-test p-value = 0.6). 
The next part of this study was to identify the diffusion constants and α values for cFos, cJun, 
and FosW that travelled along λ DNA while in a high salt buffer by using Equation 1 (as 
described in method 2.2.16). cFos produced diffusion constants ranging from 1x10-5 to 1x10-1 
µm2s-1, cJun 1x10-4 to 1x10-1 µm2s-1 and FosW 1x10-5 to 1x10-2 µm2s-1. This meant that the 
average diffusion constants for cFos, cJun and FosW were 3.4x10-3± 8x10-4 µm2s-1, 1.2x10-2 ± 
4x10-3 µm2s-1 and 2.8x10-3 ± 7x10-4µm2s-1, respectively. These findings have been shown in 
Figure 28. 
To further understand how the proteins travelled along the DNA, their α values were 
determined. This provided an insight into the mode of travel used when locating an AP1 or 
variant AP1 target site. cFos produced α values ranging from 0.6 to 1.7, cJun 0.6 to 1.8 and 
FosW 0.6 to 1.9. Their average α values were 0.9 (SEM = +/- 0.03), 1.0 (SEM = +/- 0.05) and 
1.0 (SEM = +/- 0.05) respectively. Displaying an α value of <1 is indicative of the protein 
stringently searching the DNA for target sites using random diffusion. These can be seen in 
Figure 28. 
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λ DNA 
cFos 45 ± 3.7% (n = 518) 
cJun 71 ± 3.1% (n = 266) 
cFos:cJun 
Heterodimers 39 ± 6.1% (n = 326) 
FosW 55 ± 11.0% (n = 206) 
FosW + cJun 39 ± 11.0% (n = 112) 
 
Table 3: A table showing the percentage of cFos, cJun, cFos:cJun, FosW and FosW + cJun complexes 
that were observed diffusing along λ DNA. All cFos:cJun and FosW:cJun complexes that presented as 
dual colour were quantified as Heterodimeric. All complexes were observed while high salt buffer. 
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Figure 28: Graphs showing diffusion constants (µm
2
s
-1
) against their corresponding α values for cFos, 
cJun and FosW while in a high salt buffer. (a) cFos (n = 80) displays a range of diffusion constants 
between 1x10
-5
 and 1x10
-1
 µm
2
s
-1
 and α values between 0.5 and 1.9. (b) cJun (n = 41) shows a range of 
diffusion constants between 1x10
-4
 and 1x10
-1
 µm
2
s
-1
 and α values between 0.6 and 1.8. (c) FosW (n = 
33) shows a range of diffusion constants between 1x10
-5
 and 1x10
-2
 µm
2
s
-1
 and α values between 0.6 and 
1.9. A kymograph representing each proteins movement is situated to the right of each graph. The scale 
bar on each kymograph represents 10 pixels which is 0.819 μm, the equivalent of 2410 bp. 
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2.3.2: Protein colocalisation 
To visualise heterodimeric and homodimeric complexes that had bound to λ DNA, a dual colour 
labelling technique was used. cFos and FosW were labelled with red Qdots and cJun was 
labelled with green Qdots. After the dual labelled protein mixture was loaded onto the DNA, all 
of the single and dual coloured complexes observed were quantified. An example kymograph 
showing a dual coloured cFos:cJun heterodimer can be seen in Figure 29.  
One question that arose from the protein interaction data, as presented in section 2.3.1, was 
whether cFos remained monomeric or formed a homodimeric complex. cFos labelled with red 
and green Qdots were incubated together. 369 molecules were analysed; 66% (n = 242) were 
red, 8% (n = 29) were green and 27% (n = 98) were dual coloured complexes. Visualising cFos 
as a dual coloured complex answers this question and clearly shows that cFos is capable of 
homodimerising.  
The colocalisation of cJun was also visualised. 209 molecules were analysed; 60% (n = 125) 
were coloured red, 13% (n = 28) were coloured green and 27% (n = 56) were dual coloured. To 
visualise heterodimeric complex formation, cFos and cJun were mixed together; 326 molecules 
were analysed; 43% (n = 139) were red cFos, 25% (n = 82) were green cJun and 32% (n = 105) 
were dual coloured cFos:cJun heterodimers. The antagonistic peptide inhibitor FosW was also 
mixed with its target cJun protein and 112 molecules were analysed; 54% (n = 60) were red 
FosW, 21% (n = 24) were green cJun and 25% (n = 28) were dual coloured FosW+cJun 
complexes. ~30% of all complexes were visualised as dual colour. These results can be seen in 
Table 4. 
 
 
89 
 
 
 
Figure 29: (a) An image showing a cFos:cJun heterodimer in dual colour. (b) An example kymograph 
showing the dual coloured cFos:cJun heterodimer in Figure 29a diffusing along λ DNA. The scale bar 
represents 10 pixels. 
a 
b 
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Colocalised % on λ 
DNA 
cFos 27 ± 6.4% (n = 369) 
cJun 27 ± 10.4% (n = 209) 
cFos:cJun 
heterodimers 
32 ± 4.3% (n = 326) 
FosW + cJun 25 ± 11.0% (n = 112) 
 
Table 4: A table showing the percentage of colocalised dual coloured cFos, cJun, cFos:cJun and 
FosW:cJun complexes (protein labelling has been described in method 2.2.9) that were bound to λ DNA. 
All complexes were observed while in high salt buffer.  
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2.3.3: Protein binding positions along λ DNA  
As previously mentioned, studies have shown that cJun and cFos:cJun heterodimers bind to 
their AP1 target site only (Mason et al. 2006). Many studies concluded this by performing a 
Electrophoretic Mobility Shift Assay (EMSA). These assays used oligonucleotides that 
contained a centrally positioned AP1 target site. This meant that the ratio of protein-DNA 
complexes and unbound DNA could only be quantified via a gel matrix (Orchard and May 
1993).  
Seldeen et al (2009) followed up these initial EMSA results by using isothermal titration 
calorimetry and structural modelling to study the possibility of cFos:cJun heterodimers binding to 
synthetic dsDNA oligonucleotides that contained single nucleotide variations of the AP1 target 
site sequence TGACTCA. They found that the heterodimers bound to CGACTCA, TGACTCG, 
TGTCTCA, TGACACA, TGCCTCA and TGACGCA variant target sites. 
However, this thesis has demonstrated that cFos, cJun and cFos:cJun heterodimers can 
associate and travel along λ DNA while in a high salt buffer. In addition, pausing was observed 
as shown in Figure 12. The bottom protein shows clear pausing, whereas the upper protein 
trace shows an example of pausing that is less obvious and more difficult to quantify. Therefore, 
any cFos, cJun and cFos:cJun molecules that produced a diffusion constant (µm2s-1) and α 
value were further analysed to identify where these proteins may be pausing along λ DNA.  
There are 103 AP1 and variant AP1 target sites in total that span the length of a single piece of 
λ DNA. These sites have also been listed in Table 2. The number of pauses were quantified 
using Method 2.2.19. The distance (bp) and configuration between more than 2 pause sites 
were then calculated and these values were input into the Binding Site Position Finder. The 
possibility of a protein visiting particular sites was recorded and the total percentage was 
calculated. 
Table 6 shows the sites along λ DNA where cFos paused. 26 molecules were analysed. These 
provided 126 distances (bp) between pause locations that in turn produced 20,636 binding site 
possibilities. This data shows that the percentage of cFos binding into their AP1 target sites 
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varied from 0.4-1.5%. The remaining cFos molecules that bound to each variant AP1 target 
sites varied from 0.4-2.3%. The most commonly visited variant AP1 target site was TGCCTCA.  
Similarly, Table 7 shows were cJun paused as these molecules travelled along λ DNA. 17 
molecules were analysed. These provided 126 distances (bp) between pause locations and the 
number of binding site possibilities produced was 20,378. The percentage of cJun molecules 
that bound to their AP1 target sites varied from 0.3-1.7%. Also, the percentage of cJun that 
bound to each variant AP1 target sites ranged from 0.2-2.3%. Like cFos, the most common 
pause site was the variant AP1 target site TGCCTCA.  
Table 8 however shows where cFos:cJun heterodimers paused as they travelled along λ DNA. 
7 molecules were analysed and these provided 13 distances between pause locations. 1,940 
binding site possibilities were produced. It was found that the percentage of cFos:cJun 
heterodimers that bound to their AP1 target sites varied between 0.1-1.3%. The remaining 
molecules that bound to the variant AP1 target sites ranged between 0.1-2.8%. Unlike cFos and 
cJun, the most popular binding site that cFos:cJun heterodimers paused in was TGACTTA.  
To identify whether any of the AP1 and variant AP1 target sites were preferred by cFos, cJun 
and cFos:cJun heterodimers, a correlation graph (as shown in Figure 31) was plotted. This 
shows the percentage of pausing at each of the 103 target sites by all 3 proteins. cFos (blue) 
and cJun (pink) are visually similar. The cFos:cJun heterodimers (green) however show no 
correlation with cFos or cJun proteins. 
To validate the Binding Site Position Finder, random numbers between 1000 and 40,000 (λ 
DNA is 48,502 bp long) were generated in Excel using a random numbers formula. These 
numbers mimicked the distances between pauses taken by the simulated protein as it travelled 
along λ DNA. When the simulated protein travelled along pUC19 DNA, 20 distances were 
entered into the Binding Site Position Finder and these generated 1852 binding site possibilities. 
When this simulation is compared with cFos, cJun and cFos:cJun heterodimers pausing within 
their AP1 and variant AP1 target sites, no correlation can be seen. This simulated data can be 
seen in Table 5 and Figures 30 and 32.   
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Simulated protein on λ 
Binding site 
Start 
positions 
with error % Binding site 
Start 
positions 
with error % Binding site 
Start 
positions 
with error % 
TGACTCT 313 0.6 TGACGCA 20564 1.5 TAACTCA 29638 1.1 
TCACTCA 708 0.3 TGACGCA 20962 0.9 TGACGCA 30321 1.1 
TGACGCA 1545 0.7 TGACTAA 21030 1.2 TGAATCA 30593 1.2 
TGGCTCA 1658 0.8 TGACTGA 21144 1.1 CGACTCA 30761 1.3 
TGCCTCA 2465 0.5 TGACTCA 21153 1.0 TAACTCA 31170 1.1 
TGACACA 2799 0.6 TGTCTCA 21420 1.0 TGACGCA 31344 1.1 
TGACTGA 3092 0.8 TGACTCC 21657 1.3 TGACACA 32092 0.9 
TAACTCA 3507 0.5 TCACTCA 21766 1.2 TGAATCA 32338 1.2 
TGACTCA 3843 0.8 TCACTCA 21986 1.0 TGAATCA 32825 1.2 
TGGCTCA 4995 0.6 TGACGCA 22056 1.0 TGAATCA 33563 1.0 
AGACTCA 5352 0.9 TGCCTCA 22155 1.4 CGACTCA 33769 1.1 
TGAATCA 7093 0.8 TGACTCA 22682 1.1 TGCCTCA 35793 1.0 
TGACTGA 7097 0.8 AGACTCA 22764 1.1 TGACTCA 36560 0.6 
TGTCTCA 8114 1.0 TGAATCA 22851 1.3 TGGCTCA 37410 0.9 
TGACTTA 8919 0.6 TGGCTCA 22934 1.3 TGACTCC 38677 1.0 
GGACTCA 9110 0.9 TGAATCA 23490 0.9 TGACTCA 41893 0.4 
TGACCCA 9321 0.9 TGACTAA 23531 1.1 TGAATCA 43861 0.6 
TGACTCT 9701 1.0 TGAATCA 23812 1.4 CGACTCA 43939 0.8 
TGACTCC 9827 0.7 TGACTAA 23911 1.3 TGACTCT 43963 0.8 
AGACTCA 10576 1.1 TTACTCA 24693 1.1 TGACTCT 44467 0.8 
TGACTCT 10614 1.2 TCACTCA 24705 1.1 TGACTTA 44553 0.6 
TGACTCG 11096 1.2 TTACTCA 25299 1.0 TGACTCA 44581 0.7 
TCACTCA 11100 1.2 TGAATCA 25507 1.0 CGACTCA 44805 0.5 
AGACTCA 11671 1.2 TGTCTCA 25603 1.2 TGACTCG 45437 0.7 
TGACTCT 12058 1.1 GGACTCA 26157 1.3 TGACTCT 45972 0.9 
TGACTGA 12289 1.0 TGACCCA 26191 1.3 TGACGCA 46132 0.6 
TGGCTCA 12776 1.3 TGACTCG 26281 1.3 TGACTGA 46262 0.6 
TGACACA 14134 0.7 TGACTGA 26744 1.3 TGGCTCA 47445 0.6 
TCACTCA 14361 1.2 TGAATCA 27614 1.1 TAACTCA 47817 0.5 
TGACCCA 16343 1.0 TGACTGA 27794 1.5 TGCCTCA 47884 0.5 
TGGCTCA 18179 1.4 TGGCTCA 28285 0.8 TGACTGA 47938 0.4 
TGACTCA 19119 0.9 TAACTCA 28718 1.3 TGACCCA 48180 0.3 
TGGCTCA 19341 1.1 TGACTTA 28923 1.0 TGACGCA 48391 0.6 
TGACTGA 20083 1.2 TGACTCG 29270 1.1       
TGACTCA 20096 1.3 TGACTGA 29450 1.1       
 
Table 5: A table showing the percentage of pausing within each AP1 and variant AP1 target site by a 
simulated protein as it travelled along the λ DNA. The 103 AP1 (highlighted yellow) and variant AP1 
target sites have been listed in columns 1, 4 and 7 in the order in which they appear along the DNA. The 
starting position for each corresponding site is listed in columns 2, 5 and 8. The number of times a protein 
paused within each site has been shown as a percentage. These can be seen in columns 3, 6 and 9. 
Pausing within the AP1 and variant AP1 target sites varied from 0.6-1.3% and 0.3-1.5%, respectively. 
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Figure 30: A graph representing the percentage of pausing at each of the 103 target sites by a computer 
simulated protein as it travelled along λ DNA.  
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cFos binding positions 
Binding 
site 
Start 
position 
on λ % 
Binding 
site 
Start 
position 
on λ % 
Binding 
site 
Start 
position 
on λ % 
TGACTCT 313 0.5 TGACGCA 20564 1.2 TAACTCA 29638 1.0 
TCACTCA 708 0.6 TGACGCA 20962 1.1 TGACGCA 30321 0.9 
TGACGCA 1545 0.7 TGACTAA 21030 1.1 TGAATCA 30593 1.0 
TGGCTCA 1658 1.1 TGACTGA 21144 1.0 CGACTCA 30761 1.4 
TGCCTCA 2465 1.2 TGACTCA 21153 1.3 TAACTCA 31170 1.3 
TGACACA 2799 0.6 TGTCTCA 21420 2.1 TGACGCA 31344 1.2 
TGACTGA 3092 0.6 TGACTCC 21657 1.6 TGACACA 32092 0.8 
TAACTCA 3507 0.9 TCACTCA 21766 1.3 TGAATCA 32338 0.4 
TGACTCA 3843 0.5 TCACTCA 21986 1.6 TGAATCA 32825 0.7 
TGGCTCA 4995 0.6 TGACGCA 22056 1.3 TGAATCA 33563 0.6 
AGACTCA 5352 0.7 TGCCTCA 22155 2.3 CGACTCA 33769 1.0 
TGAATCA 7093 0.8 TGACTCA 22682 1.5 TGCCTCA 35793 0.6 
TGACTGA 7097 0.5 AGACTCA 22764 0.8 TGACTCA 36560 0.5 
TGTCTCA 8114 0.4 TGAATCA 22851 1.4 TGGCTCA 37410 0.6 
TGACTTA 8919 0.9 TGGCTCA 22934 1.6 TGACTCC 38677 0.4 
GGACTCA 9110 1.2 TGAATCA 23490 1.5 TGACTCA 41893 0.4 
TGACCCA 9321 1.0 TGACTAA 23531 1.3 TGAATCA 43861 0.9 
TGACTCT 9701 1.0 TGAATCA 23812 1.0 CGACTCA 43939 1.0 
TGACTCC 9827 1.0 TGACTAA 23911 1.2 TGACTCT 43963 1.0 
AGACTCA 10576 1.0 TTACTCA 24693 0.8 TGACTCT 44467 1.2 
TGACTCT 10614 1.0 TCACTCA 24705 0.7 TGACTTA 44553 1.7 
TGACTCG 11096 0.9 TTACTCA 25299 1.0 TGACTCA 44581 0.6 
TCACTCA 11100 1.0 TGAATCA 25507 1.0 CGACTCA 44805 1.1 
AGACTCA 11671 0.8 TGTCTCA 25603 1.2 TGACTCG 45437 1.1 
TGACTCT 12058 0.9 GGACTCA 26157 0.7 TGACTCT 45972 1.0 
TGACTGA 12289 0.5 TGACCCA 26191 0.8 TGACGCA 46132 0.8 
TGGCTCA 12776 1.4 TGACTCG 26281 1.1 TGACTGA 46262 0.6 
TGACACA 14134 1.0 TGACTGA 26744 0.5 TGGCTCA 47445 1.1 
TCACTCA 14361 0.6 TGAATCA 27614 0.7 TAACTCA 47817 1.0 
TGACCCA 16343 0.5 TGACTGA 27794 0.9 TGCCTCA 47884 0.9 
TGGCTCA 18179 0.7 TGGCTCA 28285 0.7 TGACTGA 47938 0.9 
TGACTCA 19119 0.7 TAACTCA 28718 1.4 TGACCCA 48180 1.3 
TGGCTCA 19341 1.3 TGACTTA 28923 1.4 TGACGCA 48391 1.0 
TGACTGA 20083 0.5 TGACTCG 29270 1.6       
TGACTCA 20096 0.9 TGACTGA 29450 1.1       
Table 6: A table showing the percentage of moving cFos molecules (n = 26) that bound to all AP1 
(highlighted yellow) and variant AP1 target sites as they travelled along λ DNA. Columns 1, 4 and 7 show 
the 103 AP1 and variant AP1 target sites in the order in which they appear along a piece of λ DNA. 
Columns 2, 5 and 8 show the starting position (including the 80 bp error margin) of each target site and 
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columns 3, 6 and 9 show the percentage of molecules that bound to each site. 2.3% of cFos visited the 
variant AP1 target site TGCCTCA (highlighted green), making this the most commonly visited site. 0.4-
1.5% of the molecules visited their AP1 target sites. 
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cJun binding positions 
Binding 
site 
Start 
position 
on λ % 
Binding 
site 
Start 
position 
on λ % 
Binding 
site 
Start 
position 
on λ % 
TGACTCT 313 0.4 TGACGCA 20564 1.4 TAACTCA 29638 1.0 
TCACTCA 708 0.4 TGACGCA 20962 1.4 TGACGCA 30321 1.0 
TGACGCA 1545 0.5 TGACTAA 21030 1.3 TGAATCA 30593 1.1 
TGGCTCA 1658 0.9 TGACTGA 21144 1.3 CGACTCA 30761 1.2 
TGCCTCA 2465 1.0 TGACTCA 21153 1.4 TAACTCA 31170 1.1 
TGACACA 2799 0.7 TGTCTCA 21420 2.0 TGACGCA 31344 1.1 
TGACTGA 3092 0.6 TGACTCC 21657 1.8 TGACACA 32092 0.9 
TAACTCA 3507 0.8 TCACTCA 21766 1.6 TGAATCA 32338 0.6 
TGACTCA 3843 0.7 TCACTCA 21986 1.7 TGAATCA 32825 0.7 
TGGCTCA 4995 0.5 TGACGCA 22056 1.5 TGAATCA 33563 0.5 
AGACTCA 5352 0.6 TGCCTCA 22155 2.3 CGACTCA 33769 0.7 
TGAATCA 7093 0.5 TGACTCA 22682 1.7 TGCCTCA 35793 0.3 
TGACTGA 7097 0.5 AGACTCA 22764 1.3 TGACTCA 36560 0.3 
TGTCTCA 8114 0.6 TGAATCA 22851 1.5 TGGCTCA 37410 0.4 
TGACTTA 8919 0.8 TGGCTCA 22934 1.7 TGACTCC 38677 0.3 
GGACTCA 9110 1.1 TGAATCA 23490 1.5 TGACTCA 41893 0.4 
TGACCCA 9321 1.1 TGACTAA 23531 1.4 TGAATCA 43861 0.8 
TGACTCT 9701 1.0 TGAATCA 23812 1.2 CGACTCA 43939 0.9 
TGACTCC 9827 1.1 TGACTAA 23911 1.3 TGACTCT 43963 0.9 
AGACTCA 10576 1.0 TTACTCA 24693 1.0 TGACTCT 44467 1.0 
TGACTCT 10614 1.0 TCACTCA 24705 0.9 TGACTTA 44553 1.3 
TGACTCG 11096 0.9 TTACTCA 25299 1.1 TGACTCA 44581 0.8 
TCACTCA 11100 1.1 TGAATCA 25507 1.1 CGACTCA 44805 1.1 
AGACTCA 11671 0.9 TGTCTCA 25603 1.2 TGACTCG 45437 1.1 
TGACTCT 12058 0.8 GGACTCA 26157 1.9 TGACTCT 45972 1.1 
TGACTGA 12289 0.7 TGACCCA 26191 0.9 TGACGCA 46132 0.8 
TGGCTCA 12776 1.1 TGACTCG 26281 1.1 TGACTGA 46262 0.7 
TGACACA 14134 0.7 TGACTGA 26744 0.8 TGGCTCA 47445 1.0 
TCACTCA 14361 0.3 TGAATCA 27614 0.9 TAACTCA 47817 0.8 
TGACCCA 16343 0.2 TGACTGA 27794 1.1 TGCCTCA 47884 0.8 
TGGCTCA 18179 0.5 TGGCTCA 28285 0.9 TGACTGA 47938 0.8 
TGACTCA 19119 0.7 TAACTCA 28718 1.2 TGACCCA 48180 1.0 
TGGCTCA 19341 1.1 TGACTTA 28923 1.3 TGACGCA 48391 0.8 
TGACTGA 20083 0.9 TGACTCG 29270 1.3       
TGACTCA 20096 1.2 TGACTGA 29450 1.0       
Table 7: A table showing the percentage of moving cJun (n = 17) molecules that bound to AP1 
(highlighted yellow) and variant AP1 target sites as they travelled along λ DNA. Like cFos, 2.3% of all 
cJun molecules bound to the variant target site TGCCTCA (highlighted green), making this the most 
commonly visited site. 0.3-1.7% of all cJun molecules bound to their AP1 target sites. 
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 cFos:cJun binding positions 
Binding 
site 
Start 
position % 
Binding 
site 
Start 
position % 
Binding 
site 
Start 
position % 
TGACTCT 313 0.6 TGACGCA 20564 0.5 TAACTCA 29638 0.8 
TCACTCA 708 0.6 TGACGCA 20962 0.5 TGACGCA 30321 1.1 
TGACGCA 1545 0.5 TGACTAA 21030 0.3 TGAATCA 30593 0.9 
TGGCTCA 1658 1.8 TGACTGA 21144 0.2 CGACTCA 30761 1.6 
TGCCTCA 2465 1.6 TGACTCA 21153 0.6 TAACTCA 31170 1.6 
TGACACA 2799 0.1 TGTCTCA 21420 1.8 TGACGCA 31344 1.2 
TGACTGA 3092 0.1 TGACTCC 21657 0.8 TGACACA 32092 1.1 
TAACTCA 3507 1.0 TCACTCA 21766 0.1 TGAATCA 32338 0.2 
TGACTCA 3843 0.6 TCACTCA 21986 1.0 TGAATCA 32825 0.7 
TGGCTCA 4995 0.7 TGACGCA 22056 0.1 TGAATCA 33563 0.5 
AGACTCA 5352 0.8 TGCCTCA 22155 2.8 CGACTCA 33769 1.7 
TGAATCA 7093 1.3 TGACTCA 22682 1.2 TGCCTCA 35793 0.6 
TGACTGA 7097 1.3 AGACTCA 22764 0.2 TGACTCA 36560 0.7 
TGTCTCA 8114 0.5 TGAATCA 22851 1.3 TGGCTCA 37410 1.2 
TGACTTA 8919 0.6 TGGCTCA 22934 1.5 TGACTCC 38677 1.1 
GGACTCA 9110 1.4 TGAATCA 23490 1.4 TGACTCA 41893 1.4 
TGACCCA 9321 1.2 TGACTAA 23531 1.0 TGAATCA 43861 4.0 
TGACTCT 9701 0.9 TGAATCA 23812 0.8 CGACTCA 43939 1.3 
TGACTCC 9827 1.0 TGACTAA 23911 1.2 TGACTCT 43963 1.1 
AGACTCA 10576 1.0 TTACTCA 24693 0.8 TGACTCT 44467 0.9 
TGACTCT 10614 1.2 TCACTCA 24705 0.3 TGACTTA 44553 2.5 
TGACTCG 11096 0.9 TTACTCA 25299 0.5 TGACTCA 44581 0.1 
TCACTCA 11100 1.6 TGAATCA 25507 0.8 CGACTCA 44805 0.7 
AGACTCA 11671 0.4 TGTCTCA 25603 1.1 TGACTCG 45437 1.0 
TGACTCT 12058 0.7 GGACTCA 26157 0.5 TGACTCT 45972 1.6 
TGACTGA 12289 0.5 TGACCCA 26191 0.7 TGACGCA 46132 0.5 
TGGCTCA 12776 2.3 TGACTCG 26281 1.5 TGACTGA 46262 0.4 
TGACACA 14134 2.0 TGACTGA 26744 0.1 TGGCTCA 47445 1.1 
TCACTCA 14361 0.6 TGAATCA 27614 0.7 TAACTCA 47817 0.6 
TGACCCA 16343 0.6 TGACTGA 27794 1.9 TGCCTCA 47884 0.9 
TGGCTCA 18179 1.4 TGGCTCA 28285 0.5 TGACTGA 47938 0.8 
TGACTCA 19119 0.7 TAACTCA 28718 1.3 TGACCCA 48180 1.6 
TGGCTCA 19341 1.8 TGACTTA 28923 1.8 TGACGCA 48391 1.5 
TGACTGA 20083 0.1 TGACTCG 29270 1.8       
TGACTCA 20096 1.3 TGACTGA 29450 0.8       
Table 8: A table showing the percentage of moving cFos:cJun (n = 7) molecules that bound to AP1 
(highlighted yellow) and variant AP1 target sites as they travelled along λ DNA. 2.8% of the heterodimeric 
complexes commonly visited the variant AP1 target site TGCCTCA (highlighted green). 0.1-1.3% of the 
molecules visited their AP1 target sites. 
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Figure 31: This graph shows the correlation between the percentage of cFos (n = 26), cJun (n = 17) and cFos:cJun heterodimeric (n = 7) moving molecules 
that paused within AP1 and variant AP1 target sites while travelling along λ DNA (as shown by Tables 6, 7 and 8). cFos and cJun molecules are visually 
similar. However cFos:cJun heterodimers do not follow the same correlation pattern.  
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Figure 32: A graph showing a comparison between cFos, cJun and cFos:cJun heterodimers that bound to each of the target sites on λ DNA with the 
simulated protein. No correlation can be seen when comparing the proteins with the simulated protein.  
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2.4: Discussion 
The way cJun and cFos:cJun bind to DNA and locate their AP1 target sites has not been 
studied before to our knowledge. Using a single molecule tightrope approach, this study 
provides a direct insight into how these transcriptional regulators search the DNA for their AP1 
target sites. 
2.4.1: cFos, cJun and cFos:cJun heterodimers interacting with λ DNA 
It was important to understand how many proteins bound to DNA. λ DNA was used in this study 
as it is 48, 502 bp long, was readily available and also contains 8 AP1 target sites. As expected, 
cJun and cFos:cJun bound to the DNA. To test the canonical view that cFos is unable to bind to 
DNA alone, cFos was loaded onto λ. Substantial binding was observed and cFos homodimers 
as dual labelled complexes were seen. Thiscontradicted previous studies which showed that 
cFos cannot homodimerise but can only heterodimerise with cJun (Hai and Curran 1991, 
Schuermann et al. 1989, Woolfson and Alber 1995, Mason et al. 2006). The way cFos binds 
was the investigated.  
This thesis provides direct visual evidence that cFos is capable of homodimerising on DNA, 
however the structural mechanism requires analysis of cFos DNA binding domain compared 
with cJun. In terms of arginine and lysine enrichment only, cFos is not too dissimilar to cJun. 
cFos however has 24 amino acid residues within its DNA binding domain (as shown in Figure 
5). Three of which are arginine and seven lysine. cJun however has 22 amino acid residues: 
Four are arginine and seven are lysine. These positively charged amino acid residues enable 
electrostatic interactions with the negatively charged phosphate backbone of the DNA forming a 
protein-DNA complex.  However, to fully understand how cFos interacts and binds to the DNA, 
x-ray crystallography studies should be performed to determine this protein-DNA interaction at a 
structural level (Dey et al. 2012, Rohs et al. 2010).   
The percentage of cFos, cJun and cFos:cJun complexes that were observed travelling along λ 
DNA tightropes were quantified. cJun was the most mobile complex as 71% were observed 
travelling along the DNA. Although cFos was observed bound to DNA, 45% (t-test p-value = 
0.03) of these proteins were also diffusing. Therefore, like cFos, performing x-ray 
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crystallography structural studies may give a greater perspective of not only how these proteins 
are able to bind to the DNA but also of how they move. From the colocalised heterodimeric 
complexes, 39% (t-test p-value = 0.06) were observed diffusing in comparison to cJun. Despite 
the limited cFos:cJun heterodimer sample size (n = 41), a clear trend can be seen here 
although this result may not be statistically significant. This data implies that the cFos:cJun 
heterodimeric complex is so stable that it also becomes rigid and unable to bind and move 
along the DNA as efficiently as cJun. This finding suggests that residues inside of the leucine 
zipper region may be contributing towards how the protein is able to mobilise while bound to the 
DNA. Also, electrostatic interactions between arginine and lysine within the DNA binding domain 
with DNA are not completely responsible for protein movement. 
FosW and FosW+cJun complexes that were observed travelling along the DNA tightropes were 
quantified. FosW, however has the same DNA binding domain as cJun that is enriched with 
arginine and lysine. It was therefore predicted to move in the same manner as cJun. However, 
only 55% of FosW were seen moving when compared with 71% mobile cJun. When FosW 
formed a heterodimeric complex with cJun, 39% (t-test p-value = 0.7) were observed moving 
and this is not statistically significant when compared with FosW alone. The leucine zipper 
region may be contributing towards the movement of the complex. This result does show that 
FosW is capable of locating and bind to its target cJun (Worrall and Mason 2011). Therefore, 
two things can be suggested. Firstly, as hypothesised, it was believed that FosW has a much 
stronger affinity for its target cJun, more so than cJun has for itself (Mason et al. 2006). 
Secondly, increasing the ratio of inhibitor to protein may enable 100% formation of FosW+cJun 
complexes. 
2.4.2: Protein colocalisation 
As described in section 1.3, it was previously believed that cJun is capable of homodimerising in 
addition to heterodimerising with cFos (Walters et al. 2014). This theory was confirmed as 27% 
cJun were observed as dual coloured complexes when studied alone.  
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As previously mentioned, cFos was believed to be incapable of homodimerising (Schuermann 
et al. 1989). This study clearly shows that 27% of cFos can homodimerise due to the 
observation of dual coloured complexes. This result therefore contradicts other studies which 
concluded that cFos is unable to homodimerise (Walters et al. 2014, Eferl and Wagner 2003). In 
addition, this result confirms the original proposition made by Landschultz et al in 1988 
suggesting that cFos is capable of homodimerising. 
When red labelled cFos and green labelled cJun were mixed together, all complexes observed 
as dual colour were quantified. This was important as 3 different coloured complexes were 
observed, that is, red labelled cFos, green labelled cJun and dual labelled cFos:cJun 
heterodimers by using the technique described in method 2.2.9. All proteins that showed 
colocalisation appeared dual coloured. Therefore, any observed dual coloured complexes were 
quantified as heterodimers. cFos:cJun heterodimers showed 32% colocalisation. This low 
colocalisation percentage (t-test p-value = 0.4) was unexpected as it  was previously thought 
that cFos and cJun had the greatest affinity for each other out of all of the complexes formed 
(Mason et al. 2006, Nakabeppu et al. 1988).  
2.4.3: Interaction between FosW and cJun 
The antagonistic peptide inhibitor FosW was also loaded onto the DNA to observe binding 
events prior to quantifying how many complexes it formed with its target cJun. Visualising FosW 
is important due to its potential cancer therapeutic effects that could eventually lead to the 
development of a cancer fighting drug. Primarily, this peptide inhibitor was designed to target 
cJun, preventing it from homodimerising. FosW also has a more stable interaction with cJun 
than cJun has for itself (Mason et al. 2006).  
Traditionally, this inhibitor does not contain a biotin tag or a DNA binding domain and differs 
structurally from wild-type cFos (Worrall and Mason 2011). However for the purpose of this 
study, a cJun DNA binding domain was attached and cloned into the sequence enabling any 
binding events to be visualised and quantified. A cJun DNA binding domain was chosen as 
cJun is the most mobile protein and during the development of this inhibitor, it was believed that 
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cFos could not bind to DNA or homodimerise. This study has shown that FosW is also capable 
of binding to the DNA, which was expected due to its cJun DNA binding domain.  
The amount of colocalisation observed between FosW and its target cJun was 25%. As a 
primary result, this suggests that the ratio of FosW to cJun needs to be increased, especially 
when cJun is in excess during tumorigenesis. The mechanism used by the AP1 transcription 
factors and the biological peptide inhibitor FosW when swapping partners is currently unknown. 
2.4.4: Movement along DNA 
Upon binding, cFos, cJun, cFos:cJun and FosW were able to randomly diffuse along the DNA 1-
Dimensionally as indicated by their α values. This has also been simulated by a computerised 
protein taking a random walk as shown in section 2.2.16. cJun diffuses along the DNA more 
than cFos (t-test p-value = 0.02). FosW diffusion is similar to cFos (t-test p-value = 0.5) although 
there is no statistical significance. This again coincides with the possibility that core residues 
inside of the leucine zipper regions of cFos and FosW may determine how the protein is able to 
bind and move along DNA. However, when FosW was compared with cJun (t-test p-value = 
0.01), as both have the same DNA binding domain, these are statistically significant. These 
findings suggest that cFos, cJun, cFos:cJun and FosW use 3-Dimensional diffusion to locate 
and bind to a non-specific part of the DNA sequence. Once bound, these proteins and the 
inhibitor then use 1-Dimensional diffusion to search the DNA for their target sites (Kampmann 
2005).   
As the proteins search the DNA, they may be using macroscopic association and dissociation 
events, such as jumping. This diffusion mechanism not only expands the proteins search radius 
over a greater distance, it also prevents the proteins from unnecessarily searching stretches of 
DNA that is target free. When a protein jumps, it uses 3-Dimensional diffusion to bind to a site 
further away on another part of the DNA (Kampmann 2004, Berg et al. 1981, Von Hippel 1994, 
Halford and Marko 2004). In contrast to macroscopic binding events such as jumping, the 
proteins may also be using a series of microscopic association and dissociation events such as 
hopping. The protein will either re-associate itself with the DNA at a site close by that it has a 
high affinity for, or it will dissociate and reassociate itself with the same area of binding 
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(Kampmann 2004). Jumping is one mechanism used by the proteins as they use 1-Dimensional 
diffusion to randomly search along the DNA backbone for the AP1 target sites.  
2.4.5: Pausing along the DNA 
cFos, cJun and cFos:cJun heterodimers were all observed to bind non-specifically along the 
DNA and pause. To investigate why this occurs, a Binding Site Position Finder was generated. 
This determined the possibility of where cFos, cJun and cFos:cJun heterodimers paused during 
their travel along the DNA, even though there was no defined sequence context to work on. 
Less than 2% of all proteins bound to each AP1 target site present along λ DNA. This was an 
unexpected result and contradicts studies that suggest cJun and cFos:cJun heterodimers are 
able to bind directly to AP1 only (Jochum et al. 2001, Leaner et al. 2003, Mason et al. 2006). 
However, cFos is capable of locating its AP1 target site and binding to it. Now the question 
remains as to where the proteins are pausing in addition to their AP1 target sites. Based on the 
Seldeen et al (2009) study, as described in section 2.1, cFos, cJun and cFos:cJun heterodimers 
paused within all of the variant AP1 target sites and this varied from 0.1-2.8%. The most 
commonvariant AP1 target site was TGCCTCA for all 3 proteins. It was previously reported that 
cFos:cJun heterodimers have a high affinity for these variant AP1 target sites (Seldeen et al. 
2009). However this study also shows that cFos and cJun are capable of binding to this 
particular sequence. The relative binding of the proteins in two or more target sites provides a 
fingerprint for which target site sequences the proteins pause within. 
This data generated from the Binding Site Position Finder is important as it suggests that the 
proteins may be exerting alternative biological responses within the variant AP1 target sites in 
addition to binding to their AP1 target sites. This data is also in keeping with the “waiting room 
model.” This can be defined as target areas of DNA that the proteins have a high affinity for in 
addition to AP1. The proteins may intermittently bind and pause within these target areas until 
an AP1 target site becomes available, resulting in the exertion of their biological function. This 
may be a way of controlling transcription. 
 
 
106 
 
2.4.6: Conclusions 
Within this Chapter, it can be concluded that cFos is capable of homodimerising. This previously 
unseen observation was shown by the colocalisation study. Further structural studies will need 
to be performed in order to understand how, although this most likely occurs at the dimerisation 
interface between the two cFos proteins leucine zipper region. Similarly, the antagonistic 
peptide inhibitor FosW can also bind to its target protein cJun as expected. In the future, a study 
could be performed to understand what ratio of the inhibitor FosW is required to form complete 
complex formation with its target cJun when cJun is in excess using OAF microscopy.   
All cFos, cJun, cFos:cJun, FosW and FosW+cJun complexes are capable of binding to DNA 
and undergoing 1-Dimensional sliding. FosW has the same diffusion constant as cFos, even 
though it contains a cJun DNA binding domain. This may be due to core residues inside of the 
leucine zipper region controlling DNA binding. Further studies will need to be performed to gain 
a greater understanding of how this occurs.  
Finally, <2% of cFos, cJun and cFos:cJun heterodimers bind to their AP1 target sites and 
binding to each variant AP1 target site varies between 0.1-2.8%. Further studies could be 
performed in the future to understand why these proteins pause within these variant sites and 
whether this is a mechanism of controlling transcription, as described by the “waiting room 
model.”  
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Chapter 3: cFos, cJun and cFos:cJun interaction with different DNA substrates 
This chapter aims to study how cFos, cJun, cFos:cJun heterodimers and FosW +/- cJun interact 
with pUC19, pUCap1 and TFλ DNA tightropes while being visualised using OAF microscopy. 
The proteins mode of diffusion, diffusion constant and α-value will be determined using MSD 
analysis from data obtained from the proteins kymographs. Any colocalisation observed 
between AP1 family members will also be determined based on whether the proteins have 
formed homodimers or heterodimers once bound to the DNA.  
An additional aim in this chapter is to determine where the proteins bind and pause along the 
DNA tightropes using Gaussian distribution plots and the Binding Site Position Finder. This 
approach will help to identify whether the proteins are just pausing within the AP1 target sites or 
whether they are also pausing within the variant AP1 target sites as well. 
3.1: Introduction 
Confirming previous reports, it was shown in the previous chapter that cJun can homodimerise 
or heterodimerise with cFos.  cFos can also homodimerise which has previously not been seen. 
cFos, cJun and cFos:cJun heterodimers can locate and bind to areas of non-cognate DNA that 
they have a high affinity for using 3-Dimensional diffusion. Once bound, the proteins use 
random 1-Dimensional diffusion in search of their AP1 target site TGACTCA where they can 
exert their biological function that initiates cellular proliferation, differentiation and apoptosis 
(Jochum et al. 2001, Leaner et al. 2003, Campbell 2005), as described in Chapter 2. These 
cellular functions become initiated through the MAP kinase cellular signalling pathway (Shaulian 
and Karin 2001, Brown 2007). However, when the p53 gene becomes antagonised 
downstream, this causes the suppression of apoptosis and the survival of tumour cells due to 
the cell cycle being disrupted (Brown 2007, Shaulian and Karin 2001). As a result, cFos causes 
osteosarcomas (Wagner and Eferl 2005, Wang et al. 1995, Karin et al. 1997) and cJun initiates 
hepatocellular carcinoma and squamous cell carcinoma (Zhang et al. 2006), as described in 
Chapter 1. The mechanism used during the proliferation of tumorigenesis is currently unknown 
(Wagner 2001). 
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Chapter 2 has also demonstrated that while the proteins did search the DNA, less than 3% of 
cFos, cJun and cFos:cJun heterodimers were found pausing within their AP1 target sites. This 
result disputed bulk-phase experiments, such as EMSA studies, that can only quantify the ratio 
of protein-DNA binding events (Orchard and May 1993). Even though non-specific pausing was 
observed in Chapter 2, this was also observed within this chapter when the proteins interacted 
with pUC19 and pUCap1 Target-Free λ (TFλ) and DNA substrates. To understand how the 
proteins diffused and where they were pausing, the fore-mentioned DNA substrates were used. 
Based on the study by Seldeen et al (2009), all single nucleotide substitutions within the AP1 
target sequence, known in this study as variant AP1 target sites, were identified (as described in 
Chapter 2 section 1.6). The locations of each of these variant AP1 target sites along the fore-
mentioned DNA substrates were determined. As pUC19 only contains variant AP1 target sites 
(pUCap1 is composed of pUC19 with the addition of a single AP1 target site), any pausing may 
be in keeping with the “waiting room model” as described in Chapter 2 section 1.8. To determine 
where the proteins were pausing, an adapted binding site position finder was used (original 
model described in Chapter 2 section 2.218) to incorporate all variant AP1 target sites present 
on pUC19 and pUCap1 DNA substrates. However, TFλ DNA is both variant and AP1 target site 
free. The rationale here is to determine how cJun will diffuse along the DNA in the absence of 
these target sites.  
In this work, some of these variant AP1 target sites, were also integrated alongside the AP1 
target sites. Any additional pausing was identified as being within these variant AP1 target sites. 
Therefore, pausing within these variant AP1 target sites may be a mechanism used to by the 
proteins to control transcription, described as the “waiting room model.” This is where the 
proteins may wait until an AP1 target site becomes available. Alternatively, cFos and cJun may 
be exerting their biological function within these variant AP1 sites. It has previously been 
suggested that the cFos:cJun heterodimers may be regulating specific genes within these 
variant AP1 target sites (Seldeen et al. 2009). This is currently unknown, however the research 
here could lead to the establishment of these sites as important in cellular pathways that control 
the transcription of other genes in addition to the biological functions already controlled by AP1. 
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The aim of this chapter is to perform some of the same experiments, as mentioned in Chapter 2, 
to determine whether partner swapping still occurs on different types of DNA and how cFos, 
cJun and cFos:cJun heterodimers interact with pUC19, pUCap1 and Target-Free λ (TFλ) DNA 
substrates. The plasmid pUC19 is 2686 bp long and does not contain any AP1 target sites. 
However it does contain 11 variant AP1 target sites. pUCap1 DNA is a variation of pUC19 
whereby a single AP1 target site has been cloned at position 417 of the plasmid. These DNA 
substrates were used to understand whether the absence of AP1 target sites hindered or 
promoted protein movement. The final type of DNA used was TFλ, a 962 bp section of λ DNA 
that is free from AP1 and variant AP1 target sites. It was therefore hypothesised that cJun could 
continuously move along the DNA without pausing in search of its target sites. 
This chapter shows that cFos, cJun and cFos cJun heterodimers interact with different DNA 
substrates. It was observed that when cFos, cJun and cFos:cJun heterodimers interacted with 
pUC19 and pUCap1 DNA, the proteins bound, moved and paused within the AP1 and variant 
AP1 target sites. An unexpected observation was cJun was mostly static when interacting with 
TFλ. 
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3.2: Materials and methods 
3.2.1: Digestion of pUC19 
pUC19 is a commercially available small, circular DNA plasmid that is 2,686 bp in length. This 
plasmid provides resistance to the antibiotic Ampicillin (Amp1). Within the plasmid there is a 
Multiple Cloning Site (MCS) that contains many restriction endonuclease cleavage sites. There 
are no WT AP1 target sites present in the pUC19 sequence. Therefore, this makes pUC19 a 
good negative control when comparing protein movement on DNA with and without the 
presence of AP1 target sites.  
The restriction endonuclease BamHI (10 u/µL), was chosen to cleave pUC19 at its 5’- GGATCC 
-3’ recognition sequence (indicated by the red arrow at position 417 bp in Figure 33), forming a 
‘sticky’ 5’- cohesive overhang of 5’- GATC -3’. BamHI has no star activity meaning it will not 
cleave at sites other than its recognition sequence. The restriction digest mixture was left to 
incubate for 2-16 hours at 37 °C and heat inactivated at 80 °C for 20 minutes 
(ThermoFisherScientific 2015). The incubation time depended on the amount of DNA to be 
cleaved as 1 unit of restriction endonuclease can digest 1 μg of DNA in 1 hour (Fermentas). 
The restriction endonucleases BamHI (10 u/µL) and HindIII (10 u/µL) cleaved DNA 
simultaneously (indicated by the blue arrow. Recognition sequence is 5’- AAGCTT -3’ as shown 
in Figure 33) and their compatibility and efficiency with each other was ensured to be between 
50-100% within the same digestion buffer. Like single cutters, dual cutting reactions were 
incubated for 2 - 16 hours depended on the efficiency of each cutter and the amount of DNA to 
be cleaved. 
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Figure 33: A circular plasmid map of Amp
1
 resistant pUC19. Recombinant pUC19 is a high copy number 
cloning vector that is 2,686 bp in length. Most pUC19 restriction sites are located within the MCS region. 
The blue arrow shows HindIII restriction site at position 447 and the red arrow shows BamHI restriction 
site at position 417. pUC19 contains no AP1 target sites. 
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3.2.2: AP1 oligonucleotide design 
In order to introduce a single WT AP1 target site with the recognition sequence 5’-TGACTCA-’3 
into pUC19 (that is WT target site free), an oligonucleotide was designed using an 
oligonucleotide properties calculator (Northwestern.University 2007). The oligonucleotide is 27 
bp dsDNA designed to incorporate a WT AP1 target site in the middle (shown in red), a HindIII 
restriction site (shown in green) and a BamHI restriction site (shown in blue). Each restriction 
site contains a 4 base overhang. This enables ligation to occur with another complementary 
sequence due to being phosphorylated at its 5’- end. Shown in black is a sequence of non-
cognate DNA between the AP1 target site and restriction sites. These additional bases increase 
the length of the oligonucleotide and its melting temperature. The oligonucleotides were 
designed so that they were completely complementary to each other and had a low probability 
of intramolecular hairpin formation.  
As there are 2 different restriction sites at either end of the oligonucleotide, this results in a 50% 
chance of forming tandem repeats with neighbouring pUC19 DNA strands with complementary 
ends. Successful ligation also depends on the correct orientation of the oligonucleotide. By 
having different restriction sites, this will reduce the chance of the oligonucleotides forming 
concatemers by 50%.  
In order to construct the oligonucleotide (shown in Figure 34), 20 µL of 100 µM sense and 
antisense oligonucleotides (each oligonucleotide was reconstituted in sterile H2O) were heated 
up to 95 °C for 5 minutes in a sterile microcentrifuge tube causing the strands to separate. 
These volumes were used as during heating some condensation can occur, reducing the final 
volume. The oligonucleotides were then slowly cooled to room temperature, enabling the 
oligonucleotides to self anneal (Sigma-Aldrich 2015). The newly annealed oligonucleotides were 
centrifuged for 5 seconds at 12,300 xg (xg calculated using the formula: G = 1.18 x R x (
   
    
)2.  
G is the G-force, R is the radius of rotation in mm and RPM is revolutions per minute) to ensure 
the solution was at the bottom of the microcentrifuge tube before storing at 4 °C. To avoid 
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repeated freeze-thaw cycles, 20 µL of each oligonucleotide was removed from the original 
stocks and aliquoted into sterile microcentrifuge tubes. These were stored at -20 °C until used.  
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Figure 34: A 27 bp self annealed oligonucleotide that contains a HindIII restriction site (green), a BamHI 
restriction site (blue) and a single AP1 target site (red). Each oligonucleotide contains no hairpins and 
cannot anneal to itself. The oligonucleotide is phosphorylated at its 5’- end. 
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3.2.3:  Making pUCap1 
pUCap1 was constructed (as shown in Figure 35) by first double-digesting pUC19 with BamHI 
(10 u/µL) and HindIII (10 u/µL) restriction endonucleases at 37 °C for 2-16 hours 
(ThermoFisherScientific 2015). To ensure that the double cleaved vector could not self anneal 
and ligate with itself during ligation with T4 DNA Ligase, phosphate groups from the 5’- end 
were removed using Fast Alkaline Phosphatase (FastAP. (ThermoFisherScientific 2015). This 
mixture was incubated for 15 minutes at 37 °C. FastAP was heat inactivated at 80 °C in 
accordance with the manufacturer guidelines. This temperature is higher than the 65 °C 
required to heat inactivate BamHI and HindIII. This meant that the restriction endonucleases 
were also inactivated.  
In the heat inactivated digestion mixture, there are large 2656 bp long pUC19 fragments and 
small 30 bp fragments. It was imperative that these smaller fragments were removed using a 
PCR clean up kit (Qiagen), otherwise they would be competing against the larger pUC19 
fragments for the donor AP1 oligonucleotide during the construction of pUCAP1 (Figure 34). 
After using the PCR clean up kit, this resulted in the 30 bp pUC19 fragment remaining only. To 
construct pUCap1, A 20 µL ligation mixture containing a 3:1 self annealed oligonucleotides to 
vector ratio respectively (based on their molarity ratio) was placed inside a sterile PCR tube and 
incubated in a PCR thermocycler (Techne TC-3000) at 16 °C for 15 minutes prior to adding T4 
DNA ligase (Thermo Scientific). This ensured that the components within the ligation mixture 
were equilibrated to 16 °C. After the addition of T4 DNA ligase, the mixture was incubated at 16 
°C overnight for 16 hours in a PCR thermocycler. To quench the reaction, a 10 µL stop buffer 
containing 2.4 M KCl was added to the reaction mixture. The KCl then diluted to 800 mM. This 
concentration can completely inhibit T4 DNA Ligase as shown in Figure 37, and quench the 
reaction. The newly created recombinant plasmid was transformed into Top10 Chemically 
Competent E. Coli (method 3.2.6). 
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Figure 35: A diagram showing the construction of pUCap1 (adapted from SnapGene), a circular DNA plasmid 2683 bp in length. Firstly, pUC19 was doubly 
cleaved with BamHI and HindIII restriction endonucleases followed by dephosphorylation with FastAP. This prevents plasmid religation and/or 
recircularisation upon ligation. The 30 bp cleaved fragment was removed using a PCR clean up kit. The self annealed donor 27 bp oligonucleotide (Figure 34) 
was inserted using a 3 oligos:1 vector ratio and ligated at 16 °C for 16 hours overnight using T4 DNA Ligase. The reaction was quenched with 800 mM KCl. 
The newly created recombinant plasmid was transformed into Top10 Chemically Competent E. coli. 
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3.2.4: Sequencing of pUCap1 
To confirm that the correct pUCap1 construct had been made (as demonstrated in Figure 36), 
100ng/µL was sent for sequencing (GATC) using one of their available primers, EGF2, a 17 
base long primer with the sequence 5’-GGGGATGTGCTGCAAGG-3’. This primer (highlighted 
in green) was chosen as it annealed 82 bases away from the inserted AP1 oligonucleotide. This 
meant that the primer was far enough away from the insert, therefore avoiding nucleotide 
misinterpretation from the DNA polymerase and a high signal due to multiple primers binding to 
the same site (Abd-Elsalam 2003).  
 
The sequence showed that a single AP1 oligonucleotide (highlighted in pink) was successfully 
inserted between BamHI and HindIII restriction sites.  
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Figure 36: Part of the sequence of pUCap1 showing the successful insertion of the AP1 oligonucleotide (shown by the pink arrow) between the HindIII and 
BamHI restriction sites. The EGF2 primer used during the sequencing reaction is shown in green. This primer annealed 82 bases away from the inserted 
oligonucleotide.  
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3.2.5: Making chemically competent cells 
From an agar plate containing the antibiotic Amp1, a single colony that had grown for 16 hours 
at 37 °C was transferred to 100 mL of LB broth. The culture was incubated at 37 °C with 
shaking at 250 rpm until the cells reached an OD600 of 0.4 - 0.6 (IKA KS i control shaking 
incubator). The cells were then transferred to sterile 30 mL centrifuge tubes and incubated on 
ice for 10 minutes. After incubation, the cells were pelleted by centrifugation at 4086 xg at 4 °C 
for 10 minutes. The supernatant was decanted and the cells were gently resuspended in 30 mL 
of ice-cold sterile MgCl2 - CaCl2 solution (80 mM MgCl2 and 20 mM CaCl2). The magnesium and 
calcium together will cause E. coli to become competent, making it readily take up foreign DNA 
(Tsen et al. 2002). The cells were pelleted by centrifugation at 4086 xg at 4 °C for 10 minutes 
and the supernatant was decanted. The cell pellet was gently resuspended in 2 mL of ice-cold 
sterile 0.1 M CaCl2. The calcium present within the solution will counteract any electrostatic 
effects between the DNA and the cell membrane, increasing transformation efficiency (Suga 
and Hatakeyama 2003). 
Prior to storage, 140 µl dimethylsulfoxide (DMSO) was added per 4 mL of cells and gently 
mixed. This is a cryopreservative agent and prevents water crystallising which could potentially 
damage and lyse the cells (Liseth et al. 2005). The cells were incubated on ice for 15 minutes 
before a further 140 µl DMSO was added and the cells were again incubated on ice for another 
15 minutes. To prevent the cells from going through potentially damaging freeze-thaw cycles, 
100 µl of suspension was aliquoted into sterile microcentrifuge tubes and immediately snap-
frozen in liquid Nitrogen. All cell aliquots were stored at -80 °C until use. 
3.2.6: Transformation of chemically competent E. coli cells 
100 µL of chemically competent cells within a sterile microcentrifuge tube were thawed on ice 
for precisely 15 minutes. 10% (10 µL) of the cellular volume was made up of DNA (100 ng) and 
water. This was added to the cells and gently mixed, ensuring the cells were not damaged. This 
cell and DNA mixture was incubated on ice for 30 minutes and heat shocked at 42 °C using a 
heat block or water bath for precisely 30 seconds. This sudden increase in temperature allows 
pores within the E. coli plasma membrane to open, allowing the DNA to enter. Immediately 
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cooling the cells for 2 minutes after heat shocking closes these pores and the DNA cannot be 
released. Aseptic technique was used to transfer 900 µl of sterile LB broth, a nutrient growth 
medium, to the cells prior to horizontal mixing using a shaking incubator at 37 °C for 75 minutes 
at 250 rpm. As these chemically competent cells are homemade, the incubation time was 
increased to compensate for a possible lower efficiency when compared with the commercially 
prepared cells. This incubation time enabled the cells to multiply. Agar plates containing 50 
µg/mL of Amp1 were prepared aseptically. The plates were inverted and stored at room 
temperature until they were ready to be streaked.  
Post incubation, a ‘low concentration’ plate was created. 75 µL of cell suspension was pipetted 
onto a pre-made agar plate and evenly spread forming a monolayer. This was performed 
aseptically. For the ‘high concentration’ plate, the remaining suspension was centrifuged for 1 
minute at 11,406 xg. The supernatant was decanted apart from 100 µL. This remaining 
supernatant was used to resuspend the bacterial pellet. 75 µL of cell suspension was pipetted 
and spread to create an even monolayer using the spreading and plate inverting techniques as 
mentioned above. The inverted plates were incubated at 37 °C overnight for 16 hours. 
3.2.7: Preparing a bacterial culture 
After the chemically competent E. coli cells incubation at 37 °C had finished, a single isolated 
colony was chosen and collected using the end of a sterile pipette tip. The tip was placed into 
10 mL of sterile L.B broth containing 50 µg/mL Amp1. This culture was gently mixed overnight 
for 16 hours at 37 °C on a shaking incubator at 250 rpm. 
3.2.8: Preparing a 1% (w/v) agarose gel 
To resolve fragments between 500bp to 10kb, a 1% (w/v) standard agarose gel was used 
(Sambrook 2001). This gel percentage was used unless otherwise stated. Firstly, 1g of standard 
agarose powder was added to a conical flask containing 99 mL of 1x TAE buffer (40 mM Tris-
acetate and 1 mM Ethylenediaminetetraacetic acid (EDTA)). The agarose mixture was gently 
heated in a microwave on a medium setting and swirled intermittently. This assisted the agarose 
powder to dissolve. Once the solution had cooled to 65 °C, Ethidium Bromide (EtBr) was added 
to give a final concentration of 0.5 µg/ mL and gently mixed before being poured into a pre-
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taped gel tray containing a comb. EtBr was used as it intercalates in between the DNA base 
pairs and fluoresces under ultraviolet light (Reinhardt and Krugh 1978). 
The agarose gel was allowed to completely set at room temperature before the tape was 
removed and the tray was submerged in 1x TAE buffer contained within a gel electrophoretic 
tank. Additional 1x TAE buffer was added to the tanks maximum fill lines. This ensured that the 
gel was completely covered with buffer. The gel comb was then carefully removed to ensure the 
wells were not distorted or damaged. Prior to loading DNA samples into each well, the DNA was 
gently mixed with homemade 1x bromophenol blue loading dye (1.66 mM Tris-HCl (pH 7.5), 
0.03% (w/v) bromophenol blue, 10% (v/v) glycerol and 10 mM EDTA). This dye allowed the 
visual tracking of DNA migration during electrophoresis (Maniatis et al. 1975). The presence of 
glycerol enabled the DNA to sink to the bottom of the wells. 
3.2.9: Inactivating T4 DNA Ligase using KCl 
Heat causes PEG6000 to undergo conformational changes to its shape and transform from a 
free-flowing powder into a solid that has a wax-like consistency (Han et al. 1997). Therefore, an 
alternative method was found to inhibit T4 DNA Ligase using KCl. Various 20 μL ligation 
mixtures made within sterile PCR tubes were equilibrated to 16 °C for 15 minutes prior to the 
addition of T4 DNA Ligase. Each tube contained 350 ng of pUC19 cleaved with BamHI (10 
u/µL), 15% (w/v) PEG6000 (method 3.2.10 & Figure 38) and varying concentrations of KCl 
increasing from 0 M to 1.2 M in 100 mM increments (Figure 37). The aim was to find which KCl 
concentration quenched the reaction by completely inhibiting T4 DNA Ligase. Upon the addition 
of T4 DNA Ligase, each ligation mixture was incubated at 16 °C for exactly 30 minute. This 
ligation time was chosen based on the 1% (w/v) agarose gel results as shown in Figure 39. All 
samples were stored at -20 °C until use. The 1% (w/v) agarose gel shows that at a KCl 
concentration of 800 mM, ligation stopped. This means that 800 mM KCl is a sufficient 
concentration to completely inhibit T4 DNA Ligase. 
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Figure 37: A standard 1% agarose gel image showing single cleaved pUC19 (with BamHI) that was 
ligated with T4 DNA ligase in the presence of 15% PEG6000 (Figure 38) and varying concentrations of KCl. 
The same stock of single cleaved pUC19 was used. From this, 13 aliquots, each containing 350 ng of 
DNA were ligated in the conditions mentioned above for 30 minutes. This time was chosen due to the 
results shown from the concatemerisation of pUC19 at different time points gel (Figure 39). Lane 2 shows 
undigested pUC19 and lane 3 shows cleaved pUC19. Lanes 4-11 shows various species of 
concatemerised pUC19 that formed in the presence of 0-700 mM KCl, some of which are comparable 
with λ DNA. Lanes 12-16 show that at 800 mM KCl, ligation stops. This means that 800 mM KCl is a 
sufficient concentration to completely inhibit T4 DNA Ligase. 
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3.2.10: PEG6000 concentration for optimal DNA ligation 
Polyethylene Glycol6000 (PEG6000), a high molecular weight macromolecule that was used to 
promote the end-to-end ligation of single cleaved pUC19 by crowding around the DNA 
(Zimmerman and Pheiffer 1983). PEG6000 is not incorporated into the reaction but does act as 
background macromolecules. To identify which percentage of PEG6000 was required to promote 
the concatermerisation of pUC19, a concentration gradient was performed.  
A 1 mL 50% (w/v) stock of PEG6000 was made and stored at room temperature by adding 
PEG6000 crystals to water until dissolved by vigorous vortexing. In a final volume of 20 µL each, 
several ligation mixtures were made containing 1.5 µg of single cleaved pUC19 and varying 
percentages of PEG6000 within sterile PCR tubes. These percentages (w/v) were 0%, 5%, 10%, 
15% and 20%. Prior to the addition of T4 DNA Ligase, the ligation mixtures were equilibrated to 
16 °C for 15 minutes to ensure that each component was at this temperature. 5 Weiss U/ µL of 
T4 DNA Ligase was added and the ligation mixtures were incubated overnight for precisely 16 
hours. After incubation, as PEG6000 cannot be heated, ligation was terminated by adding a 10 μL 
of 3x KCl stop buffer (2.4 M KCl and water). 800 mM KCl (as shown in Figure 37) is a sufficient 
concentration to completely chemically inhibit T4 DNA Ligase. The samples were then 
immediately stored at -20 °C until use. The analytical gel in Figure 38 shows that 15% PEG6000 
is the optimum percentage to use as this generated the longest DNA concatemers. 
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Figure 38: A standard 1% (w/v) agarose gel image showing single cleaved pUC19 (with BamHI) that has 
been ligated for 16 hours at 16 °C with T4 DNA ligase in the presence of varying concentrations of 
PEG6000. Lane 2 shows λ DNA. This served as a size marker. Lanes 3-8 show pUC19 that was ligated 
together while in 0%, 5%, 10%, 15% and 20% (w/v) PEG6000. These PEG6000 concentrations were used to 
identify which concentration promoted DNA concatemerisation that was comparable with the length of λ 
DNA or longer. 15% (w/v) PEG6000 was chosen as the DNA remains in the well, meaning that it is longer 
than λ. This DNA substrate serves as a negative control as there are no WT AP1 target sites present. 
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3.2.11: A time course to create pUC19 tightropes that are comparable with the length of λ 
DNA   
To identify the time duration needed to ligate pUC19 so that it could concatemerise to the same 
length as λ DNA which is 48,502 bp in length, a time course experiment was performed. 12 
separate ligation mixtures containing 1.5 µg of single cleaved pUC19 (with BamHI (10 u/µL)) 
were firstly incubated in sterile PCR tubes at 16 °C in the presence of 15% (w/v) PEG6000. The 
mixtures were left to equilibrate for 15 minutes inside of the PCR thermocycler. Figure 39 shows 
the time course used to determine which time proved sufficient to form pUC19 concatemers that 
are comparable with the length of λ DNA. 5 Weiss U/ µL T4 DNA Ligase was added to each 
ligation mixture. After each time duration had been reached, T4 DNA Ligase was chemically 
inactivated with 800 mM KCl (as shown by Figure 37). The zero time point was created by 
directly adding T4 DNA Ligase to the 1x KCl stop buffer which was then immediately added to 
the ligation mixture. The results of the level of ligation at each time point can be seen in Figure 
39 and shows that a minimum of 30 minutes is sufficient time for pUC19 to ligate and form 
concatemers that are comparable with λ DNA. 
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Figure 39: A 1% (w/v) agarose gel showing the concatemerisation of 2686 bp long pUC19 at different 
time points using T4 DNA Ligase. Lane 2 shows λ DNA. This was used as a size marker. Lane 3 shows 
pUC19 plasmid. Lane 4 shows pUC19 that was cleaved with BamHI. Lanes 5-16 show the time course. 
At precisely each time point, T4 DNA Ligase was inhibited with 800 mM KCl (method 3.2.9). During the 
time course, different species of DNA can be seen, ranging from 5.5 kb (2mer) to 48 kb (18mer). This gel 
shows that a ligation time of 30 minutes is optimal (see lane 14). 
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3.2.12: Creating pUC19 concatemers. 
DNA Tightropes were created using pUC19 that was cleaved once with BamHI (10 u/µL) as 
described in method 3.2.1. This type of DNA was chosen as it does not contain any WT AP1 
target sites. This results in pUC19 serving as a negative control when compared to λ DNA that 
contains 8 WT AP1 target sites (as shown in Chapter 2, Figure 11).  
To create pUC19 DNA tightropes, firstly T4 DNA Ligase was used to ligate 1.5 µg of pUC19 for 
30 minutes at 16 °C while in the presence of 15% (w/v) PEG6000. This was performed inside a 
PCR thermocycler. T4 DNA Ligase was added after the DNA mixture was equilibrated to 16 °C 
for 15 minutes, ensuring that each component was at this temperature. These optimal 
conditions were chosen based on the results shown in the agarose gels represented in Figures 
36 and 37. At precisely 30 minutes, T4 DNA Ligase was inactivated using 800 mM KCl. This 
KCl concentration is needed to completely inhibit T4 DNA Ligase as shown by the agarose gel 
in Figure 37. Next, 500 ng of ligated pUC19 containing 800 mM KCl (total volume of 10 µL) was 
added to 1x ABC buffer as it contains 50 mM KCl (total volume of 90 µL), making a total volume 
of 100 µL. This buffer was chosen as the final KCl molarity reduced from 800 mM to 125 mM, 
less than the high salt buffer used for imaging that contains 150 mM KCl. The adapted DNA 
tightrope method, as described in method 3.2.13, was used to create pUC19 tightropes inside a 
flow cell chamber. 
3.2.13: Creating pUC19 tightropes. 
This method is an adaptation of Chapter 2’s method 2.2.7. 
Firstly, beads were introduced into the flow cells chamber. The chamber was then equilibrated 
with 50 mM KCl by flushing through with 1x ABC buffer as described in method 2.2.5.1. Next, a 
10 µL volume containing 500 ng of newly ligated pUC19 within 800 mM KCl (as described in 
method3.2.9) was added to 90 µL of 1x ABC buffer that contained 50 mM KCl (as previously 
mentioned). This made a final KCl molarity of 125 mM. Once the DNA was introduced into the 
chamber, it became equilibrated with 125 mM KCl. This KCl concentration still remains less than 
the 150 mM KCl concentration used during imaging. 
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The method as described in 3.2.12 was followed to create pUC19 tightropes. However, the 1x 
ABC buffer previously used during bi-directional flow during the creation of tightropes was 
replaced with high salt buffer instead of low salt buffer. The high salt buffer equilibrated the 
chamber to 150 mM KCl. High salt buffer was also used during DNA labelling with YOYO-1 dye 
(as shown in method 3.2.14.2) and to flush the chamber prior to imaging. 
3.2.14: Buffers 
 3.2.14.1: High salt buffer containing ATP 
T4 DNA Ligase (ThermoFisherScientific 2015), an Adenosine Triphosphate (ATP)-dependent 
enzyme, is able to form an enzyme-DNA complex upon binding to DNA (Wilkinson et al. 2001). 
In order for this complex to form, ATP is utilised by the enzyme. If the amount of ATP present is 
less than the amount required to complete its self-adenylation reaction, this can result in the 
reaction slowing down, eventually causing the enzyme to stall on the DNA (Rossi et al. 1997).  
T4 DNA Ligase is used with a 1x reaction buffer containing 25 mM Tris-HCl (pH 7.6), 5 mM 
MgCl2, 0.5 mM ATP, 0.5 mM DTT and 2.5% (w/v) PEG8000 (ThermoFisherScientific 2015). 1 mM 
ATP was added to the high salt buffer. By maintaining the ATP concentration at 1 mM, this will 
ensure that the enzymes adenylation reaction can complete. This means that the enzyme will 
be free from stalling on the DNA and the enzyme-DNA complex can readily dissociate. 
3.2.14.2: High salt buffer containing YOYO-1 
To observe the formation of TFλ DNA (method 3.2.17) tightropes inside the flow cell chamber 
using OAF microscopy, high salt buffer (as described in method 2.2.5.1) was adapted by 
substituting 20 µL water with YOYO-1 dye to give a 1:50 YOYO-1 iodide dye to buffer ratio. This 
made a final YOYO-1 dye concentration of 20 nM. This buffer shall be referred to as high salt 
buffer + YOYO-1. 
3.2.15: Phenol:Chloroform extraction and DNA precipitation 
During protein translocation along DNA, it appeared that adding ATP to the high salt buffer did 
not aid the complete dissociation of T4 DNA Ligase from the DNA as protein movement 
appeared inhibited (as shown in Table 9). Therefore, a Phenol:Chloroform extraction (PCE) and 
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precipitation of DNA (Palmiter 1974) method was performed as this would completely remove 
T4 DNA Ligase from the DNA, allowing proteins free movement again.  
Firstly, a mixture containing equal volumes of Phenol and Chloroform were prepared in a 
microcentrifuge tube, making a final volume of 200 μL. In another microcentrifuge tube, a 40 μL 
volume containing 3 μg of newly ligated DNA was added to 160 μL of water. This made an 
equal volume to the PCE mixture. These volumes were chosen to ensure pipetting accuracy. 
Next, the PCE mixture was vigorously vortexed for 15 seconds to ensure that the Phenol and 
Chloroform had thoroughly mixed. Immediately after vortexing, the DNA was added. The PCE + 
DNA mixture was then placed on a rotator for precisely 1 hour. The rotator is a custom made 
device whereby a ~3 inch diameter Perspex wheel was attached to a motor and clamped at a 
39° angle using a clamp and stand. The wheel was set to slowly turn at 43 rpm and when 
combined with the tilt, this aided gentle sample mixing. This method for mixing was chosen as 
long DNA is prone to fragmenting and shearing, especially during vortexing. Gently inverting the 
sample in the afore-mentioned way prevented the DNA from becoming damaged. The mixture 
was separated into 3 layers: the aqueous layer (top), interphase (middle) and organic layer 
(bottom) by centrifugation at 11,406 xg for 1 minute. If the layers had not completely separated, 
the mixture was recentrifuged. The top aqueous layer that contained the DNA was aspirated 
and placed in a microcentrifuge tube and its volume measured. An equal volume of Chloroform 
was then added. The Chloroform and DNA mixture was then gently mixed on the rotator for 1 
hour. After mixing, the Chloroform and DNA mixture was phase-separated into 3 layers by 
centrifugation at 11,406 xg for 1 minute. If the layers had not fully formed, this step was 
repeated. The top aqueous layer containing the DNA was aspirated, placed in a microcentrifuge 
tube and its volume measured. 0.111 volumes of 3 M sodium acetate at pH 5.2 and 2.5 
volumes of ice-cold 100% (v/v) ethanol was added to the DNA. This mixture was incubated on 
ice for 30 minutes to precipitate the DNA.  
 
Post incubation, the DNA was pelleted by centrifugation at 11,406 xg for 20 minutes at 4 °C. 
The ethanol was aspirated and 500 μL of 70% (v/v) ethanol was carefully added to the DNA 
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pellet. This was then centrifuged at 11,406 xg for 10 minutes at 4 °C. The ethanol was carefully 
aspirated and the DNA pellet was allowed to air dry at room temperature to remove any residual 
ethanol. The DNA pellet was dissolved in an appropriate volume of water when no ethanol 
droplets were observed within the microcentrifuge tube. 
The gel images in Figures 40 and 41 both show the successful removal of T4 DNA Ligase from 
ligated pUC19 as a band shift can be seen after the DNA was extracted using 
Phenol:Chloroform. This occurs due to the T4 DNA Ligase denaturing and partitioning into the 
organic layer during the extraction (Palmiter 1974). The DNA is also free from shearing and 
severing. PCE and DNA precipitation were chosen instead of heat inactivation as PEG6000 
cannot be heated. This is present during the ligation of DNA (as described in method 3.2.10). 
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Figure 40: A 1% (w/v) standard agarose gel showing ligated pUC19 before and after PCE and DNA 
precipitation. Lane 1 shows uncut pUC19 plasmid. Similarly this is shown in lane 2, however the plasmid 
was extracted using Phenol:Chloroform and its DNA was precipitated. Lane 3 shows a linearised pUC19 
plasmid that was cleaved once with the restriction enzyme BamHI. The next 3 lanes show pUC19 that 
has been ligated and tandemised over a 30 minute period. 4 species can be clearly identified across the 
lanes. These range from 2686 bp (single pUC19) to over 10,000 bp in length. The smears at the top are 
long concatermerised DNA that contains various different species and their lengths cannot be identified. 
Lane 4 shows ligated pUC19 that contains bound T4 DNA Ligase. A clear band shift can be seen when 
compared to the PCE DNA seen in lanes 5 and 6. This shows that the enzyme has been successfully 
removed. Lanes 5 and 6 also show that post PCE, the DNA has not been broken or sheared.  
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Figure 41: A 1% (w/v) standard agarose gel showing pUC19 that was ligated together at 16 °C for 30 
minutes using T4 DNA Ligase. This gel determines which method was best at completely removing T4 
DNA Ligase from the DNA, as described in 3.2.15, and without altering the integrity of the DNA. Lane 2 
contains λ DNA. This was used as a size marker. Lane 3 contains pUC19 plasmid. This was also used as 
a size marker. Lane 4 contains pUC19 that was first treated with Phenol:Chloroform and then precipitated 
using method 3.2.23. This checked for any DNA shearing or damage. None can be seen here. Lane 5 
shows pUC19 that was single cleaved with the restriction endonuclease BamHI (as described in method 
3.2.1). Lane 6 shows ligated pUC19 that still contained active T4 DNA Ligase. Four clear bands can be 
seen. These show unligated pUC19 (2686 bp), open circle DNA, 3mers (8058 bp) and 10mers (26,860 
bp). The smear shows pUC19 that has concatermerised to the length of λ DNA. Lane 7 shows ligated 
pUC19 containing 800 mM KCl. This salt concentration completely inhibits T4 DNA Ligase (as shown in 
Figure 37). The same DNA species can be seen as shown in Lane 6. Lane 8 shows ligated pUC19. T4 
DNA Ligase was completely inhibited with 65 °C heat. The four DNA species have a lower molecular 
weight, suggesting that the T4 DNA Ligase has been removed from the DNA. Lane 9 shows Ligated 
pUC19 that was treated using PCE and the DNA was precipitated. The same DNA species can be seen. 
Like the DNA species shown in lane 8, a band shift can be seen. This again shows the complete removal 
of T4 DNA Ligase from the DNA. 
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3.2.16: Adaptation of Phenol:Chloroform extraction and DNA precipitation 
Initially, the PCE and DNA precipitation method as described in 3.2.15 was used to remove T4 
DNA Ligase from TFλ DNA. However, this method frequently produced yields as low as 10%. 
Due to the minimal amount of TFλ obtained after gel extraction (as shown in Figures 42), this 
meant that the PCE and DNA precipitation method needed to be adapted. To lose such a large 
amount of ligated TFλ during the removal of T4 DNA Ligase from the DNA not only made the 
generation of TFλ a time consuming process but also effected experiments downstream due to 
limited DNA availability. Therefore, this method has been adapted and successfully increased 
the DNA yield to approximately 90% post PCE and DNA precipitation.  
Firstly, equal volumes of Phenol and Chloroform were added to a microcentrifuge tube, making 
a total volume of 200 μL. An 80 μL volume that contained 2.8 μg of newly ligated TFλ (as 
described in method 3.2.15) was added to 120 μL of water. The PCE mixture was vigorously 
vortexed for 15 seconds to ensure that the Phenol and Chloroform had thoroughly mixed. 
Immediately after vortexing, the DNA was added to the PCE mixture and gently inverted 15 
times to mix. Next, the the PCE and DNA mixture was placed on the rotator for 15 minutes at 43 
rpm. The mixture was then phase-separated into 3 layers using centrifugation at 11,406 xg for 1 
minute. If the layers had not completely separated, the mixture was recentrifuged.  
The top aqueous layer containing the DNA was aspirated and placed in a microcentrifuge tube 
and its volume measured. An equal volume of Chloroform was added. The Chloroform DNA 
mixture was gently inverted 30 times to mix prior to centrifugation. The DNA was then 
precipitated at -20 °C for 16 hours overnight instead of 30 minutes on ice. 
3.2.17: Identifying target free λ (TFλ) DNA 
To help identify an area of λ DNA that did not contain any WT AP1 target sites or variant AP1 
target sites, the program SnapGene (SnapGene 2013) was used. This target free λ DNA (TFλ) 
region would allow DNA bound proteins to be studied without the presence of their AP1 target 
and variant AP1 target sites, therefore serving as a true negative control.  
The restriction endonucleases NdeI (recognition sequence 5’- CATATG -3’. Fermentas) and 
EcoRI (recognition sequence 5’- GAATTC -3’. Fermentas) were used to cleave λ DNA. By using 
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2 different restriction endonucleases, this increased the probability of locating a target free area 
along the DNA. NdeI and EcoRI could cleave the DNA simultaneously with 100% efficiency and 
with no star activity while in restriction buffer O (ThermoFisherScientific 2015). The restriction 
digest was performed according to the method supplied by the manufacturer.  
Equal amounts (10u/ µL) of NdeI and EcoRI were added to the digest mixture that contained 3 
μg of λ DNA. This amount of DNA was cleaved due to the number of DNA fragments that would 
be produced and the DNA was left incubating at 37 °C for 16 hours overnight to ensure 
complete DNA cleaving (as shown in Figure 43). Both enzymes were heat inactivated at 80 °C 
for 20 minutes. This 962 bp TFλ region has been indicated by the red arrows in Figure 42. 
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Figure 42: A diagram representing a single piece of λ DNA (created using SnapGene). The location of all NdeI and EcoRI restriction sites can be seen in 
addition to the WT AP1 target sites (red) and variant AP1 target sites (multicolour). The red arrows highlight part of the λ DNA that is free from all of these 
target sites. This target free region also has a single NdeI and EcoRI restriction site at either end. 
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3.2.18: Double digestion of pUC19 for λpUC construction 
In preparation for the construction of λpUC (as shown in Figure 43), 3 μg of pUC19 was 
simultaneously cleaved with the restriction endonucleases NdeI (10 u/µL) and EcoRI (10 u/µL) 
(Fermentas) for 2-16 hours at 37 °C as described in method 3.2.24. To ensure that the double 
cleaved vector could not self-anneal during ligation, phosphate groups from the 5’- end were 
removed using Fast Alkaline Phosphatase (FastAP) (ThermoFisherScientific 2015). This 
mixture was incubated for 15 minutes at 37 °C. FastAP was heat inactivated at 80 °C in 
accordance with the manufacturer’s guidelines. This temperature is higher than the 65 °C 
required to heat inactivate NdeI and EcoRI. This meant that both of the restriction 
endonucleases were also inactivated. 
3.2.19: Constructing λpUC 
λpUC is a 3436 bp circular DNA plasmid. This can be seen in Figure 44. It was constructed 
using pUC19 and the λ DNA fragment TFλ that were doubly cleaved with restriction 
endonucleases NdeI (10 u/µL) and EcoRI (10 u/µL) (as described in method 3.2.17).  
Prior to DNA construction, both doubly digested pUC19 and λ DNA were run on a 1% (w/v) 
agarose gel containing 1x TAE buffer and 0.5 ug/mL of EtBr to separate out the fragments 
based on their molecular weight. This can be seen in Figure 43. 1.5 ug of cleaved pUC19 and λ 
DNA was loaded onto the gel. This would increase the amount of DNA present in each band. 
The 2474 bp long pUC19 fragment and 962 bp long TFλ DNA fragment were then excised and 
gel extracted using a gel extraction kit (Qiagen 2015). 
Next, λpUC was constructed by creating a 20 uL ligation mixture containing a ratio of 3 TFλ 
DNA fragments to 1 pUC19 vector (based on their molarity ratio). This ligation mixture was 
placed in a sterile PCR tube and incubated inside of the PCR machine at 16 °C for 15 minutes 
prior to adding T4 DNA Ligase. This ensured that the components within the ligation mixture 
were equilibrated to 16 °C. After the addition of T4 DNA Ligase, the mixture was incubated at 16 
°C for 16 hours. This was then immediately stored at 4 °C. The newly created recombinant 
plasmid was transformed using Top10 Chemically Competent E. coli (method 3.2.6). This 
construction process has been represented by the diagram shown in Figure 44. 
137 
 
 
 
Figure 43: A 1% (w/v) agarose gel showing doubly cleaved pUC19 and λ DNA with the restriction 
endonucleases NdeI and EcoRI (Fermentas. Method 3.2.17). Lane 2 shows pUC19 plasmid. Lanes 3 and 
4 show pUC19 that has been single cleaved with NdeI and EcoRI respectively. This shows that the 
restriction endonucleases are cleaving and no star activity has occurred. Lane 5 shows pUC19 that has 
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been doubly cleaved with both NdeI and EcoRI. Two bands can be seen. These are 2474 bp, indicated 
by the blue arrow, and 212 bp in length. Lane 6 shows λ DNA that has been cleaved with NdeI. Seven 
DNA species can be seen. These range from 1700 bp to 48,000 bp in length. Lane 7 shows λ DNA that 
has been cleaved with EcoRI. Five fragments were produced. These range from 4000 bp to 48,000 bp in 
length. Lane 8 shows λ DNA that was doubly cleaved with NdeI and EcoRI. This produced several 
fragments consisting of single and doubly cleaved ends. The target free DNA fragment of interest, as 
shown in Figure 42, is 962 bp in length. This has been indicated by the red arrow. 
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Figure 44: A diagram showing the construction of the 3436 bp long circular DNA plasmid λpUC (adapted from SnapGene). pUC19 was first doubly cleaved 
with the restriction endonucleases NdeI and EcoRI and dephosphorylated with FastAP before being heat inactivated and gel extracted. The gel extracted 
donor 964 bp λ DNA fragment was inserted using a 3 fragments:1 vector ratio. These fragments were ligatedtogether using T4 DNA Ligase at 16 °C for 16 
hours. The newly created recombinant plasmid was transformed using Top10 Chemically Competent E. coli.  
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3.2.20: PEG6000 concentration for optimal TFλ DNA ligation 
To identify which PEG6000 concentration would promote end-on-end ligation of the 962 bp long 
TFλ fragment during ligation with T4 DNA Ligase, a concentration gradient was performed. This 
method is an adaptation of the method 3.2.19.  
Firstly, a 1mL stock of 60% (w/v) PEG6000 was made. The percentage of PEG6000 was increased 
due to the minimal space available within the ligation mixture. This is due to TFλ having a low 
concentration, therefore requiring a larger proportion of the mixture. In a final volume of 20 µL 
each, several ligation mixtures were made containing 700 ng of TFλ and varying percentages of 
PEG6000 within sterile PCR tubes. These percentages were 0%, 10%, 15%, 20% and 25% (w/v). 
Prior to the addition of T4 DNA Ligase, the ligation mixtures were equilibrated to 16 °C for 15 
minutes to ensure that each component was at this temperature. 1 µL of T4 DNA Ligase was 
added and the ligation mixtures were incubated overnight for precisely 16 hours. Post 
incubation, a 10 µL 3x stop buffer (2.4 M KCl and water) was added. Used at 1x, 800 mM KCl 
inactivated T4 DNA Ligase. The samples were then immediately stored at -20 °C until use.  
The analytical gel image represented in Figure 45 shows that 20% (w/v) PEG6000 is the optimum 
percentage to use as this facilitated formation of the longest TFλ DNA concatemers. 
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Figure 45: A 1% (w/v) agarose gel image showing TFλ that had been ligated for 16 hours at 16 °C with 
T4 Ligase in the presence of varying concentrations of PEG6000. Lane 1 shows λ DNA. This was used as 
a size marker. Lane 3 shows TFλ before ligation. Lanes 4-8 show ligated TFλ in the presence of 0%, 
10%, 15%, 20% and 25% (w/v) PEG6000. These PEG6000 concentrations were used to identify which 
concentration promoted DNA concatemerisation. 20% (w/v) PEG6000 was chosen as the DNA is shown to 
be comparable with λ and longer. Unlike pUC19 that contains variant AP1 target sites; this DNA construct 
serves as a true negative control as it is completely free from AP1 and variant AP1 target sites. 
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3.2.21: A time course to create TFλ tightropes that are comparable with the length of λ 
DNA   
A time course experiment was performed to identify which time duration was required to ligate 
and concatemerise TFλ to the same length as λ DNA which is 48,502 bp in length. The method 
used here is an adaptation of method 3.2.11. Inside of the PCR thermocycler, 6 separate 
ligation mixtures, each containing 700 ng of TFλ DNA and 20% (w/v) PEG6000, were incubated in 
sterile PCR tubes at 16 °C for 15 minutes to equilibrate. Upon the addition of 5 Weiss u/ μL of 
T4 DNA Ligase to 2 ligation mixtures simultaneously, their ligation time commenced. TFλ DNA 
was ligated for 30 minutes, 1 hour and 16 hours. Time point 0 hours was created by firstly 
adding T4 DNA Ligase to the 1x KCl stop buffer which was then immediately added to the 
ligation mixture. T4 DNA Ligase was inactivated 800 mM KCl after each time duration.  
The gel shown in Figure 46 shows the level of ligation at each time point. A ligation time of 16 
hours was chosen to concatermise TFλ. Firstly, 16 hours is a convenient time as the ligation 
could occur overnight and secondly, this provided sufficient time for TFλ to concatemerise to a 
length that is comparable with λ DNA. 
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Figure 46: A 1% (w/v) agarose gel showing the concatemerisation of 92 bp long fragment TFλ DNA at 
different time points using T4 DNA ligase. T4 DNA Ligase was inactivated with 800 mM KCl after each 
time duration. Lane 2 shows λ DNA. This was used as a size marker. Lane 3 shows unligated TFλ DNA. 
Lane 4 shows ligation at time 0 minutes. DNA species of varying length can be seen. Lanes 5 also shows 
a vast range of DNA species. Most of the DNA has remained in the well, suggesting that it has formed 
extremely long concatermers. Lane 6 shows TFλ DNA that has formed a variety of species, however a 
prominent band can be seen at 48,000 bp. This shows that the DNA has concatermerised to the length of 
λ DNA after 1 hour. Lane 7 shows similar results to lane 6, whereby a 16 hour time duration produces 
DNA species of varying length and a distinct tandem DNA species that is comparable in length to λ DNA. 
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3.2.22: Adapted TFλ DNA ligation method 
λPUC was cleaved with the restriction endonucleases NdeI (10 u/µL) and EcoRI (10 u/µL). 
This yielded a small quantity of TFλ DNA fragments that were 962 bp in length (as described in 
section 3.3.1). As TFλ is much smaller when compared with other DNA substrates used in this 
study, extra care was taken to promote the fragments tandem end-on-end ligation, producing a 
DNA substrate that was similar in length to λ DNA. The following steps were taken to achieve 
this.  
Firstly, a ligation mixture containing 20% (w/v) PEG6000 (as described in method 3.2.20) was 
incubated in a PCR thermocycler for 15 minutes at 16 °C. This ensured that the mixture was 
equilibrated to this temperature. During equilibration, 700 ng of TFλ DNA was placed in a sterile 
PCR tube. To self-anneal the fragments, the DNA was heated at 60 °C for precisely 5 minutes 
prior to cooling in an ice bath for 1 minute. The self-annealed TFλ DNA fragments were added 
to the ligation mixture. T4 DNA Ligase (5 Weiss u/ µL) was added to the mixture 10 minutes 
after the addition of the DNA fragments. This ensured that the mixture was equilibrated to 16 
°C. Ligation occurred for 16 hours. This was immediately followed by PCE and DNA 
precipitation (as described in method 3.2.23).  
3.2.23: The Binding site Finder for pUC19 
This Binding Site Position Finder, inclusive of the 80 bp error margin, functions in the same way 
as the Site Finder used to determine where cFos, cJun and cFos:cJun heterodimers were 
pausing as they diffused along λ DNA, both with and without variant AP1 target sites as 
described in Chapter 2, Figures 24 and 25.  
pUC19 however is 2686 bp in length, 18 times smaller than λ DNA. There are no AP1 target 
sites present along pUC19, however, there are 11 variant AP1 target sites. Due to the size of 
pUC19, 3 pieces of linear DNA have been consecutively tandemised so that the DNA is longer 
in length. This ensures that any distances between pause locations that are greater than 2686 
bp can be quantified.  
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All “Yes” answers that appeared within the first piece of pUC19 were quantified only. This is due 
to a repeating pattern of “Yes” being seen in strands 2 and 3. If, for example, a “Yes” response 
within strand 1 showed that the protein paused at binding sites where one site was on the first 
DNA strand and the second site was on the second strand, these were also quantified. A 
section of this pUC19 Binding Site Position Finder can be seen in Figure 47. 
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Figure 47: The adapted Binding Site Position Finder for pUC19 DNA. All 11 variant AP1 target sites that appear on a single piece of pUC19 DNA have been 
incorporated into this Site Finder. 3 pieces of pUC19 have been tandemised. Like the previous Binding Site Position Finders mentioned in Chapter 2, the user 
simply types the known distance in the red outlined box and presses enter. 
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3.2.24: The Binding site Finder for pUCap1 
The pUCap1 Binding Site Position Finder functions in the same way as the pUC19 Site Finder 
as described in method 3.2.23. All data obtained from this Site Finder is analysed in the same 
manner as well. Although pUCap1 is 3 bp shorter than pUC19, the fundamental difference is 
that pUCap1 contains a single AP1 target site. This meant that there were 12 target sites of 
interest. Figure 48 shows a section of this pUCap1 Binding Site Position Finder. 
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Figure 48: The adapted Binding Site Position Finder for pUCap1 DNA. 1 AP1 target site and 11 variant AP1 target sites that appear on a single piece of 
pUCap1 DNA have been incorporated into this Site Finder. The only difference between this Site Finder and the one for pUC19 is anadditional AP1 target 
site. Like the previous Binding Site Position Finders mentioned in Chapter 2, the user simply types the known distance in the red outlined box and presses 
enter. 
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3.3: Results 
This chapter aimed to gain a greater understanding of how cFos, cJun and cFos:cJun 
heterodimers interact with different DNA substrates. The first DNA substrate used in this study 
was pUC19. This DNA is free from AP1 target sites; however there are 11 variant AP1 target 
sites present. The second type of DNA investigated was pUCap1. This DNA is composed of 
pUC19 that has a single AP1 target site cloned into it. Lastly, TFλ is a DNA substrate that is 
completely free from AP1 and variant AP1 target sites. Using these different types of DNA will 
enable studies to be performed to understand whether the presence or absence of AP1 and 
variant AP1 target sites affects the proteins complex formation, diffusion characteristics 
(represented by their α values), diffusion constants (µm2s-1) and to quantify in which AP1 and 
variant AP1 target sites the proteins pause. 
3.3.1: Restriction mapping λpUC 
To confirm that the correct doubly digested pUC19 fragment and λ DNA fragment were ligated 
together forming λpUC, a λpUC plasmid was simultaneously cleaved with the restriction 
endonucleases NdeI (10 u/µL) and EcoRI (10 u/µL). This was performed as described in 
methods 3.2.17. The plasmid was incubated at 37 °C for 2 hours. Both of the restriction 
endonucleases were heat inactivated at 65 °C for 20 minutes. This was performed in 
accordance with Fermentas guidelines. Figure 49 shows λpUC before its construction and 
Figure 44 shows the completed construct (schematic diagram). To further confirm the correct 
DNA components were used to construct λpUC, the plasmid was sequenced. 
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Figure 49: A 1% (w/v) agarose gel showing the DNA components used to create λpUC and its diagnostic 
cleavage with the restriction endonucleases NdeI and EcoRI. Lane 2 shows pUC19 plasmid. Lane 3 
contains pUC19 that has been doubly cleaved with the restriction endonucleases NdeI and EcoRI. This 
produced a large fragment of 2474 bp, indicated by the blue arrow, and a small fragment of 212 bp. Lane 
4 shows λ DNA that was cleaved with NdeI and EcoRI. This produced several fragments consisting of 
single and double cleaved ends. The 962 bp λ DNA fragment that contains no WT or variant AP1 target 
sites has been indicated by the red arrow. Lane 5 shows uncut λpUC. To show that the correct fragments 
had been ligated together to form λpUC, a λpUC plasmid was doubly cleaved with the restriction 
endonucleases NdeI and EcoRI.The correct pUC19 fragment of 2474 bp and λ DNA fragment of 962 bp 
are shown. This can be seen in lane 6. Sequencing the λpUC plasmid also confirmed the correct insertion 
of the donor λ DNA fragment TFλ into pUC19. 
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3.3.2: Protein interaction with pUC19 DNA. 
As described in Chapter 2 section 2.2.8, all of the proteins used within this study were 
biotinylated as handles for attaching Qdots. cFos was labelled with red 655 nm Qdots and cJun 
was labelled with green 525 nm Qdots using a 1:4 peptide to Qdot ratio. Dual colour 
experiments provided a host of red, green and dual coloured complexes. It is these dual 
coloured complexes that indicated heterodimeric complex formation. This colour labelling 
strategy was adopted throughout the entire duration of this study, ensuring that all proteins were 
fluorescently tagged prior to being loaded onto the DNA. All studies were performed in a high 
salt buffer. Proteins that were bound to DNA tightropes were analysed providing they were not 
close to any beads, the tightropes were not swaying or overcrowded with proteins as described 
in Chapter 2 section  3.1.1.  
The first study performed aimed to identify what percentage of cJun moved while on ligated 
pUC19 tightropes. cJun was chosen for this study as it was the most mobile protein observed 
on λ DNA. 119 pUC19 tightropes were studied. 54 ± 3.7% (n = 242. t-test p-value = 0.06) of 
cJun molecules were observed moving. This is 17% less than the percentage of cJun moving 
along λ DNA, as shown in Chapter 2 section 3.1.1.  
This result raised the possibility that T4 DNA Ligase could be inhibiting protein movement. To 
determine this, 1 µM ATP was added to the ligated DNA tightropes (107 tightropes were 
analysed) as T4 DNA Ligase utilises this during adenylation (Rossi et al. 1997). The aim here 
was to remove T4 DNA Ligase from the DNA and keep it in solution. Upon the addition of ATP, 
37 ± 3.1% (n = 229. t-test p-value = 0.9) of cJun molecules were now observed moving. This 
percentage shows a large reduction in movement, increasing the possibility that T4 DNA Ligase 
was in fact inhibiting protein movement. To solve this problem, 118 tightropes were studied 
where T4 DNA Ligase was completely removed from the DNA post ligation using PCE and DNA 
precipitation (as described in method 3.2.15). Afterward, 58 ± 0.4% (n = 269. t-test p-value = 
0.1) of cJun molecules were observed to diffuse freely along PCE pUC19 tightropes.  
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Next, cFos and cFos:cJun heterodimers were independently introduced to PCE pUC19 DNA 
tightropes and the number of moving complexes were quantified. 104 tightropes containing 
cFos were studied and 49 ± 1.2% (n = 183) of the molecules were observed to diffuse freely. 
This result can be compared with the 45% of cFos (t-test p-value = 0.35) that moved along λ 
DNA. 46 tightropes containing a mixture of red cFos (n = 23), green cJun (n = 26) and dual 
coloured cFos:cJun (n = 34) complexes were also studied. 47 ± 2.2% (n = 16. t-test p-value = 
0.54) of cFos:cJun heterodimers were also observed moving along the DNA, 8% greater than 
cFos:cJun moving along λ DNA. 
The introduction of a single AP1 target site into pUC19, termed pUCap1 (as described in 
method 3.2.3), enabled cFos, cJun and cFos:cJun to be studied when in the presence of 1 AP1 
and 11 variant AP1 target sites. This was to see whether the presence of an AP1 target site 
would promote or hinder protein movement. This DNA substrate was studied alongside cJun on 
ligated pUC19. 
Firstly, cJun was loaded onto ligated pUCap1 and the number of moving proteins was 
quantified. 109 tightropes were studied. 46 ± 4.5% (n = 161) cJun molecules were observed to 
diffuse freely. Next, 1 µM ATP was added to the ligated DNA tightropes and 118 tightropes were 
analysed. Again, like with pUC19 ligated tightropes, this was to remove T4 DNA Ligase from the 
DNA. 42 ± 3.9% (n = 169) of cJun molecules were observed moving along pUCap1+ATP. To 
prevent protein inhibition while moving, T4 DNA Ligase was removed from the DNA using PCE 
and DNA precipitation. On this clean DNA substrate 62 tightropes were analysed and 52 ± 2.6% 
(n = 195) of cJun were observed to diffuse freely. This can be compared with cJun (t-test p-
value = 0.78) moving along PCE pUC19 DNA. 
cFos was the next protein to be loaded PCE pUCap1 DNA tightropes. 88 tightropes were 
studied and 55 ±1.8% (n = 145) were observed moving. This observation can be compared with 
the percentage of cFos (t-test p-value = 0.20) moving on both λ (45%) and PCE pUC19. Finally, 
pre-mixed cFos and cJun were loaded onto the DNA enabling the number of moving cFos:cJun 
heterodimers to be quantified. 71 tightropes containing a mixture of red cFos (n = 53), green 
cJun (n = 90) and dual coloured cFos:cJun (n = 99) complexes were also studied. 32 ± 1.6% (n 
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= 32) were moving dual coloured cFos:cJun heterodimeric complexes. This percentage is 
comparable with λ DNA although there was 15% less diffusion when compared with cFos:cJun 
moving on PCE pUC19 DNA. Lastly, cJun was loaded onto TFλ DNA. Only 3% (n = 79. t-test p-
value = 0.80) of cJun molecules were observed to diffuse when compared with cJun diffusing 
along λ DNA. This data can be seen in Table 9. 
The next part of this study was to identify the diffusion constants and α values (as described in 
Chapter 2) for cFos and cJun that travelled along PCE pUC19 and PCE pUCap1 DNA 
substrates while in a high salt buffer. The first DNA substrate to be analysed was PCE pUC19. 
On this DNA, cFos produced diffusion constants ranging from 1x10-5 to 1x10-2 µm2s-1 and cJun 
1x10-6 to 1x10-1 µm2s-1. This meant the average diffusion constants for cFos and cJun were 
1.5x10-3 ± 3x10-4 µm2s-1 and 2.6x10-3 ± 6.7x10-4 µm2s-1, respectively (as shown in Figure 50). 
Next, PCE pUCap1 DNA was analysed. cFos produced diffusion constants ranging from 1x10-4 
and 1x10-2 µm2s-1 and cJun from 1x10-6 and 1x10-2 µm2s-1. This resulted in the average diffusion 
constants for cFos and cJun being 1.96x10-3 µm2s-1 and 2.46x10-3 µm2s-1, respectively (as 
shown in Figure 51).  
To understand the proteins mode of travel as they moved along PCE pUC19 and PCE pUCap1 
DNA tightropes in search of their target sites, their α values (as described in Chapter 2) were 
calculated. Firstly, cFos produced α values ranging from 0.4 to 1.9 and cJun 0.5 to 1.4 with PCE 
pUC19. Their average α values were 0.9 ± 0.05 and 0.9 ± 0.02 respectively. Lastly, cFos and 
cJun’s α values were determined as they travelled along PCE pUCap1 DNA tightropes. cFos 
produced α values ranging from 0.4 to 1.4 and cJun 0.4 to 1.6. Their average α values were 0.9 
± 0.04 and 1.0 ± 0.04, respectively. The proteins displaying α values of <1 indicates that an 
anomalous sub-diffusion process may be occurring. 
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Table 9: A table showing the percentage of cFos, cJun and cFos:cJun complexes that were observed moving along pUC19, pUCap1 and TFλ. 1 µM ATP was 
added to pUC19 and pUCap1 DNA substrates. This dissociated T4 Ligase from the DNA and kept it in solution, preventing it from inhibiting protein 
movement. To completely remove T4 DNA Ligase from the DNA, PCE and DNA precipitation was used.  
 
pUC19 pUC19 + ATP PCE pUC19 pUCap1 
pUCap1 + 
ATP PCE pUCap1 PCE TFλ 
cFos **** **** 
49 ± 1.2% (n = 
183) **** **** 
55 ± 1.8% (n = 
145)  **** 
cJun 
54 ± 3.7% (n = 
242) 
37 ± 3.1% (n = 
229)  
58 ± 0.4% (n = 
269)  
46 ± 4.5% (n = 
161)  
42 ± 3.9% (n = 
169)  
52 ± 2.6% (n = 
195)  
3 ± 1.5% (n = 
79)  
cFos:cJun 
Heterodimers **** **** 
47 ± 2.2% (n = 
34)  **** **** 
32 ± 1.6% (n = 
99)  **** 
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Figure 50: Graphs showing diffusion constants (µm
2
s
-1
) against their α values for cFos and cJun as they 
travelled along PCE pUC19 DNA while in a high salt buffer. (a) cFos interacting with PCE pUC19 DNA (n 
= 37) displays a range of diffusion constants between 1x10
-5
 and 1x10
-2
 µm
2
s
-1
 and α values between 0.4 
and 1.9. (b) cJun interacting with PCE pUC19 DNA (n = 50) shows a range of diffusion constants 
between 1x10
-6
 and 1x10
-1
 µm
2
s
-1
 and α values between 0.5 and 1.4. 10 pixels correspond to 0.819 μm, 
the equivalent of 2410 bp (represented by the scale bar). 
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Figure 51: Graphs showing diffusion constants (µm
2
s
-1
) against their α values for cFos and cJun as they 
travelled along PCE pUCap1 DNA while in a high salt buffer. (a) cFos interacting with PCE pUCap1 DNA 
(n = 41) displays a range of diffusion constants between 1x10
-4
 and 1x10
-2
 µm
2
s
-1
 and α values between 
0.4 and 1.5. (b) cJun interacting with PCE pUCap1 DNA (n = 40) shows a range of diffusion constants 
between 1x10
-6
 and 1x10
-2
 µm
2
s
-1
 and α values between 0.4 and 1.7. 10 pixels correspond to 0.819 μm, 
the equivalent of 2410 bp (represented by the scale bar). 
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3.3.3: Protein colocalisation 
To determine whether DNA other than λ affected the formation of cFos:cJun heterodimeric 
complexes, PCE pUC19 and pUCap1 DNA substrates were used as these were completely free 
from T4 DNA Ligase. 83 proteins were observed bound to PCE pUC19. 28% were red cFos (n = 
23), 31% were green cJun (n = 26) and 41% (n = 34) were dual coloured cFos:cJun 
heterodimers. 242 proteins were also observed bound to PCE pUCap1. 23% (n = 53) were red 
cFos, 37% (n = 90) green cJun and 41% (n = 84) were dual coloured cFos:cJun heterodimers. 
These results can be seen in Table 10. 
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Colocalised 
% on PCE 
pUC19 DNA 
Colocalised 
% PCE 
pUCap1 DNA 
cFos:cJun 
heterodimers 
41 ± 1.8% (n = 
83) 
41 ± 1.8% (n = 
242) 
 
Table 10: A table showing the percentage of colocalised, dual coloured cFos:cJun heterodimeric 
complexes (protein labelling described in chapter  2, method 3.1.2) that were bound to PCE pUC19 and 
PCE pUCap1 DNA substrates. All complexes were observed while in a high salt buffer. 
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3.3.4: Protein binding positions along Phenol:Chloroform extracted pUC19 and pUCap1 
DNA  
This part of the study follows on from Chapter 2 section 2.2.18.2 regarding where cFos, cJun 
and cFos:cJun heterodimers were pausing along λ DNA and to quantify the number of times the 
proteins paused within each AP1 and variant AP1 target sites. In this part of the study, the DNA 
substrates PCE pUC19 and PCE pUCap1 were used. All proteins were observed while in a high 
salt buffer. 
As previously mentioned, originally it was thought that pUC19 was free from AP1 target sites 
and therefore target free. However the proteins were pausing. The question that arose was 
where? By revisiting the DNA sequence, and using the single nucleotide substitutions within the 
AP1 target sequence TGACTCA by Seldeen et al (2009), 11 variant sites were found. These 
are: TGACACA, TCACTCA, TAACTCA, TGACTCT, TCACTCA, GGACTCA, TTACTCA, 
TGCCTCA, TGACTCC, TCACTCA and TGTCTCA. These findings can be seen in Figure 55.  
To find out whether cFos:cJun heterodimers bound to specific AP1 and variant AP1 target sites, 
the binding affinity (Kd) for each site was determined using ITC by Seldeen et al (2009). In this 
study, the following sites with the highest Kd were located along λ DNA (DNA substrates pUC19 
and pUCap1 could not be used to due to a very small sample size) to determine which sites had 
the greatest occupancy by cFos:cJun heterodimers. There were 19 sites in total and these 
include; TGACTCA (Kd/µM = 0.21 ± 0.01), TGACGCA (Kd/µM = 0.64 ± 0.01) and TGACACA 
(Kd/µM = 0.92 ± 0.03). The sites that had the greatest cFos:cJun occupancy were TGACGCA 
and TGACTCA. These findings can be seen in Table 11 and Figure 52. 
After the distances (bp) between more than 2 pause sites were identified and all configurations 
were calculated (as described in Chapter 2, method 2.2.19) to cover all possible distances, 
these distances were input into the Binding Site Position Finder (methods 3.2.23 and 3.2.24). 
The possibility of a protein visiting particular sites was recorded and the total percentage was 
calculated.  
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Table 14 shows cFos, cJun and cFos:cJun heterodimers that bound to variant AP1 target sites 
along PCE pUC19 DNA. cFos provided 218 distances (bp) between pause locations that in turn 
produced 5,614 binding site possibilities. This data shows that the percentages of cFos 
molecules bound to the variant AP1 target sites varied between 8.0-10.6%. The most highly 
occupied pause site was GGACTCA (highlighted green). cJun provided 686 distances (bp) 
between all pause locations and 18,314 binding site possibilities were produced. The 
percentage of cJun binding to variant AP1 target sites varied from 8.3-10.3%. Like cFos, the 
most highly occupied site was GGACTCA. cFos:cJun molecules provided 4 binding distances 
between pause locations and 114 binding site possibilities. Unlike cFos and cJun, cFos:cJun’s 
frequently visited the site TGTCTCA (highlighted green).  
Table 15 shows cFos, cJun and cFos:cJun heterodimers that bound to variant AP1 target sites 
along PCE pUCap1 DNA. cFos provided 405 distances (bp) between pause locations that in 
turn produced 12,718 binding site possibilities. The percentage of cFos molecules that bound to 
the AP1 target site was 9.1%. However, the percentage of cFos that bound to the variant AP1 
target sites varied from 8.1-8.9%. Like cFos on PCE pUC19 DNA, the most highly occupied 
variant target site was GGACTCA (highlighted green). cJun molecules provided 393 distances 
between pause locations and therefore produced 12,356 binding site possibilities. 9.1% of cJun 
bound to the AP1 target site. The remaining cJun molecules that bound to the variant AP1 
target sites varied from 7.5-9.1%. Like cFos, the most highly occupied site was GGACTCA. 
cFos:cJun heterodimers produced 159 distances that provided 4,800 binding site possibilities. 
9.8% of cFos:cJun bound to its AP1 target site. The remaining molecules that bound to the 
variant AP1 target sites varied from 7.5-9.4%. Here, like cFos and cJun, cFos:cJun’s most 
frequently visited site is GGACTCA. Overall, the most highly occupied site was AP1. 
Correlation graphs was then plotted to identify which target sites were preferred by cFos, cJun 
and cFos:cJun heterodimers (as shown in Figure 54). These graphs show the percentage of 
pausing by all of the 3 proteins at each of the target sites. The first graph (a) shows cFos (blue), 
cJun (pink) and cFos:cJun (green). cFos and cJun appear to correlate visually, however the 
cFos:cJun heterodimers only show correlation at binding sites TCACTCA (site 5), TGCCTCA 
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(site 8) and TCACTCA (site 10). The second correlation graph (b) appears to show visual 
correlation between all 3 proteins.  
As described in Chapter 2 section 3.1.3, the Binding Site Position Finder was validated using 
random numbers between 800 and 2600 (pUC19 and pUCap1 are 2686 bp and 2683 bp long, 
respectively) that were generated in Excel. These random numbers simulated the distances 
between pauses that a simulated protein took as it travelled along each of these DNA 
substrates. When the simulated protein travelled along pUC19 DNA, 36 distances were typed 
into the Binding Site Position Finder and these generated 1134 binding site possibilities. 
Similarly, when this protein travelled along pUCap1 DNA, 37 distances produced 1264 binding 
site possibilities. When this simulation is compared with cFos, cJun and cFos:cJun heterodimers 
pausing within their AP1 and variant AP1 target sites, visual correlation can be seen at positions 
2, 3, 8 and 9 on pUC19 with cFos and cJun. Visual correlation can also be seen at positions 3 
and 4 on pUCap1 with cFos, cJun and cFos:cJun heterodimers. This simulated data can be 
seen in Tables 12, 13 and Figures 53 and 55.  
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cFos:cJun heterodimers on λ DNA 
  
Start 
positions 
with error n % 
TGACGCA 1465 1 1.6 
TGACACA 2719 1 1.6 
TGACTCA 3763 0 0.0 
TGACACA 14054 0 0.0 
TGACTCA 19039 2 3.2 
TGACTCA 20016 4 6.5 
TGACGCA 20484 15 24.2 
TGACGCA 20882 16 25.8 
TGACTCA 21073 11 17.7 
TGACGCA 21976 3 4.8 
TGACTCA 22602 3 4.8 
TGACGCA 30241 1 1.6 
TGACGCA 31264 1 1.6 
TGACACA 32012 2 3.2 
TGACTCA 36480 0 0.0 
TGACTCA 41813 0 0.0 
TGACTCA 44501 1 1.6 
TGACGCA 46052 1 1.6 
TGACGCA 48311 0 0.0 
 
Table 11: Table showing the percentage of pausing within variant and AP1 target sites that cFos:cJun 
heterodimers (n = 62) occupied with high binding affinity. Column 1 shows the 19 target sites in the order 
that they appear along λ DNA. All AP1 target sites have been highlighted yellow. Column 2 shows the 
start position of each site, including the error. Column 3 shows the number of times a cFos:cJun 
heterodimer occupied each site and column 4 shows each sites occupancy as a percentage. This varied 
between 1.6-25.8%. 
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Figure 52: A graph representing the percentage of occupancy at each of the 19 high Kd variant and AP1 
target sites (shown in Table 11) by cFos:cJun heterodimers (n = 62). 
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Simulated protein on PCE pUC19 
  
Start 
positions 
with error n % 
TGACACA -47 143 12.6 
TCACTCA 479 98 8.6 
TAACTCA 488 93 8.2 
TGACTCT 625 83 7.3 
TCACTCA 670 84 7.4 
GGACTCA 1096 57 5.0 
TTACTCA 1525 90 7.9 
TGCCTCA 1564 97 8.6 
TGACTCC 1613 93 8.2 
TCACTCA 2021 146 12.9 
TGTCTCA 2450 150 13.2 
 
Simulated protein on PCE pUCap1 
  
Start 
positions 
with error n % 
TGACACA -47 107 8.5 
TGACTCA 165 107 8.5 
TCACTCA 479 100 7.9 
TAACTCA 488 101 8.0 
TGACTCT 625 94 7.4 
TCACTCA 670 91 7.2 
GGACTCA 1096 102 8.1 
TTACTCA 1525 108 8.5 
TGCCTCA 1564 113 8.9 
TGACTCC 1613 119 9.4 
TCACTCA 2021 121 9.6 
TGTCTCA 2450 101 8.0 
 
Tables 12 and 13: Tables showing the percentage of pausing within each target site as a simulated 
protein travels along pUC19 (top table) and pUCap1 (bottom table) DNA substrates. The target sites have 
been listed in column 1 as they appear along the DNA and column 2 shows the corresponding start 
position, with error, for each site. Column 3 shows the number of times a protein visited each site and 
column 4 shows the number of visits per site as a percentage. Table 11 shows the percentage of pausing 
within each target site along pUC19. This varied between 5.0-13.2%. Table 12 shows the percentage of 
pausing within each target site along pUCap1. This varied from 7.2-9.6%. 
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Figure 53: Graphs representing the percentage of pausing at each target site by a computer simulated 
protein as it travelled along DNA. (a) A computer simulated protein pausing within each of the 11 variant 
AP1 target sites as it travelled along pUC19 DNA. (b) A computer simulated protein pausing within the 
AP1 target site, located at binding position 2, and within the 11 variants AP1 target sites. The percentage 
of binding at each target site for pUC19 and pUCap1 DNA can be seen in Tables 12 and 13. 
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cFos on PCE pUC19 
P:C 
 
cJun on PCE pUC19 
P:C 
 
cFos:cJun on PCE 
pUC19 P:C 
  
Start 
positions 
with error n % 
 
n % 
 
n % 
TGACACA -47 548 9.8 
 
1717 9.4 
 
8 7.0 
TCACTCA 479 462 8.2 
 
1528 8.3 
 
5 4.4 
TAACTCA 488 464 8.3 
 
1514 8.3 
 
4 3.5 
TGACTCT 625 476 8.5 
 
1604 8.8 
 
12 10.5 
TCACTCA 670 506 9.0 
 
1692 9.2 
 
11 9.6 
GGACTCA 1096 595 10.6 
 
1892 10.3 
 
14 12.3 
TTACTCA 1525 483 8.6 
 
1602 8.7 
 
13 11.4 
TGCCTCA 1564 451 8.0 
 
1555 8.5 
 
10 8.8 
TGACTCC 1613 483 8.6 
 
1602 8.7 
 
12 10.5 
TCACTCA 2021 568 10.1 
 
1804 9.9 
 
11 9.6 
TGTCTCA 2450 578 10.3 
 
1804 9.9 
 
14 12.3 
 
Table 14: A table showing the percentage of moving cFos, cJun and cFos:cJun molecules that bound to 
the variant AP1 target sites as they travelled along PCE pUC19 DNA. Column 1 shows the variant AP1 
target sites in the order in which they appear along a piece of pUC19 DNA. Column 2 shows the starting 
position (including the 80 bp error margin) of each target site. Columns 3, 5 and 7 show the number of 
molecules that bound to each site and columns 4, 6 and 8 show this as a percentage.10.6% of cFos (n = 
52) visited the variant AP1 target site GGACTCA (highlighted green), making this the most commonly 
visited site. 10.3% of cJun (n = 75) also visited this variant AP1 target site GGACTCA (highlighted green). 
Like cFos, this was also cJun’s most popular site. 12.3% of the cFos:cJun heterodimers (n = 2)bound to 
both GGACTCA and TGTCTCA (highlighted green), therefore making these the most commonly visited 
sites.  
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cFos on PCE pUCap1 
P:C 
 
cJun on PCE pUCap1 
P:C 
 
cFos:cJun on PCE 
pUCap1 P:C 
  
Start 
positions 
with error n % 
 
n % 
 
n % 
TGACACA -47 1094 8.6 
 
1097 8.9 
 
413 8.6 
TGACTCA  165 1158 9.1 
 
1117 9.0 
 
469 9.8 
TCACTCA 479 1037 8.2 
 
1009 8.2 
 
383 8.0 
TAACTCA 488 1030 8.1 
 
1003 8.1 
 
380 7.9 
TGACTCT 625 1024 8.1 
 
1003 8.1 
 
391 8.1 
TCACTCA 670 1043 8.2 
 
1030 8.3 
 
387 8.1 
GGACTCA 1096 1138 8.9 
 
1124 9.1 
 
449 9.4 
TTACTCA 1525 991 7.8 
 
942 7.6 
 
360 7.5 
TGCCTCA 1564 1027 8.1 
 
966 7.8 
 
368 7.7 
TGACTCC 1613 985 7.7 
 
930 7.5 
 
359 7.5 
TCACTCA 2021 1078 8.5 
 
1037 8.4 
 
423 8.8 
TGTCTCA 2450 1113 8.8 
 
1098 8.9 
 
418 8.7 
 
Table 15: A table showing the percentage of moving cFos, cJun and cFos:cJun molecules that bound to 
AP1 (highlighted in yellow) and the variant AP1 target sites as they travelled along PCE pUCap1 DNA. 
Column 1 shows the AP1 and variant AP1 target sites in the order in which they appear along a piece of 
pUCap1 DNA. Column 2 shows the starting position (including the 80 bp error margin) of each target site. 
Columns 3, 5 and 7 show the number of molecules that bound to each site and columns 4, 6 and 8 show 
this as a percentage. Panel A) 9.1% of cFos (n = 52) bound to their AP1 target site. 8.1-8.6% of cFos 
bound to the variant AP1 target sites. The most popular variant AP1 target site is GGACTCA (highlighted 
green). Panel B) 9.0% cJun (n = 46) bound directly to their AP1 target site. 7.5-9.1% cJun also bound to 
variant AP1 target sites. Like cFos, cJun have the same popular AP1 variant target site GGACTCA. Panel 
C) 9.8% cFos:cJun heterodimers (n = 14) bound to their AP1 target site. 7.5-9.4% bound to the variant 
AP1 target sites. CFos:cJun heterodimers also share the same popular variant AP1 target site GGACTCA 
with cFos and cJun. 
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Figure 54: These graphs show the correlation between the percentage of cFos, cJun and cFos:cJun 
heterodimeric moving molecules that paused within their target sites while travelling along PCE pUC19 
and PCE pUCap1 DNA substrates. (a) cFos (n = 52) and cJun (n = 75) molecules appear to visually 
correlate. However cFos:cJun heterodimers (n = 2) do not follow the same correlation pattern.( b) cFos (n 
= 52), cJun (n = 46) and cFos:cJun heterodimers (n = 14) appear to visually correlate. 
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Figure 55: Graphs showing the percentage of pausing at each site by cFos, cJun, cFos:cJun 
heterodimers and the simulated protein on PCE pUC19 and pUCap1 DNA to observe any correlation. (a) 
Visually, correlation appears to occur at positions 2, 3, 8 and 9 between the simulated protein and cFos, 
cJun and cFos:cJun heterodimers. (b) Apparent visual correlation between the proteins and the simulated 
protein can be seen at positions 3 and 4. 
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3.4: Discussion 
3.4.1: Protein movement along pUC19, pUCap1 and TFλ 
pUC19 was the first DNA substrate used to form tightropes as it did not contain any AP1 target 
sites and was therefore believed to be target free. As pUC19 is only 2686 bp long, the DNA was 
tandemised using T4 DNA Ligase, enabling tightropes to be created matching the length of λ 
DNA or longer. This DNA substrate was used to understand how proteins would interact with 
DNA when their AP1 target sites were not present.  
The DNA substrate pUCap1 was also studied in parallel with pUC19 DNA. This is a variation of 
pUC19 whereby a single AP1 target site was introduced at position 417 within the plasmid 
pUC19. This DNA was constructed to understand whether a single AP1 target site located every 
2683 bp (length of pUCap1) would affect protein interaction with the DNA and whether the 
proteins would pause at this specific site only.  
The first protein used in this study was cJun as it was the most diffusive protein out of all of the 
complexes (as shown in Chapter 2, section 3.1.1). 242 cJun proteins were observed bound to 
pUC19 tightropes and 54% were seen moving. This percentage of mobility is 17% less (t-test p-
value = 0.06) than when this protein travelled along λ DNA. Although this is not a statiscially 
significant result, it shows a trend between the percentage of cJun diffusing along pUC19 and λ 
DNA. In a parallel study, 161 cJun proteins were also observed bound to pUCap1 DNA and 
46% (t-test p-value = 0.72) were seen moving. Like cJun on pUC19, this was also an 
unexpected finding as the percentage of moving cJun along pUCap1 DNA was now similar to 
cFos (t-test p-value = 0.72) as it moved along λ DNA.  
There are two main hypotheses that could explain pausing in the absence of specific sites. 
Firstly, it may be possible that T4 DNA Ligase was inhibiting protein movement by acting as an 
obstacle. Secondly, pUC19 and pUCap1 have regions of target free DNA that vary between 9 
bp and 526 bp long. When compared with λ DNA where the longest non-specific region is 3216 
bp, these regions are much smaller resulting in the proteins having less non-cognate DNA to 
search for their target sites and may pause within regions where they have high affinity. 
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To determine whether T4 DNA Ligase was inhibiting cJun from travelling along pUC19 and 
pUCap1 DNA, 1 µM ATP was added to the high salt buffer to remove the Ligase from the DNA. 
37% of cJun travelled along pUC19 DNA and 42% (t-test p-value = 0.82) travelled along 
pUCap1 DNA. Although these results are not statistically significant when compared, they do 
show that cJun is less diffusive. This suggests that T4 DNA Ligase is preventing the protein 
from moving. Adding ATP to the imaging buffer aimed to prevent the T4 DNA Ligase from 
binding to the DNA. However instead, ATP may have been evoking T4 DNA Ligase to 
deadenylate, causing it to form a stable enzyme-DNA complex and stall rather than remaining in 
solution (Rossi et al. 1997). 
PCE and DNA precipitation was used to completely remove the enzyme from the DNA (Palmiter 
1974). This meant that the DNA would be free from obstacles and cJun could move freely. 58% 
(t-test p-value = 0.55) of cJun now moved on pUC19 and 52% (t-test p-value = 0.54) moved on 
pUCap1 when compared with the 71% of cJun that travelled along λ DNA. These differences 
are not statistically significant. This indicates that pUC19 and pUCap1 DNA substrates may 
contain non-specific regions that cJun has a higher affinity for in addition to the known AP1 and 
variant AP1 target sites. This may account for why there is less movement when compared with 
cJundiffusing along λ DNA.  
cFos was also loaded onto pUC19 and pUCap1 DNA that was free from T4 DNA Ligase. 49% 
and 55% of cFos (t-test p-value = 0.56) travelled along pUC19 and pUCap1 DNA, respectively. 
Despite the limited sample size, no significant difference could be seen when cFos moved along 
these DNA substrates. There is little variation between cFos moving on pUC19 (t-test p-value = 
0.35) and pUCap1 (t-test p-value = 0.20) when compared with the percentage of movement 
along λ DNA. These comparisons show no statistical significance. To understand how cFos is 
capable of homodimerising, structural studies such as computational analysis will need to be 
performed. This involves studying the coiled coil structure, and alternative structures generated 
by algebraic parameters, to explore the significance of conformational specificity and any 
physiological changes upon binding (Kortemme and Baker 2004). Another structural study that 
could be performed involves using x-ray crystallography to understand how the protein binds to 
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and interacts with DNA (Rohs et al. 2010). 47% and 32% (t-test p-value = 0.13) of cFos:cJun 
heterodimers were observed moving along PCE pUC19 and pUCap1 DNA, respectively.  
3.4.2: Protein colocalisation 
Colocalisation studies, were performed to quantify the amount of cFos:cJun heterodimeric 
complexes. As described in Chapter 2, red labelled cFos was mixed with green labelled cJun. 
This produced 3 differently coloured complexes: red cFos, green cJun and dual coloured 
cFos:cJun heterodimers. 41% colocalisation was observed between cFos with cJun on both 
pUC19 (t-test p-value = 0.54) and pUCap1 (t-test p-value = 0.18) DNA substrates. This is a 9% 
increase when compared to colocalised cFos:cJun heterodimers that were observed bound to λ 
DNA. This data indicates that partner swapping may be taking place within the AP1 family 
(Turner 1989). Prior to visualisation using OAF microscopy in this study, previous studies using 
EMSAs have shown that partner swapping is capable within the AP1 family due to the protein 
complexes that had bound to DNA (Hellman and Fried 2007), however, how this occurs is yet to 
be understood. 
3.4.3: Movement along DNA 
To understand how cFos, cJun and cFos:cJun heterodimers move along both pUC19 and 
pUCap1 DNA substrates in search of their AP1 target sites, their diffusion constants and α 
values were determined. While travelling along PCE pUC19 DNA, cFos and cJun had diffusion 
constants of 1.5x10-3 µm2s-1 and 2.6x10-3 µm2s-1, meaning that both proteins could diffuse along 
these different DNA substrates. The corresponding α values for cFos and cJun were both 0.9. 
These α values indicate that cFos and cJun are both randomly diffusing along the DNA in 
search of their AP1 target sites while potentially using anomalous sub-diffusion since their 
values are <1 (Saxton 1997). When cFos and cJun diffused along PCE pUCap1, their diffusion 
constants were 1.9x10-3 µm2s-1 and 2.4x10-3 µm2s-1, respectively. Like pUC19 DNA, cJun (t-test 
p-value = 0.54) is more mobile on pUCap1 DNA in comparison to cFos. This may be due to the 
stable core Leucine residues inside of the cJun dimerisation region (Wagner 2001). The 
corresponding α values for cFos and cJun were 0.9 and 1.0, respectively. These values are also 
<1 indicating that when the proteins are on pUCap1, also randomly diffuse. Therefore, as 
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described in Chapter 2, the proteins may be using 3-Dimensional and 1-Dimensional searching 
mechanisms (Kampmann 2004, Gorman and Greene 2008) to locate their AP1 target sites 
along the DNA.  
3.4.4: Pausing along the DNA 
There are no AP1 target sites present along pUC19 DNA, however cJun were observed 
pausing. Based on the study by Seldeen et al (2009) who made single nucleotide substitutions 
throughout the AP1 sequence (as described in sections 2.1, 2.2.6.2 and 2.3.3), pUC19 and 
pUCap1 DNA sequences was checked for the presence of these variant AP1 target sites. Along 
both DNA substrates, there were 11 variant AP1 target sites. 
As cFos, cJun and cFos:cJun heterodimers diffused along PCE pUC19 and pUCap1 DNA 
substrates, they were observed to pause. Similarly, as described in Chapter 2, the binding site 
position finder was used to determine whether the proteins were pausing non-specifically, within 
an AP1 target site (with the exception of pUC19 DNA) or within the 11 variant AP1 target sites.  
The percentage of cFos and cJun that bound to the variant AP1 target sites located along PCE 
pUC19 DNA varied from 8.1-8.9% and 8.3-10.3% respectively. cFos:cJun heterodimers binding 
to the variant AP1 target sites varied from 7.5-9.4% favouring TGTCTCA. The percentage of 
cFos, cJun and cFos:cJun heterodimers that bound to their AP1 target sites located on PCE 
pUCap1 DNA were 9.1%, 9.1% and 9.8% respectively. The percentage of cFos, cJun and 
cFos:cJun heterodimers that bound to the variant AP1 target sites varied from 8.1-8.9%, 7.5-
9.1% and 7.5-9.4%. These results show little variation in the percentage of pausing within their 
variant AP1 or AP1 target sites while diffusing along pUC19 and pUCap1 DNA substrates.  
These results support the “waiting room model”, as described in section 1.8 and Figure 9, a 
mechanistic approach whereby the variant AP1 target sites may be used by the proteins to 
control transcription. How this occurs is currently unknown, however protein-DNA interaction 
studies such as EMSAs (Hellman and Fried 2007), Filter binding assays (Rio 2012), x-ray 
crystallography (Rohs et al. 2010) and computational analysis (Kortemme and Baker 2004) 
could be performed to understand how this occurs.  
 
179 
 
The final DNA substrate engineered was TFλ. This was created to understand how cJun 
interacted with DNA that was completely AP1 and variant AP1 target site free. Only 2 cJun 
proteins were observed to diffuse out of the 79 that were observed bound to this DNA moved. 
This result was unexpected as it contradicts 1-Dimensional mechanistic theories suggesting that 
a protein will search the DNA for its intended target site (Wang et al. 2006, Li et al. 2009). To 
ensure that cJun had not degraded, the same batch of proteins was loaded onto λ DNA as 
previously 71% were moving (as described in Chapter 2). The protein was observed diffusing 
along λ DNA which showed that cJun had not degraded. This result therefore suggests that 
cJun does have high affinity binding sites on TFλ as multiple bound proteins were observed. 
As cJun was observed bound to the DNA, this suggests that the protein does have an affinity for 
the target free substrate. Based on studies regarding 3-Dimensional DNA searching methods 
(Gorski et al. 2006, Li et al. 2009, Mirny et al. 2009b), it may be possible that cJun used 3-
Dimensional searching to locate high affinity areas along the DNA.  Once bound, why cJun was 
predominately static currently remains unknown, especially as this protein was the most 
diffusive out of all the complexes used throughout this study. To my knowledge, there is no 
evidence in the literature about how AP1 proteins bind and diffuse along non-cognate areas of 
DNA.  
Therefore, to understand whether a lack of AP1 and variant AP1 target sites could be 
contributing towards cJun becoming static when bound to non-cognate areas of DNA, in the 
future a single AP1 target site could be cloned into TFλ. This future study may assist with 
determining whether this target site does promote protein movement along the DNA. 
 
3.4.5: Conclusion 
The results in this chapter have shown that cFos, cJun and cFos:cJun heterodimers are able to 
bind onto different DNA substrates in addition to λ DNA (as mentioned in Chapter 2) and 
approximately half of the observed protein population moved. However, in contrast, cJun 
became predominately static when observed bound to TFλ. This may be due to the DNA having 
a lack of AP1 and variant AP1 target sites. Why this occurs may be due to evolution, whereby 
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point mutations, deletions and substitutions within the DNA binding domains of these 
transcription factors results in a high affinity towards their AP1 target sites or any site that has a 
similar sequence. Although the leucine zipper remains conserved, the DNA binding domain is 
synonymous (Mechta-Grigoriou et al. 2001). This may occur through positive selection, 
improving the efficiency of the protein selecting specific binding sites (Pál et al. 2006). To 
understand why, future studies could be performed such as inserting an AP1 target site into TFλ 
to determine whether more protein movement will occur. In addition, studies can be performed 
to understand which areas of non-specific DNA cFos, cJun and cFos:cJun heterodimers have a 
high affinity for and whether this also promotes protein movement. 
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Chapter 4: Final conclusions 
Since the discovery of cancer, medical treatments have evolved and the first known treatment to 
arrest cellular growth was cytotoxic nitrogen mustard during World War II (Ewig and Kohn 
1977). This became the first chemotherapeutic agent. Now, modern day medicine has evolved 
whereby chemotherapy and radiotherapy have been developed to try and preserve human life 
by attempting to eradicate cancer.  
Since the discovery of the AP1 family of transcription factors (Bohmann et al. 1987, Vinson et al. 
1993), it has been important to understand their role in tumorigenesis (Zhang et al. 2007, 
Latchman 1995). It has been well documented in cancer research that when in excess, cFos 
causes osteosarcomas and cJun causes hepatocellular carcinoma and squamous cell 
carcinoma (Eferl and Wagner 2003, Shaulian and Karin 2001, Wang et al. 1995, Zhang et al. 
2006).  
Understanding the mechanisms used by cFos and cJun as they interact with themselves and 
the DNA is vital for the development of site specific pharmaceutical agents. The antagonistic 
peptide inhibitor FosW was designed to interact with cJun (Mason et al. 2007a, Mason et al. 
2006). In the future, FosW can potentially lead to a pharmaceutical agent that could reduce the 
excess quantities of cJun and hopefully free patients of hepatocellular carcinoma and 
squamous cell carcinoma. 
In this thesis, Chapter 2 aimed to identify how cJun, cFos:cJun heterodimers and FosW+cJun 
interacted with λ DNA and each other in real time. In addition, whether cFos could form protein-
DNA complexes and diffuse was also explored. Table 3 has shown the percentage of diffusion 
by each of the protein complexes as they search the DNA for target sites. cFos, cJun, 
cFos:cJun heterodimers, FosW and Fos+cJun diffused 45%, 71%, 39%, 55% and 39%, 
respectively. As the proteins searched the DNA, the diffusion constants for cFos, cJun and 
FosW were 3.4x10-3 µm2s-1, 8x10-4 µm2s-1 and 1.2x10-2 µm2s-1, respectively. These complexes 
also used anomalous sub-diffusion due to α values being <1. This data can be seen in Figure 
28. Upon loading the proteins onto the DNA tightropes, evidence of colocalisation and partner 
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swapping (shown in Table 4) was observed on the DNA. cFos, cJun, cFos:cJun heterodimers 
and FosW+cJun showed 27%, 27%, 32% and 25% colocalisation, respectively.  
The final part of Chapter 2 looked at whether cFos, cJun and cFos:cJun heterodimers on 
paused within their AP1 target sites where they are known to exert their biological function. 
Tables 6, 7 and 8 show that the proteins not only paused within their AP1 target sites, they also 
paused within variant AP1 target sites as well. This data shows that each site had ~2% 
occupancy. All of the aims itemised in this chapter were achieved. 
Chapter 3 expanded on the aims mentioned in Chapter 2 by observing how cFos, cJun and 
cFos:cJun heterodimers interacted with different DNA substrates. These included; AP1 target 
site free pUC19, pUCap1, a variation of pUC19 incorporating a single AP1 target site, and AP1 
and variant AP1 target site free TFλ DNA. Partner swapping was also determined on pUC19 
and pUCap1 DNA. Firstly, Table 9 showed that 49% cFos, 58% cJun and 47% cFos:cJun 
heterodimers diffused along PCE pUC19. 55% cFos, 52% cJun and 32% cFos:cJun 
heterodimers also diffused along PCE pUCap1 DNA.  Secondly, as cFos and cJun diffused 
along PCE pUC19 DNA in search of target sites, their diffusion constants were 1.5 x 10-3 µm2s-1 
and 2.6 x 10-3 µm2s-1. When cFos and cJun searched PCE pUCap1 DNA for target sites, their 
diffusion constants were 1.96 x 10-3 µm2s-1 and 2.46 x 10-3 µm2s-1. When searching both pUC19 
and pUCap1 DNA, cFos and cJun used anomalous sub-diffusion due to α values being <1 
(shown in Figures 48 and 49).  
To determine whether cFos and cJun were able to heterodimerise on pUC19 and pUCap1 DNA 
substrates, the proteins were loaded onto each DNA type. 41% colocalisation was observed on 
both PCE pUC19 and PCE pUCap1. This data is shown in Table 10. 
The next part of this chapter was to observe how cJun interacted with TFλ. Only 3% of 
molecules diffused which was unexpected since this DNA substrate is completely AP1 and 
variant AP1 target site free. Why this occurs is currently unknown and to my knowledge, there is 
no evidence in the literature suggesting why this may occur when the protein stall on non-
cognate DNA. Therefore in the future, an AP1 target site could be cloned into TFλ to determine 
whether AP1 and variant AP1 target sites do promote protein movement. 
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The final part of this chapter identified the percentage of cFos, cJun and cFos:cJun 
heterodimers that occupied each AP1 and variant AP1 target site located along pUC19 and 
pUCap1. This data showed that each pUC19 target site was ~12% occupied and ~10% of each 
site located along pUCap1 DNA also showed occupancy. This data is shown in Tables 14 and 
15. All of the aims within this chapter have been achieved, however further work will need to be 
performed on cJun forming a protein-DNA complex with TFλ as described above. 
The data shown in Chapters 2 and 3 regarding the binding position of cFos, cJun and 
cFos:cJun heterodimers along each DNA substrate appears to support the “waiting room” 
model. However, future studies should be performed to support this model such as Filter 
Binding Assays. Instead of using an oligonucleotide containing a single AP1 target site, each 
short section of DNA should contain each variant AP1 target sites. cFos, cJun and cFos:cJun 
protein complexes should interact with each oligonucleotide variation during EMSA studies.  
Therefore, within this final chapter, the major conclusions drawn from this study will be 
discussed and any work that could be performed in the future to enhance this study and its 
findings will also be discussed. 
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4.1: Major conclusions from this thesis 
This study has shown that cJun can bind to λ DNA and diffuse along it, homodimerise or 
heterodimerise with cFos, as suggested in the literature (Landschulz et al. 1988, Hai and Curran 
1991, Ito et al. 2001). Dimerisation was observed by performing dual coloured colocalisation 
studies. Surprisingly, cFos is capable of binding to the DNA and diffusing along it, albeit more 
slowly than cJun, and homodimerising with itself. This was a previously unseen observation in 
earlier in vitro studies such as EMSAs as cFos was found to be less stable in comparison to 
cJun and cFos:cJun heterodimers while showing no homoassociation (Porte et al. 1995). This 
lack of association may have occurred due to the forces experienced by unstable cFos 
molecules as they travel through the gel matrix (Orchard and May 1993). However, a recent 
study by Szalóki et al (2015) used Fӧrster resonance energy transfer (FRET) on live HeLa cells 
containing cFos and showed that cFos is capable of homodimerising (Szalóki et al. 2015). This 
recent evidence suggests that cFos is capable of binding to chromatin and may possibly act as 
a transcriptional regulator, especially when over-expressed during oncogenesis (Szalóki et al. 
2015). 
When the biological peptide inhibitor FosW, a modified version of cFos, was loaded onto the 
DNA, 25% colocalisation was observed between itself and its intended target cJun. This shows 
that FosW is able to heterodimerise with its intended target cJun for which it has a high affinity, 
more so than cJun has for itself, therefore confirming the original hypothesis. Upon binding, 
FosW renders cJun inactive as static complexes were seen. It was also found that FosW 
diffuses along the DNA in search of its intended target slower than cJun itself.  
Traditionally FosW does not contain a DNA binding domain. However, for the purpose of this 
study a cJun DNA binding domain was cloned into FosW. This enabled any interaction with 
cJun to be visualised. Unlike wild-type cFos:cJun heterodimers that has a melting temperature 
(Tm) 16 °C, FosW+cJun has a Tm 63 °C, indicating that this complex has high stability, specificity 
and a low dissociation constant (Kd) in comparison to wild-type cFos:cJun heterodimers; this 
has been previously determined by Circular Dichroism (Mason et al. 2006). This high stability 
and specificity that FosW has for cJun may be due to to the optimised core packing, 
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electrostatic interactions and natural tendency to form an α-helical structure due to residues 
within the dimerisation domains a positions (See Figure 3) being substituted with Leucine and 
Isoleucine (Mason et al. 2006) and may contribute towards slower 1-Dimensional diffusion. 
While diffusing along the DNA in search of their AP1 target sites, cFos, cJun and cFos:cJun 
heterodimers were observed to pause within variant AP1 target sites in addition to AP1 binding 
sites. By incorporating a standard error margin of 80 bp either side of each AP1 and variant AP1 
target site, the Binding Site Position Finder determined whether the distance between pause 
sites, as a protein diffused along the DNA, corresponded to binding into AP1 or variant AP1 
target sites. There was little difference in the percentage of pausing within AP1 and the variant 
AP1 target sites. This suggests a “waiting room model” where the proteins may travel in and out 
of the variant AP1 target sites until an AP1 target site becomes free so that they can exert their 
biological function. This may be a way of controlling transcription.  
To understand how the proteins interacted with different DNA substrates, pUC19, pUCap1 and 
TFλ DNA templates were used. The DNA substrate pUC19 is canonical AP1 binding site free, 
however it does contain 11 variant AP1 target sites. The proteins were observed to pause on 
this template. A similar observation was seen when the proteins were loaded onto pUCap1. This 
data is in keeping with the “waiting room model” as the proteins were non-specifically pausing in 
the variant AP1 target sites regardless of whether an AP1 target site was present or not. 
When cJun was loaded onto TFλ DNA, the majority of the proteins were static despite the fact 
that on λ the same protein preparation on the same day was seen diffusing. Why this occurs is 
currently unknown and to my knowledge, there is no evidence in the literature suggesting why 
this may happen. Therefore, to determine whether the target sites may be contributing towards 
protein movement, a single AP1 target site could be cloned into TFλ DNA.  
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4.2: Future work 
This study has been able to answer some questions but at the same time has raised even 
more. Throughout the different sections of this thesis, these questions have been outlined and 
methods have been suggested to try to answer them. Therefore, this final section of the thesis 
aims to propose ideas that may be performed in the future to advance this study. 
In Chapter 2 it was highlighted that cFos is capable of homodimerising and this was confirmed 
by dual labelling studies. These dual labelling studies also confirmed the formation of cJun 
homodimers and cFos:cJun heterodimers. Partner swapping within the AP1 family clearly 
occurs, although how each protein selects its intended partner is currently unknown. To gain an 
insight into how the proteins partner swap, the binding affinity of each protein could be 
determined using Fluorescence Correlation Spectroscopy (FCS). This technique uses a 
confocal microscope to image fluorescently labelled molecules by focusing the laser right down 
to the optical resolution limit. A solution volume well below micromolar range becomes confined 
(Bacia and Schwille 2007). Any fluorescence emitted from the molecules as they pass through 
this tiny space enables their physics parameters to be determined. These parameters include; 
molecule concentrations; mobility; rate constants; interactions and dynamics of the molecules. 
Any intensity in fluorescence is due to the molecules fluctuating as they diffuse through the 
detection volume. Using an extension of FCS such as dual FCS allows two corresponding 
binding partners to be cross-correlated, enabling the physics parameters between partners to 
be determined. The proteins binding affinity can be calculated based on the increased 
fluorescence (Ries and Schwille 2012).  
The use of dual FCS in relation to partner swapping within the AP1 family will prove a useful 
imaging tool. This will give an insight into the rate of reaction and the dynamics behind how 
these proteins interchange partners. 
  
Chapters 2 and 3 show that as cFos, cJun and cFos:cJun heterodimers searched the DNA, they 
paused within AP1 and variant AP1 target sites. As previously described, the “waiting room 
model” may provide one explanation as to why these proteins pause in these variant sites in 
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addition to AP1. This scenario suggests that the proteins may intermittently bind and pause at 
these variant sites. The proteins leave these variant sites when an AP1 target site becomes 
available so that they can exert their biological function. To understand the interaction between 
a protein with DNA, computational biology studies using bio-modelling could be performed. This 
approach could help to identify whether the dimers undergo any conformational changes upon 
binding to each of the target sites (Kortemme and Baker 2004).This may shed light on which 
sites are preferred by the proteins and may help support the “waiting room model.” X-ray 
crystallography  could also be performed to identify the protein-DNA structure (Leonard et al. 
1997) upon binding to each variant AP1 target site as single molecule studies are unable to do 
this. 
It was hypothesised in Chapter 3 that cJun would continuously search non-cognate regions of 
DNA for AP1 target sites. To test this hypothesis, the DNA substrate TFλ was created and used. 
cJun bound to the DNA, however minimal movement was observed. One study that could be 
performed is to clone a single AP1 target site into TFλ to see whether cJun will use 1-
Dimensional diffusion. 
 The antagonistic peptide inhibitor FosW still has scope for future experiments to be performed. 
In this study, 39% colocalisation between FosW and its target cJun was observed when bound 
to the DNA. In the future, the ratio of the inhibitor FosW to cJun would have to be optimised in 
relation the amount of over-expressed cJun and the progression of hepatocellular carcinoma 
and squamous cell carcinoma. In addition, this study only looked at FosW and cJun together on 
DNA tightropes. Whether FosW is capable of locating and binding to cJun when cFos is present 
could be studied using triple colour experiments, an enhanced version of the method used in 
this study to visualise colocalised complexes in dual colour. Imaging in triple colour would 
involve fluorescently labelling each protein and FosW with a different coloured Qdot (as 
described in method 2.2.9), loading the proteins and inhibitor onto the DNA tightropes and 
imaging using OAF (described in method 2.2.11). All coloured complexes could be identified 
and quantified. This method could determine whether FosW can disrupt cFos:cJun 
heterodimers as well as cJun homodimers. 
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